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Title – Notch signaling, genital cellular remodeling and reproductive function 
 
 
Abstract: The objective of this thesis is to evaluate the association between Notch signaling, 
genital cellular remodeling and reproductive function, in the mouse model.  Five experimental 
chapters are included in this thesis. In experiments 1 and 2, we evaluated transcription and 
expression patterns of Notch component and effector genes in testis post-natal development, 
along the spermatogenic cycle and the epididymis. In experiment 3, we evaluated the male 
reproductive phenotype of in vivo Notch blockade by DAPT. In experiments 4 and 5 we 
evaluated transcription and expression patterns of Notch component and effector genes in 
the ovary, oviduct and uterus along the estrous cycle.  
Results indicate that Notch signaling is active and associated to male and female genital 
cellular remodeling. In the male, results prompt for a regulatory role of Notch signaling in 
spermatogonia pool maintenance, onset of spermatogenesis, in the pace of the 
spermatogenic cycle, germ cell identity, and epididymis spermatozoa maturation. In the 
female, results prompt for a regulatory role in ovarian follicle and corpus luteum 
development, and oviduct and uterus epithelial cell turnover and function. Notch signaling is 
operating in the testis and ovarian cellular interstitium, and in luminal and glandular epithelia 























Resumo : Esta tese avalia a relação entre a via de sinalização Notch, o remodelação celular 
genital e a função reprodutiva, sendo constituída por cinco capítulo experimentais. Nos dois 
primeiros, avaliamos o padrão de transcrição e expressão dos componentes e efectores da 
via Notch no desenvolvimento testicular pós-natal, ao longo do ciclo espermático e no 
epidídimo. Na experiência 3, avaliamos o fenótipo reprodutivo masculino decorrente do 
bloqueio in vivo da via Notch por DAPT. Nas experiências 4 e 5 analisamos o padrão de 
transcrição e de expressão dos componentes e efectores da via Notch no ovário, oviduto e 
no útero ao longo do ciclo éstrico. 
Os resultados indicam que a via Notch está activa e associada à remodelação genital 
masculino e feminino. No macho, os resultados apontam-lhe um papel regulador na 
manutenção do pool de espermatogónias, no início da espermatogénese, na coordenação 
do ciclo espermático, na identidade celular germinal, e na maturação espermática. Na 
fêmea, os resultados apontam para um papel regulador no desenvolvimento folicular e do 
corpo lúteo, e na função e ciclicidade do oviduto e útero. A via Notch opera no interstício 
celular do testículo e do ovário, e no epitélio luminal e glandular do tracto reprodutivo, 
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“In a world that needs vigorous control of population growth, concerns about 
infertility may seem odd, but the adoption of a small family norm makes the issue 
of involuntary infertility more pressing.” 
Mahmoud Fathalla,  
Former Director of the WHO HRP 
(Bull World Health Organ, 2010; 88:881–882) 
 
Reproductive biology gathers increasing interest both in human and animal health. This is 
driven by the economic and social problems associated with reproductive control. Infertility is 
a huge concern throughout the world, both in humans and farm animals (Johnson & Gentry, 
2000; Mascarenhas, Flaxman, Boerma, Vanderpoel, & Stevens, 2012). New strategies to 
prevent and control infertility are great demands of modern societies (van der Poel, 2012). 
On the other hand, control of human and animal overpopulation by means of contraception is 
also a present big issue. Further knowledge inside the complex regulation of reproductive 
biology would allow the development of new therapies, with less secondary effects, more 
controllable and easy to use, that ultimately would increase both the user’s compliance and 
the global final effect in the population. 
During the last century, mammalian reproductive function has been intensively studied and 
major aspects of endocrine regulation of histological/cytological events are well known. 
However, the molecular mechanisms underneath reproductive function are still poorly 
understood. The intercellular relations and communication are of great importance in 
morphogenetic events, such as those occurring in reproduction. Apart from the endocrine 
control, reproductive events are also regulated by paracrine intercellular signaling, which 
controls cellular proliferation, apoptosis, differentiation, secretory functions and others. Many 
of these cellular regulatory mechanisms have not been completely described and several of 
their aspects are entirely unknown. The gene pathways involved in the control of the highly 
complex cellular remodeling associated with reproductive function are poorly understood. 
Deciphering these mechanisms could potentially lead to the development of new therapeutic 
strategies addressed to male and female infertility and contraception. 
Notch is an evolutionarily well-conserved cell signaling pathway that has been implicated in 
cell fate decisions in several tissues (Artavanis-Tsakonas, Matsuno, & Fortini, 1995; 
Borggrefe & Oswald, 2009). The research work presented in this thesis aimed to analyze the 
Notch pathway enrolment in male and female reproductive function, using the mouse model. 
In the male, the transcription and expression patterns of Notch pathway components and 
effectors were evaluated during male gonad post-natal (pn) development and along adult 
2 
 
spermatogenesis and spermatozoa maturation along the epididymis. Additionally, Notch 
pathway blockade during adult spermatogenesis and sperm maturation was accessed 
through the use of a γ-secretase inhibitor. In the female, the transcription and expression 
patterns of Notch pathway components and effectors were analyzed in the reproductive tract 
(ovary, oviduct and uterus) along the estrous cycle (EC), and associated to key cellular 
events of follicle and corpus luteum (CL) development.  
The above studies were converted into five manuscripts, submitted for publication in 
international journals, and constitute the five chapters of the experimental work include in this 
thesis, as follows: 
 
1. Dynamics of Notch pathway expression during mouse testis post-natal 
development and along the spermatogenic cycle 
Murta, D., Batista, M., Silva, E., Trindade, A., Henrique, D., Duarte, A., Lopes da Costa, L. 
(2013). Plos One, 8 (8).  
 
2. Notch pathway gene components and effectors are differentially transcribed and 
expressed along the epididymis epithelium. 
Murta, D., Batista, M., Silva, E., Trindade, A., Henrique, D., Duarte, A., Lopes da Costa, L. 
Submitted to Molecular Reproduction and Development 
 
3. In vivo Notch blockade induces male germ cell fate aberrations and apoptosis, and 
increases spermatozoa defects. 
Murta, D., Batista, M., Trindade, A., Silva, E., Henrique, D., Duarte, A., Lopes da Costa, L. 
Submitted to Fertility & Sterility 
 
4. Differential expression of Notch component and effector genes during ovarian 
follicle and corpus luteum development along the estrous cycle 
Murta, D., Batista, M., Silva, E., Trindade, A., Mateus L., Duarte, A., Lopes-da-Costa L. 
Submitted to Reproduction Fertility and Development 
 
5. Dynamics of Notch signaling in the oviduct and uterus along the mouse estrous 
cycle 
Murta, D., Batista, M., Trindade, A., Silva, E., Mateus L., Duarte, A., Lopes da Costa, L. 






1. Mammalian reproduction 
“If you press a piece of underwear soiled with sweat together with some wheat in 
an open jar, after about 21 days the odor changes and the ferment, coming out of 
the underwear and penetrating the husks of wheat changes the wheat into 
mice… But what is remarkable is the mice of both sexes emerge, and these mice 
successfully reproduce with mice born naturally from parents…But what is even 
more remarkable is that the mice which come out of the wheat and underwear 
are not small mice, not even miniature adults or aborted mice, but adult mice 
emerge!” 
Jean Baptiste Van Helmont (1577–1644) 
 
Individuals are transient and a population transcends finite life spans only by reproduction, 
the creation of new individuals from existing ones. Our knowledge on reproductive biology 
has evolved exponentially during the last century. Presently, the great focus is on how to 
control reproductive function.  
Although, in the animal kingdom both asexual and sexual reproduction occurs, in the case of 
mammals, there is the need of the fusion of oocyte and sperm, and so the fusion of different 
pools of genes, to generate new life. This way, sexual reproduction increases genetic 
variability among offspring by generating unique combinations of genes inherited from two 
parents.  
In sexual reproduction the creation of offspring results from the fusion of haploid (1n) 
gametes, which then form a diploid (2n) zygote. Mammalian gametes arise by meiosis. The 
female gamete, the oocyte, is a large immotile cell, whereas the male gamete, the sperm, is 
a much smaller and motile cell. In the male, spermatozoa develop in the testis, whereas in 
the female, oocytes develop in the ovary. During mating, sperm are ejaculated in the female 
reproductive tract. Fertilization depends on mechanisms that help sperm to meet the oocyte.  
The male gonads, the testes, consist of highly coiled tubules, the seminiferous tubules, 
interspersed by interstitial tissue and surrounded by several layers of connective tissue. 
Leydig cells are scattered in interstitial tissue and secrete testosterone and other androgens. 
Following release in the seminiferous tubules, spermatozoa pass along the coiled tubules of 
the epididymis. During this passage, spermatozoa become motile and gain the ability to 
fertilize. At ejaculation, spermatozoa are propelled through the duct deferens, ending, in case 
of a successful copulation, in the female reproductive tract. 
The female gonads, the ovaries, contain many follicles. Each follicle consists of one oocyte 
surrounded by one or more layers of granulosa cells, which nourish and protect the 
developing oocyte. However, throughout life, only a small portion of these oocytes will 
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develop and ovulate. The granulosa cells are also enrolled in producing female sex steroids, 
the estrogens (E2). Nevertheless, after ovulation, the remaining granulosa cells grow within 
the ovary to form the CL. This cyclic transient endocrine gland main function is to secrete 
progesterone (P4), which plays a central role on the regulation of the EC and on pregnancy 
establishment and maintenance. 
 
2. The mouse as an experimental model 
The relationship between mice and men has always been close and essentially difficult. Mice 
has long been a problem to man. In huge numbers, mice can extensively destroy crops and 
become a great economical and nutritional problem for human populations. As a pest, mouse 
is also a great problem, as a vector of several diseases. However, mice also became of 
human interest, probably first as a pet, and then as a research model. It was the setting of an 
inbred strain by Clarence Cook Little (Staats, 1966) that launched mice as a tool for the 
understanding of the biology and genetics of ourselves. This led the way to the establishment 
of defined strains with diverse but repeatable genotypes for biomedical study. 
The beginning of mice era in research started when Mendel’s work was rediscovered, and 
Lucien Cuénot decided to evaluate whether Mendel’s laws applied to animals as well 
(Cuénot, 1902). Soon after, it was found that tumors transplanted into mice only continued 
development in the host in some strains, but not in others, and, in 1909, it was reported that 
at least part of the basis for tumor rejection was heritable (Tyzzer, 1909). This work was 
continued, and in 1916 it was published “a Mendelian explanation of rejection and 
susceptibility” (Little & Tyzzer, 1916). These studies convinced Clarence Cook Little that a 
genetically uniform stock of mice was required to further understanding the genetics of 
cancer susceptibility. With this goal in mind, he began mice crosses that led to the 
development of the first inbred strain, DBA.  
With large mouse populations under observation, it was soon recognized that the mouse had 
similar (sometimes nearly identical) diseases to humans and that it could provide a powerful 
basis for a practical understanding of the human medical condition. Furthermore, the mouse 
is small, breeds quickly, and is easily and economically maintained.  
Since the beginning of the twenty century, the mice, as a research model, gained impact and 
new technologies and manipulations arouse to respond to specific research needs. Mice 
have provided invaluable models of normal and aberrant processes affecting metabolism, 
reproduction, aging, cancer, immunologic function, and many others. Recently developed 
gene-driven approaches, that complement more established phenotype-driven studies, have 
profited immeasurably from the unique ability to selectively alter the mouse genome by 
adding, subtracting, and replacing genes. Indeed, the preeminent status of mouse among 
research organisms at the beginning of the twenty-first century was marked by its selection 
as the first to be targeted for complete genomic sequencing (Waterston et al., 2002). 
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3. The male reproductive function 
3.1. Spermatogenesis 
Spermatogenesis is a complex process of cellular transformation in which unspecialized 
diploid (2n) spermatogonia stem cells gives raise to highly specialized male haploid (1n) 
spermatozoa. This occurs within the seminiferous tubules. The seminiferous epithelium 
(Figure 1) consists of germ cells that form numerous concentric layers penetrated by a single 
type of somatic cell, the Sertoli cells. Germ cells evolve through sequential divisions. At first 
by repeated mitotic divisions, to maintain germ cell pools, and then by meiosis, that lead to 
production of haploid gametes. Meiosis involves the duplication of chromosomes, genetic 
recombination, and then reduction of chromosomes through two cell divisions to produce 
spherical haploid spermatids that differentiate into spermatozoa, which are then release into 
the lumen (Hess & Franca, 2008).  
This complex and lengthy cellular process was divided in several stages (Figure 1) (Leblond 
& Clermont, 1952; Hess & Franca, 2008; Hermo, Pelletier, Cyr, & Smith, 2010). These 
stages are however artificial definitions (Kluin, Kramer, & de Rooij, 1982). The stages 
cyclically evolve over time and along the seminiferous tubule forming the cycle of the 
seminiferous epithelium, which has a well-defined duration for a given species. Additionally, 
the overall time length to spermatogenesis completion (release of spermatozoa within the 
seminiferous tubule lumen) is specific of each mammalian species, ranging from 30 to 78 
days (Clermont & Trott, 1969; França et al., 1998; Hermo et al., 2010). In the mouse, each 
spermatogenic cycle encompasses 12 stages and takes 8.6 to 8.9 days, the total duration of 
spermatogenesis being 39 to 40 days (Figure 1) (Clermont & Trott, 1969). 
The seminiferous epithelium consists of one somatic cell type, the Sertoli cell, and many 
different germ cell types (Hess & Franca, 2008). Germ cells within each layer of the 
seminiferous epithelium change in synchrony with the other layers over time, producing the 
sequence of stages (Hess & Franca, 2008). These cells do not migrate laterally along the 
length of the seminiferous tubule. However, at least in rodents, a strict ordering of the stages 
is observed, whereby sequential stages occur along the length of the tubules, in the so-called 
‘wave’ of the seminiferous epithelium. This way, stage I is followed by stage II, and so on 
until stage XII, which is then followed by stage I (Figure 1) (Hess, 1999). This wave is the 
result of the synchronous development of germ cells through cellular signaling mechanisms 
that remain largely unknown. 
The mechanism by which spermatogonia stem cells transform into differentiating 
spermatogonia and simultaneously renew their own population is now a major focus of 
reproductive biology. Spermatogonia are indeed promising targets for the treatment and 
control of several reproductive conditions (Brinster, 2007). Spermatogonia give rise to 





Figure 1 – Mouse spermatogenic cycle stages. 
 
A – Draw scheme of the mouse spermatogenic cycle stages showing the histological relationship of 
cells in the seminiferous tubules of the testis. In the diagram, the lower row of cells rests close to the 
basement membrane, and the upper row of cells is close to the lumen of the seminiferous tubule. In, 
intermediate spermatogonia; B, type B spermatogonia; Pl, preleptotene spermatocytes; L, leptotene 
spermatocytes; Z, zygotene spermatocytes; P, pachytene spermatocytes; D, diplotene spermatocytes, 
m2ºm, meiotic divisions. Drawing adapted from (França et al., 1998). B – Adult mouse spermatogenic 
cycle stages. Haematoxylin staining. 400x magnification. spermatogenic stages are aligned with their 
drawn correspondents in image A. Arrow head point Sertoli cells. Arrows point spermatogonia. p, 
pachytene spermatocytes; pl, preleptotene spermatocytes; L, leptotene spermatocytes; z, zygotene 
spermatocytes; div, meiotic divisions; r, round spermatids. 
 
In well-studied laboratory rodents, such as rats and mice, four classes of spermatogonia are 
present: undifferentiated type A spermatogonia, differentiated type A spermatogonia, 
intermediate spermatogonia, and type B spermatogonia, identified in light and transmission 
electron microscopy according to the presence and distribution of heterochromatin (de Rooij 
& Russell, 2000; Chiarini-Garcia & Russell, 2001; Chiarini-garcia, Hornick, Griswold, & 
Russell, 2001). Type B spermatogonia divide by mitosis forming two preleptotene 
spermatocytes, cells representing the beginning of meiotic prophase (Hess & Franca, 2008). 
Initially, these cells rest on the basement membrane, however, as they progress to leptotene 
and zygotene spermatocytes they move through the blood-testis-barrier (Russell, 1977). 
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Spermatocytes are the meiosis cells. These cells are found in all meiotic stages, as meiosis 
is a prolonged period within spermatogenesis, extending in the mouse for approximately 14 
days. However, the meiotic cell division occurs in and defines a single spermatogenic cycle 
stage (XII). (Hess & Franca, 2008). Round spermatids are formed after the completion of 
both meiotic divisions. These spherical haploid (1n) cells transform into elongate, highly 
condensed spermatozoa, which are then released into the seminiferous tubule lumen, a 
process called spermiogenesis (Hermo et al., 2010). In this process, round spermatids 
become elongated and pass through a series of four different phases know as Golgi, 
capping, acrosomal, and maturation. In these phases the acrosome is formed and packed, 
the nuclear chromatin condensates, and the excess cytoplasm is removed (Hess & Franca, 
2008). The excess of cytoplasm is removed in stage VII-VIII and results in the formation of 
prominent cytoplasmic lobes and residual bodies, which contain unused mitochondria, 
ribosomes, lipids, vesicles and other cytoplasmic components (Firlit & Davis, 1965; Hess et 
al., 1993). Compared to many other well-known self-renewing cell systems in the body, 
spermatogenesis is thought to have the greatest number of cell divisions (Hess & Franca, 
2008).  
Germ cell apoptosis is a normal event during mammalian spermatogenesis and plays a 
critical role in determining total sperm output and normal spermatogenesis (Russell, Chiarini-
garcia, Korsmeyer, & Knudson, 2002). Although a significant germ cell loss occurs during the 
spermatogonia phase, apoptosis is also frequent during meiosis, probably related to 
chromosomal damage (Hess & Franca, 2008). 
The Sertoli cells are responsible for the support and nutrition of the developing germ cells 
and compartmentalization of the seminiferous tubule. This is accomplished by tight junctions, 
which provides a protected and specialized environment for the developing germ cells. 
Sertoli cells also control the release of mature spermatids into the tubular lumen, secrete 
proteins and several growth factors, and phagocyte degenerating germ cells and residual 
bodies that remain from released spermatozoa (Griswold, 1998). Sertoli cells are the target 
of hormonal regulation of spermatogenesis (Griswold, 1998; De Gendt et al., 2004). The 
gene pathways involved in the regulation of the highly complex cellular remodeling 
associated with spermatogenesis are poorly understood.  
 
3.2 The epididymis and spermatozoa maturation 
After leaving the testis through the efferent duct, spermatozoa enter the epididymis. In rodent 
species the epididymis is subdivided into four major anatomical regions known, from 
proximal to distal, as the initial segment, the head/caput, the body/corpus, and the tail/cauda 
(Figure 2) (Abou-Haïla & Fain-Maurel, 1984; Turner, Bomgardner, Jacobs, & Nguyen, 2003). 
Spermatozoa travel throughout this structure for 10-13 days, depending on the species, and 
is stored for variable periods in the tail and duct deferens (Turner, 1995; Belleannée, Thimon, 
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& Sullivan, 2012). Along the epididymis, spermatozoa experience maturational changes that 
will ultimately enable them to acquire fertilizing capacity. This involves the acquisition of 
progressive forward motility, the ability to undergo the post ejaculatory events (capacitation 
and hyperactivation), and the capacity to recognize and to bind to the oocyte (Guyonnet, 
Dacheux, Dacheux, & Gatti, 2011).  
These maturation changes involve biochemical modifications are induced by the 
continuously evolving epididymal intraluminal composition, which in turn is modulated by the 
epididymal epithelium (Cuasnicú et al., 1984). Proteins secreted by epididymal epithelial cells 
interact with maturing spermatozoa to generate fully functional gametes (Sullivan, Saez, 
Girouard, & Frenette, 2005). The secreted epithelium protein profile changes from one 
segment to the other, which relies on an fine regulation of epididymis gene expression (Krull, 
Ivell, Osterhoff, & Kirchhoff, 1993; Gebhardt et al., 1999; Guyonnet et al., 2011). Epithelial 
gene expression along the epididymis is related with the different steps of sperm maturation 
(Johnston et al., 2005, 2007; Guyonnet et al., 2009). The acquisition of fertilizing ability 
occurs at a location in the epididymis that is species-dependent (Dacheux & Paquignon, 
1980). In general, whereas luminal secretions from the epididymis head and body are 
beneficial for the acquisition of sperm motility and fertilizing ability, epididymis tail secretions 
are important for the proper storage of spermatozoa for several days in conditions that 
preserve their fertility (Turner, 1995; Jones & Murdoch, 1996). 
Epididymal proteins are added to spermatozoa during the maturation process by unusual 
mechanisms and may have an important role in this process (Saez, Frenette, & Sullivan, 
2003). These proteins are transferred to sperm cells in vesicles, named epididymosomes, 
which have been described in several mammalian species (Légaré et al., 1999; Frenette & 
Sullivan, 2001; Rejraji et al., 2006). The epididymosome protein composition changes 
between epididymis segments and between those and the ejaculated semen (Frenette, 
Girouard, & Sullivan, 2006a), which is relevant for epididymis sperm maturation (Sullivan, 
Frenette, & Girouard, 2007). 
The composition of the luminal milieu is controlled by the surrounding pseudostratified 
epithelium, which is composed by several cell types displaying distinct functions: principal, 
narrow, apical, clear and basal cells (Figure 2) (Joseph, Shur, & Hess, 2011; Belleannée et 
al., 2012). These different cell types need to perform extensive intercommunication in order 
to regulate the sequential composition of the luminal milieu and the biochemical changes 
associated with spermatozoa maturation (Shum, Ruan, Da Silva, & Breton, 2013). However, 





Figure 2 – Segmental structure of the mouse epididymis and deferens duct. 
Haematoxylin staining. 400x magnification. Arrow heads point narrow and apical cells. Arrows point 
basal cells. Bold arrows point clear cells. Principal cells are the majority of epithelial cells and are not 
marked. Draw scheme is shown with the different epididymis segments separated by fibrous septa. 




4. The female reproductive cycle 
The mouse EC lasts approximately 4 to 5 days and can be divided into four stages: 
proestrus, estrus, metestrus and diestrus. Cellular remodeling events occurring at the ovary 
and tubular tract are regulated by changes in circulating hormones levels. Estrogens peak 
prior to ovulation, which occurs at estrus, while P4 concentrations rise during metestrus and 
diestrus, and then decline from proestrus to estrus (Walmer, Wrona, Hughes, & Nelson, 
1992; Fata, Chaudhary, & Khokha, 2001). These hormonal changes can be used to stage 
the EC (Walmer et al., 1992; Fata et al., 2001; Wood, Fata, Watson, & Khokha, 2007). 
Vaginal cytology and uterus histology can also be used to stage the mouse EC (Figure 3) 
(Wood et al., 2007). Although the main EC cellular events are controlled by hormonal 
changes, ovarian and uterine functions are not completely dependent on this hormonal 
regulation. This is the case of postnatal follicle development (Peters, Byskov, & Lintern-
Moore, 1973). After initial recruitment from the primordial follicle resting pool, most follicles 
will develop independently of hormonal stimulus until the follicle stimulating hormone (FSH) 
dependent early antral stage. Only if a follicle arrives the FSH-dependent stage in the 
‘window’ when FSH is elevated, it can proceed to the next developmental stage (Hirshfield, 
1991; Le Nestour, Marraomi, & Lahlou, 1993). This reduces the number of follicles 
developing to ovulation. Still, the number of follicles in the cohort that continue to develop is 
greater than the desired ovulatory number, so a further process of reduction occurs. This 
second phase of follicle selection is known as follicle dominance. Dominant follicles continue 
to the final stages of development while the remaining subordinate follicles in the cohort 
ultimately undergo atresia and regress (Baker & Spears, 1999). These larger follicles in a 
cohort indirectly cause the cessation of growth and development in subordinate members 
(Zeleznik & Hillier, 1984; Gibbons, Wiltbank, & Ginther, 1997). Follicular dominance is mainly 
mediated through endocrine regulation. Nevertheless, intra-ovarian interactions are also 
involved in this regulation. Follicle–follicle interactions have various possible roles both at 
early stages when follicles are being selected from a cohort or cluster of follicles and/or later, 
when dominant follicles are affecting the subordinate’s growth (Baker & Spears, 1999). 
However, the cell signaling pathways enrolled in such regulation are still under inquiry. 
The formation, maintenance, regression, and steroidogenesis of the CL are among the most 
closely regulated events in mammalian reproduction (Stocco, Telleria, & Gibori, 2007). The 
CL has a short life span and is the site of rapid cellular remodeling, growth, differentiation, 
and death of several cell types, including granulosa, theca, endothelial and mesenchymal 
cells. The interactions between these cell types are essential in maintaining the development 




Figure 3 – Vaginal cytology and uterine histology along mouse EC stages. 
 
EC stage identification through vaginal cytology, giemsa staining (100x magnification). Proestrus is 
characterized by the presence of few if any neutrophils, some parabasal and intermediate epithelial 
cells. At this stage there are already some large cornified epithelial cells. In estrus only large cornified 
epithelial cells are present. Metestrus is characterized by the presence of neutrophils, intermediate 
and some parabasal cells. Large cornified epithelial cells are present in large agglomerates. During 
diestrus the smear includes numerous neutrophils and basal and parabasal epithelial cells. Arrow - 
parabasal epithelial cells. Bold arrow - cornified epithelial cells. Arrow head - basal epithelial cells. 
Uterine section at each EC stage, haematoxylin staining (40x magnification). Proestrus has a typical 
undulating endometrium, estrus has a pronounced increase in extracellular fluid throughout the 
endometrium, at metestrus the luminal surface is very irregular, and at diestrus the uterine lumen is 
collapsed. 
 
The oviduct is the site of fertilization and its epithelium establishes relationships with both 
male and female gametes (Myoungkun & Bridges, 2011; Coy, García-Vázquez, Visconti, & 
Avilés, 2012). Along the EC, the oviduct undergoes cyclic changes involving growth and 
regression of its epithelial cell layer constituted by both ciliated and secretory luminal 
epithelial cells.  
The endometrium also undergoes extensive cellular remodeling along the EC, in response to 
systemic changes in steroid hormones, E2 and P4 (Wood et al., 2007). Both in humans and 
mice, these changes involve a synchronized sequence of cellular proliferation, apoptosis and 
differentiation events, along with extracellular matrix turnover, angiogenesis, and leukocyte 
infiltration (Evans et al., 1990). Nevertheless, unlike humans and primates, menstruation, the 
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physical shedding of the endometrium, is not a feature of the rodent EC. Even so, due to 
practical aspects regarding laboratory environment, manipulation and genetic tractability, the 
mouse uterus has been extensively used as a model to understand human and other animal 
species uterine function. In the mouse, changes from one EC stage to the next occur over a 
24 hour period, requiring a rapid cellular response to hormonal fluctuations (Hewitt et al., 
2003). This leads to massif changes in epithelial, stroma and gland cell turnover during each 
EC stage (Wood et al., 2007). Metestrus is also characterized by the migration of neutrophils 
into the uterine luminal epithelium (Corbeil, Chatterjee, Foresman, & Westfall, 1985). Again, 
the molecular mechanisms responsible for the regulation of all the cellular remodeling that 
occurs during the EC are far from being well understood.  
 
5. Molecular and cellular regulation of reproduction 
Besides endocrine regulation, several molecular and cellular mechanisms control 
reproductive function. Gametogenesis involve the interplay of endocrine factors within the 
hypothalamic-pituitary-gonadal axis, and autocrine, paracrine and juxtracrine interactions 
between germ cells within the seminiferous tubules/ovaries and neighboring somatic cells. 
The first genes shown to play a role in reproductive biology were identified on the basis of 
their abilities to influence sexual differentiation or to alter hormone production or sensitivity. 
In 1905, the X and Y chromosomes were hypothesized to influence sex determination in 
insects, however, only in 1959 it was shown that the Y chromosome contains the mammalian 
male-determining gene (Ford et al., 1959; Jacobs & Strong, 1959). However, several years 
had to roll until the sex-determining region Y (SRY) gene was identified both in humans and 
mice (Berta et al., 1990; Koopman et al., 1990; Sinclair et al., 1990). Many other genes and 
signaling pathways were so far identified as being enrolled in reproductive function 
regulation. These discoveries historically evolved from the study of cases of infertility and 
subfertility in male and female human individuals (Matzuk & Lamb, 2002, 2008).  
The transforming growth factor β (TGFβ) superfamily is one example of signaling pathway 
involved in the regulation of reproductive function. Most of TGFβ family proteins signal 
through a canonical pathway that involves serine threonine kinase receptors, being also 
related with SMAD and bone morphogenetic proteins (BMPs). Mutations in essentially every 
major component of these signaling pathways have been created in mice and, along with 
additional studies in humans and other species, have shown that this signaling pathway is 
essential to nearly every developmental and physiological process, both in male and female 
reproductive biology (Chang, Brown, & Matzuk, 2002; Matzuk & Burns, 2012). 
Another example are the vascular endothelial growth factor (VEGF) family proteins, which 
has been implicated in the regulation of both male and female reproductive events, including 
neoangiogenesis in female genital tract (Gabler, Einspanier, Schams, & Einspanier, 1999; 
Irusta, Abramovich, Parborell, & Tesone, 2010; Caires, de Avila, Cupp, & McLean, 2012; Kim 
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et al., 2013). Fibroblast growth factor (FGF) (Sugiura et al., 2008) and growth differentiation 
factor-9 (GDF9) (Dong et al., 1996) were implicated in follicle growth regulation.  
Amazingly, the known number of genes intervening in reproductive function is much higher in 
the case of the male than of the female. Approximately 1 out of 25 of all mammalian genes 
are specifically expressed in the male germline (Schultz, Hamra, & Garbers, 2003), 
illustrating the complexity of the spermatogenic cycle. Several genes have a role both in 
male and female reproductive biology. Such is the case of the Notch signaling pathway, 
object of study in this thesis, which has been related to reproductive events occurring in both 
sexes, from Drosophila to humans. 
 
 
6. Notch signaling enrolment in mammalian reproductive function 
6.1. Introduction 
Mammalian reproductive function is essentially regulated by hormones. Changes in 
circulating hormone concentrations trigger a series of cellular responses, including 
proliferation, apoptosis and differentiation. However, these events require extensive 
intercellular communication, coordinated through cell signaling pathways. The Notch cell 
signaling pathway is implicated in cell fate decisions and morphogenetic changes in several 
tissues (Artavanis-Tsakonas et al., 1995). This cell signaling pathway is also implicated in 
reproductive function of organisms like Drosophila (López-schier & Johnston, 2001; Ward et 
al., 2006; Assa-Kunik et al., 2007; Song, Call, Kirilly, & Xie, 2007; Kitadate, 2010) and C. 
elegans (Kimble & Crittenden, 2007). 
In this literature review we address the enrolment of Notch cell signaling pathway in male 
and female genital development and reproductive function. 
 
6.2. Notch cell signaling pathway 
Notch pathway is a well conserved cell signaling pathway that plays a central regulatory role 
in the specification of cell fates, determined by local cell interactions, in a wide range of 
tissues and organisms (Artavanis-Tsakonas et al., 1995). This signaling pathway was first 
identified in Drosophila and since then from C. elegans to humans (Borggrefe & Oswald, 
2009). In mammals, four receptors (Notch1-4) and five ligands (three delta-like - Dll1, Dll3 
and Dll4 - and two serrate-like - Jagged1 and Jagged2) were identified so far (Borggrefe & 
Oswald, 2009). 
This signaling pathway is best understood as a ligand-receptor communication between 
adjacent cells, whereby both the ligands and receptors are trans-membrane proteins 
anchored to their respective cell surfaces. Notch signaling is activated through receptor 
binding with ligands expressed on neighboring cells. Ligand binding promotes two proteolytic 
cleavages in the receptor. One of them is mediated by a γ-secretase, and other one is 
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catalyzed by ADAM-family metalloproteases. γ-secretase cleavage of receptors releases 
their intracellular domain (NICD), which is translocated to the nucleus. Here, together with 
co-activators like Mastermind/MAML and p300/CBP, NICD converts the transcriptional 
repressor DNA-binding protein RBPJk into a transcriptional activator, thus activating 
transcription of Notch target genes (Borggrefe & Oswald, 2009). The more ubiquitous Notch 
target genes are the hairy/enhancer-of-split (HES) and HES-related with YRPW motif (HEY) 
families of transcription factors (Ohtsuka et al., 1999; Iso, Sartorelli, Chung, & Shichinohe, 
2001; Fischer & Gessler, 2007). Canonically, HES and HEY proteins inhibit expression of 
other genes by forming complexes with co-repressors (Fischer & Gessler, 2007). 
Besides the activation of target genes via RBPJk, referred to as the canonical pathway, 
additional non-canonical pathways of Notch were described, although are less characterized 
(Fischer & Gessler, 2007). Notch signaling at distance, without direct cell contact, was also 
recently reported (Sheldon et al., 2010; Lu et al., 2013). Although there is increasing 
evidence that signaling through different Notch receptors induce different cellular responses 
(Shimizu et al., 2002; Yuan et al., 2012), and that different Notch ligands may reveal different 
affinities to Notch receptors (Benedito et al., 2009), Notch components may be redundant in 
some scenarios (Zeng, Younger-shepherd, Jan, & Jan, 1998; Kitamoto et al., 2005). 
 
6.3. Notch regulation of cell fate decisions 
Notch signaling is enrolled in the regulation of cell fate decisions, including lineage decisions 
during embryonic development, and homeostasis of adult self-renewing organs (Artavanis-
Tsakonas, Rand, & Lake, 1999; Bray, 2006).  
Notch can act through lateral inhibition, lateral induction, stem cell maintenance and cell 
differentiation (Bray, 2006; Borggrefe & Oswald, 2009). Lateral inhibition occurs when in a 
group of equipotent cells, expressing equal amounts of Notch receptors and ligands, one cell 
begins to gradually increase ligand expression. This activates a Notch signaling cascade in 
the neighboring cells, thereby inhibiting their differentiation (Bray, 2006). In lateral induction, 
Notch ligands are expressed by a different cell type in close proximity, which determines the 
final cell fate. In the absence of ligands, Notch receptor is not activated and the cell will 
progress to a different cell fate (Borggrefe & Oswald, 2009). In another way, Notch signaling 
can either guarantee a stem cell pool maintenance, or drive a terminal differentiation 




6.4. Notch pathway enrolment in reproductive function of invertebrate animal 
models 
Notch signaling is implicated in reproductive function of organisms as Drosophila (López-
schier & Johnston, 2001; Ward et al., 2006; Assa-Kunik et al., 2007; Song et al., 2007; 
Kitadate, 2010) and C. elegans (Kimble & Crittenden, 2007). In Drosophila, Notch is 
implicated in ovarian follicular development (López-schier & Johnston, 2001; Assa-Kunik et 
al., 2007) and germ-line stem cell niche formation in both male and female gonads (Ward et 
al., 2006; Song et al., 2007; Kitadate, 2010), whereas in C. elegans is implicated in germ cell 
physiology (reviewed by Kimble & Crittenden, 2007). 
 
6.5. Notch signaling in mammalian male reproductive tract post-natal development 
Notch is involved in testis embryonic (Tang et al., 2008; K L Hahn et al., 2009; DeFalco et al., 
2013) and pn development (Dirami, Ravindranath, Achi, & Dym, 2001; Hayashi et al., 2001; 
Hasegawa, Okamura, & Saga, 2011; Garcia, Defalco, Capel, & Hofmann, 2013). The present 
state-of-art regarding involvement of Notch in testis pn development is summarized in Figure 
4.  
In the mouse, only Sertoli cells and spermatogonia are present in seminiferous tubules until 
pn day 8 (Nebel, Amarose & Hacket, 1961; Bellvi et al., 1977), being the spermatogonia pool 
maintained quiescent. At pn day 1 Notch1 is transcribed in Sertoli cells (Hasegawa et al., 
2011) and spermatogonia (Huang, Rivas, & Agoulnik, 2013), at pn day 3, Notch signaling is 
activated in Sertoli cells (Garcia et al., 2013), and at pn day 5, Jagged2 is transcribed in 
spermatogonia and cleaved Notch1 intracellular domain (N1ICD) is detected in Sertoli cells 
(Hasegawa et al., 2011). Cell cultures obtained from testis at pn day 6 express Notch2 and 
Jagged1 in Sertoli cells, and express Notch1, Notch2, Notch3 and Dll1 in spermatogonia 
(Dirami et al., 2001). At pn day 10, when meiosis starts (Nebel et al., 1961; Bellvi et al., 
1977), Jagged2 is transcribed in spermatogonia (Hasegawa et al., 2011). The activation of 
Notch signaling continues to be detected in Sertoli cells at pn day 12 and 18 (Garcia et al., 
2013), when round spermatids first appear (Nebel et al., 1961; Bellvi et al., 1977). Hayashi et 
al. (2001) analyzed the expression of Notch1 and Jagged2 in pn day 19 rat testis, and 
detected expression of Notch1 and Jagged2 in pachytene spermatocytes and in round and 
elongated spermatids. In the mouse, at pn day 20, Hasegawa et al. (2011) detected 
transcription of Notch1 in Sertoli cells and of Jagged2 in spermatogonia. These authors also 




Figure 4 - Notch pathway along testis post-natal development 
Notch pathway components and effectors time and cell type specific detection along the testis pn 
development is represented in shapes and colors according to legend. pn – post-natal; in situ - in situ 
hybridization; GFP – Green Fluorescent Protein; N1ICD – Notch1 intracellular domain; Sp – 




The involvement of Notch in Leydig cells’ embryonic and pn development was evaluated in 
two studies (Tang et al., 2008; DeFalco et al., 2013). Inhibition of Notch activation in 
interstitial cells was evaluated through the use of TNR-GFP transgenic Notch reporter mouse 
(DeFalco et al., 2013). This study showed the enrolment of Jagged1 in maintenance of the 
Leydig progenitor cells population. Results also lead authors to the suggestion that active 
Notch signaling may play a role in fetal Leydig cells development and transition into adult 
Leydig cells prior to puberty, although being not required during adulthood (DeFalco et al., 
2013). 
Transcription of Notch1 and Jagged2 in the epididymis and deferens duct was also analyzed 
(Hayashi, et al., 2004c). In fact, the first mutant mouse line used to explore Notch function in 
reproductive events, had the constitutive expression of active Notch1 (Lupien et al., 2006). 
This mutant developed abnormal duct formation and sterility, demonstrating that the 
constitutive activation of Notch1 significantly affects development of male reproductive 
organs. A similar phenotype was latter shown to occur in mice with deficiency of lunatic 
fringe (Hahn et al., 2009). Involvement of Notch in germ cell pool maintenance was shown 
through the use of a mutant mouse line with constitutive activation of Notch1 in Sertoli cells 
(Garcia et al., 2013).  
 
6.6. Notch signaling in male reproductive function 
Several Notch pathway components have been identified in the testis during adult 
spermatogenesis (Mori, Kadokawa, Hoshinaga, & Marunouchi, 2003; Sahin et al., 2005; 
Hasegawa et al., 2011; Garcia et al., 2013; Huang et al., 2013). The present state-of-the art 
regarding transcription and expression patterns of Notch components in the testis during 
adulthood are summarized in Figure 5. 
Sertoli cells express Notch1 and Notch2 (Sahin et al., 2005; Hasegawa et al., 2011), and 
Notch signaling was shown to be active in Sertoli cells, as both N1ICD and Hes1 were 
detected in these cells (Hasegawa et al., 2011). Another study, using a mouse TNR-GFP 
transgenic Notch reporter, confirmed this activation (Garcia et al., 2013).  
The presence of Notch components was also described in germ cells. Notch1, Notch2, 
Notch4, Jagged2 and the intracellular domains of Notch1, Notch2 and Notch3 were detected 
in spermatogonia (Mori et al., 2003; Sahin et al., 2005; Hasegawa et al., 2011). Transcription 
of Jagged2 (Hasegawa et al., 2011) and expression of Notch1, Notch2, Notch4 and their 
intracellular domains were detected in spermatocytes (Mori et al., 2003; Sahin et al., 2005; 
Huang et al., 2013). Round spermatids express Notch receptors 1, 2 and 4, and the 
presence of their intracellular domains was also detected (Mori et al., 2003; Sahin et al., 
2005; Huang et al., 2013). The presence of Notch1 and Nocth2 and the transcription of 
Jagged1 was detected in elongated spermatids (Sahin et al., 2005; Hasegawa et al., 2011). 
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Although transcription and expression of Notch pathway components in the testis were 
detected by several authors, the enrollment of this signaling pathway in spermatogenesis is 
still controversial. Recently, two studies reported that Notch signaling was not required for 
spermatogenesis (Hasegawa et al., 2011; Batista, Lu, Williams, & Stanley, 2012). These 
authors used Pofut1 conditional loss-of-function mutant lines, blocking Notch signaling. 
Pofut1 protein is implied in Notch receptors configuration (Wang et al., 2001). However, in 
mammals, an unrelated α-glucosidase1 can compensate for Pofut1 in promoting Notch 
folding and function and thus, Pofut1 is not absolutely required for stable cell surface 
expression of Notch (Stahl et al., 2008). Other studies, using spermatogonia specific 
conditional loss-of-function mutant lines showed that Notch1 is not required for 
spermatogenesis (Batista et al., 2012; Huang et al., 2013). These studies used Notch1 
mutant mouse models. Redundancy in Notch receptors may be crucial to normal signaling 
since paralogues exert redundant or additive effects in maintaining the balance (Zeng et al., 
1998). Therefore, blocking Notch1 activation probably do not inhibit overall Notch signaling. 
In fact, several studies associated Notch pathway dysfunction with male fertility problems 
(Hayashi et al., 2001; Hayashi, Yamada, Kageyama, Negishi, & Kihara 2004b; Sahin et al., 
2005; Lupien et al., 2006; Hahn et al., 2009; Garcia et al., 2013; Huang et al., 2013). 
Spermatogenesis was suppressed in vitro through the blockade of Notch1 and Jagged2 
(Hayashi et al., 2001) and, failure of Notch expression was associated with the pathogenesis 
of maturation arrest in male human infertility patients (Hayashi, et al., 2004b). A change in 
the expression pattern of Notch receptors was also related to rat varicocele induced 
spermatogenesis arrest (Sahin et al., 2005). Both the deficiency of lunatic fringe and the 
constitutive activation of Notch1 resulted in male reproductive tract defects and fertility 
problems (Lupien et al., 2006; Hahn et al., 2009). Garcia et al. (2013) reported the enrolment 
of Notch1 in Sertoli cells and spermatogonia pool maintenance (Garcia et al., 2013), whereas 
Huang et al. (2013), also using a Notch1 gain of function mouse model, reported the 
relevance of Notch signaling in the regulation of male germ cells survival and differentiation 
(Huang et al., 2013). Although DeFalco et al. (2013) showed a decline in Notch activation in 
Leydig cells throughout adulthood, Sahin et al. (2005) identified expression of Notch 





Figure 5 - Notch pathway in the adult testis 
 
Notch pathway components and effectors cell type specific detection in the testis during adulthood is 
represented in shapes and colors according to legend. in situ - in situ hybridization; GFP – Green 
Fluorescent Protein; N1ICD – Notch1 intracellular domain; N2ICD – Notch2 intracellular domain; 
N3ICD – Notch3 intracellular domain; N4ICD – Notch4 intracellular domain; Sp – spermatogonia; St – 




6.7. Notch pathway enrolment in female reproductive tract post-natal development 
At the very first days of pn life (until pn days 4-6), oocytes become surrounded by somatic 
cells to form primordial follicles. During this process only one-third of the initial number of 
oocytes survive to form primordial follicles (Pepling, 2012). The genetic mechanisms behind 
the regulation of these events are still poorly understood. Perturbations during the critical 
period of primordial follicle formation can significantly affect the size of the primordial follicle 
pool and follicular phenotypes (Trombly, Woodruff, & Mayo, 2009). Components of Notch 
pathway were reported to be present in the neonate mammalian ovary (Trombly et al., 2009; 
Xu & Gridley, 2013). Trombly et al. (2009) identified expression of Notch2 in granulosa cells 
and Jagged1 in germ cells, and reported that blockade of Notch signaling through the use of 
a γ-secretase inhibitor resulted in retained germ cell nests and reduced number of primordial 
follicles (Trombly et al., 2009). Xu & Gridley (2013), using a mouse line with conditional 
deletion of Notch2 in granulosa cells, demonstrated that Notch2-mediated signaling regulates 
oocyte apoptosis non-cell autonomously, and breakdown of germ-cell nests and formation of 
primordial follicles (Xu & Gridley, 2013).  
 
6.8. Notch pathway in female reproductive function 
During adulthood, just a small proportion of the ovarian pool of primordial follicles escape 
their arrested state and resume growth and development, the major proportion becoming 
atretic. As follicles reaches maturity, ovulation occurs and the CL is formed. Notch pathway 
components were identified in the ovary and Notch signaling was implicated in adult 
mammalian ovarian (Uyttendaele et al., 1996; Baker & Spears, 1999; Johnson et al., 2001; 
Hahn et al., 2005; Vorontchikhina et al., 2005; Hernandez et al., 2011; Zhang et al., 2011; 
Fraser et al., 2012; García-Pascual et al., 2013; Jovanovic et al., 2013) and uterine 
regulation (Cobellis et al., 2008; Mazella, Liang, & Tseng, 2008; Mikhailik, Mazella, Liang, & 
Tseng, 2009; Afshar, et al., 2012a; Afshar, Miele, & Fazleabas, 2012b; Degaki, Chen, 
Yamada, & Croy, 2012). 
Notch2 and Notch effector Hes1 were identified in granulosa cells of primordial follicles 
(Trombly et al., 2009), and primary follicles (Trombly et al., 2009; Zhang et al., 2011). 
Expression of Notch2 and Notch effectors were maintained in granulosa cells when primary 
follicles progress into secondary follicles; following this follicle developmental stage, Notch3 
and Jagged2 also became expressed until the antral follicle stage (Johnson et al., 2001; 
Zhang et al., 2011; Jovanovic et al., 2013). Notch2, Jagged1 and several Notch pathway 
effectors were also detected in oocytes (Johnson et al., 2001; Trombly et al., 2009; Zhang et 
al., 2011). Notch1, Notch3, Notch4, Dll4 and the ICD of Notch1 and Notch4 were detected 
both in mouse and rat luteal cells (J. Johnson et al., 2001; Hernandez et al., 2011). Notch1, 
Notch3, Notch4, Jagged1 and Dll4 were also detected in ovarian blood vessels (J. Johnson 
et al., 2001; Vorontchikhina et al., 2005; Hernandez et al., 2011; García-Pascual et al., 2013; 
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Jovanovic et al., 2013). All Notch receptors and both Jagged ligands were detected in human 
cumulus cells (Tanriverdi et al., 2013). The present state-of-the art regarding transcription 
and expression patterns of Notch pathway components and effectors in the ovary is 
summarized in Figure 6. 
Notch detection in the ovary was associated with follicle selection and dominance (Baker & 
Spears, 1999) and the implication of this signaling pathway in this phenomenon was 
straightened by the analysis of its transcription pattern (Johnson et al., 2001). The following 
studies essentially associated Notch with ovarian neovascularization (Vorontchikhina et al., 
2005; Fraser et al., 2012; García-Pascual et al., 2013; Jovanovic et al., 2013), follicle 
recruitment and CL function (Hernandez et al., 2011; Zhang et al., 2011; García-Pascual et 
al., 2013; Tanriverdi et al., 2013). Vorontchikhina et al. (2005) reported expression of Notch1, 
Notch4 and Jagged1 in ovarian blood vessels, and associated their expression with the 
regulation of ovarian neovascularization during follicular growth and CL formation. In fact, it is 
well known that neoangiogenesis plays a relevant role in those events (Wulff et al., 2002; 
Zimmermann et al., 2003; Fraser et al., 2005, 2006). Gonadotropin dependent follicular 
growth is not depend on Notch ligand Dll4 (Fraser et al., 2012; Jovanovic et al., 2013), but 
this ligand is central in the regulation of CL angiogenesis and function (Fraser et al., 2012; 
García-Pascual et al., 2013). Recently, Hernandez et al. (2011) suggested that Dll4-Notch 
signaling pathway has a luteotropic role by promoting luteal cell viability and steroidogenesis. 
Notch pathway was also associated to follicle granulosa cell proliferation (Zhang et al., 
2011).  
At each reproductive cycle, the female reproductive tract undergoes extensive remodeling, to 
render the genital tract receptive for the developing embryos. These changes involve a well-
orchestrated synchrony of cellular proliferation, apoptosis, and differentiation events, along 
with extracellular matrix turnover, angiogenesis, and leukocyte infiltration. These events are 
regulated by sexual steroid hormones, E2 and P4. Notch pathway components were first 
identified in the human uterus through protein localization (Cobellis et al., 2008; Mazella et 
al., 2008) and gene transcription (Mikhailik et al., 2009). Later, the use of animal models 
allowed the evaluation of Notch involvement in uterine physiology (Afshar, et al., 2012a; 
Degaki et al., 2012). Notch pathway components were identified in the uterus epithelium, 
glands and stroma. Notch1 and Dll4 were identified in uterus luminal epithelial cells (Mazella 
et al., 2008; Afshar, et al., 2012b) and Notch1, Notch4, Jagged1 and Dll4 were identified both 
in uterine glands and stroma cells (Cobellis et al., 2008; Mazella et al., 2008; Afshar, et al., 
2012a; Afshar, et al., 2012b). The present state-of-the art regarding the transcription and 





Figure 6 - Notch pathway components and effectors in the ovary 
 
Notch pathway components and effectors cell type and ovarian structure specific detection in the adult 
ovary is represented in shapes and colors according to legend. in situ - in situ hybridization; N4ICD – 





Figure 7 - Notch pathway components detection in the uterus 
Notch pathway components cell type and uterine structure specific detection in the adult uterus is 
represented in shapes and colors according to legend. 
 
In the uterus, Notch was associated with uterine angiogenesis (Mazella et al., 2008; Degaki 
et al., 2012), uterine cyclic cellular events (Cobellis et al., 2008; Mikhailik et al., 2009; Afshar, 
et al., 2012b) and embryo implantation (Afshar, et al., 2012a; Afshar, et al., 2012b; Degaki et 
al., 2012). Additionally, Notch1 and Dll1 were implicated in decidualization (Afshar, et al., 















Chapter I - Dynamics of Notch pathway expression during mouse testis post-natal 
development and along the spermatogenic cycle 
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The transcription and expression patterns of Notch pathway components (Notch 1-3, Dll1, 
Dll4 and Jagged1) and effectors (Hes1, Hes2, Hes5 and Nrarp) were evaluated (through RT-
PCR and IHC) in the mouse testis at key moments of pn development, and along the adult 
spermatogenic cycle. Notch pathway components and effectors are transcribed in the testis 
and expressed in germ, Sertoli and Leydig cells, and each Notch component shows a 
specific cell-type and time-window expression pattern. This expression at key testis 
developmental events prompt for a role of Notch signaling in pre-pubertal spermatogonia 











Spermatogenesis, the generation of haploid, highly specialized germ cells (spermatozoa) in 
the testis, is the result of a complex orchestration initiated at puberty, involving continuous 
and serial cellular proliferation and differentiation events (Kimmins, Kotaja, Davidson, & 
Sassone-Corsi, 2004). In the mouse, only Sertoli cells and spermatogonia are present in the 
seminiferous tubules until pn day 8, meiosis begins on pn day 10, round spermatids appear 
by pn day 18 after completing meiosis, and another 14 days are required for spermatids to 
complete their differentiation and to be released from the seminiferous epithelium (Nebel et 
al., 1961; Bellvi et al., 1977). In this species, the spermatogenic cycle length is about 8.6 
days and is divided in 12 stages arranged in order along the length of the seminiferous 
tubules (Oakberg, 1957; Clermont & Trott, 1969). Leydig cells are interstitial endocrine cells 
that mainly secrete testosterone. In mammals, two main periods of Leydig cell function occur. 
A first Leydig cell generation develops during fetal life and the secreted testosterone is 
responsible for the masculinization of the urogenital system (Habert, Lejeune, & Saez, 2001). 
These cells regress thereafter, although some fetal Leydig cells persist in adult life 
(Ariyaratne & Chamindrani Mendis-Handagama, 2000). A second Leydig cell population 
appears at puberty secreting testosterone required for the onset of spermatogenesis and 
overall maintenance of male reproductive function (Habert et al., 2001). 
The gene pathways involved in the regulation of the highly complex cellular remodeling 
associated with spermatogenesis and male hormone secretion are poorly understood. 
Deciphering these mechanisms could potentially lead to the development of new therapeutic 
strategies addressed to male infertility and male contraception. The Notch pathway is an 
evolutionarily well-conserved system that has been implicated in cell fate decisions in several 
tissues (Artavanis-Tsakonas et al., 1995; Borggrefe & Oswald, 2009). In mammals, four 
receptors (Notch1-4) and five ligands (three delta-like - Dll1, Dll3 and Dll4 - and two serrate-
like - Jagged1 and Jagged2) were identified (Borggrefe & Oswald, 2009). The Notch 
signaling pathway is activated by binding of the extracellular domain of the receptors with the 
ligands expressed on neighboring cells. This leads to the cleavage of the Notch intracellular 
domain by the γ-secretase complex and its translocation to the nucleus, where it associates 
with other transcriptional factors, thus regulating transcription of Notch target genes 
(Borggrefe & Oswald, 2009). The hairy/enhancer of split (Hes) genes, coding for highly 
conserved proteins, are the more ubiquitous Notch effector genes (Fischer & Gessler, 2007). 
In mammals, Hes1 and Hes5 are the more represented of these genes (Borggrefe & Oswald, 
2009). 
Notch signaling was implicated in germ cell development in Caenorhabditis elegans (Kimble 
& Crittenden, 2007) and Drosophila (Ward et al., 2006; Assa-Kunik et al., 2007; Song et al., 
2007; Kitadate, 2010), and components of the Notch pathway were reported to be present in 
the neonate and adult mammalian testis (Dirami et al., 2001; Hayashi et al., 2001; Mori et al., 
27 
 
2003; Hayashi, et al., 2004b; von Schönfeldt, Wistuba, & Schlatt, 2004; Sahin et al., 2005; 
Hahn et al., 2009; Hasegawa et al., 2011; Garcia et al., 2013). In rodents and humans, 
aberrant Notch activity was associated with male infertility (Hayashi et al., 2001; Hayashi, 
2004b; Sahin et al., 2005; Lupien et al., 2006; Hahn et al., 2009; Garcia et al., 2013). 
However, other studies (Hasegawa et al., 2011; Batista et al., 2012) reported that most of 
Notch pathway components are not transcribed in the mouse testis and that Notch blockade 
in germ and Sertoli cells had no effect on spermatogenesis. Therefore, the overall available 
information regarding the potential involvement of Notch signaling in spermatogenesis is 
fragmentary and controversial. 
The objective of this work was to identify transcription and perform a detailed evaluation of 
the expression patterns of Notch pathway components during mouse testis pn development 
and, at adult life, along the spermatogenic cycle. Additionally, the transcription and 
expression of Notch effector genes in the adult testis was investigated to allow a conclusion 
regarding the activation of the pathway during spermatogenesis. Our main hypothesis is that 
Notch signaling might be involved in the regulation of spermatogenesis and male testis 
endocrine secretion. As a first approach, we identified transcripts in the adult testis by 
reverse transcription PCR (RT-PCR) and then performed the immunolocalization (through 
immunohistochemistry - IHC) of Notch receptors and ligands in the testis at serial moments 
of the testis pn development (pn day 4; pn day 15; 1 month; 3 months). This was 
complemented with the identification of transcription of Notch effector genes and their 
immunolocalization (through IHC) in the testis during adult spermatogenesis. 
Altogether, results strongly prompt for a role of Notch signaling in spermatogonia pool 
maintenance, onset of spermatogenesis, regulation of spermatogenesis pace, germ cells 
identity and differentiation, and Leydig cells function. 
 
3. Materials and Methods 
3.1. Animals 
Experiments were conducted in compliance with the Portuguese legislation for the use of 
animals for experimental purposes (Decreto-Lei nº 129/92 and Portaria nº 1005/92, DR nº 
245, série I-B, 4930-42) and with the European Union legislation (Directive n. 86/609/EEC, 
from the 24th November 1986). Mice manipulation protocols were approved by the national 
regulatory agency (DGV – Direção Geral de Veterinária) and the Institutional Animal Care 
and Use Committee (CEBEA – Comissão de Ética e Bem-Estar Animal). All authors are 
accredited as FELASA category C scientists or equivalent. 
CD1 mice were maintained in a 12-hour light/dark cycle, in ventilated cages with corn cob as 
bedding, and were given access to standard laboratory diet and water ad libitum. The mice 
health was routinely monitored. Outbred CD1 animals were chosen to introduce normal 




3.2 Experimental design 
Expression of Notch pathway components in the testis was evaluated at four time-points of 
pn development: pn day 4; pn day 15; 1 month; 3 months. CD1 male mice were euthanized 
through cervical dislocation under ketamine (15mg/kg)/xylazine (1mg/kg) anesthesia, 
followed by exsanguination. Four mice were allocated to each of the above four time-points 
and their testis were collected and processed for IHC. Dissected testes from another four 
adult mice were individually processed for RT-PCR. 
 
3.3 Immunohistochemistry 
Testes were fixed in 4% neutral phosphate buffered formalin at room temperature for 24h 
and, after subsequent dehydration in ethanol, were embedded in paraffin. Spatial localization 
of expression of Notch pathway components (Notch1, Notch2, Notch3, Dll1, Dll4, Jagged1) 
and effectors (Hes1 and Hes5) was evaluated by IHC, according to a previously described 
method (Silva et al., 2010). Slices were orientated transversally to the longitudinal axis of the 
testis, considering sequential sections of 3 µm and sequential twin-slides with each of the 
three cell markers for each Notch component (minimum of 3 slices per testis for each Notch 
component in all 16 animals). Tissue sections were stained by haematoxylin and 
identification of cell types was done through histology (Hess & Franca, 2008) and the use of 
cell markers in twin slides: The goat anti-3β-HSD antibody was used to identify Leydig cells 
and the rabbit anti-DAZL and anti-DDX4 antibodies were used to identify pre-meiotic and 
post-meiotic germ cells, respectively. The antigen retrieval step was performed in citrate 
buffer (10mM, pH 6.0), except for both anti-Notch1, anti-Hes1, anti-Hes5 and anti-Jagged1 
(ab7771) antibodies (Tris-EDTA, pH 9.0). Blocking was performed in PBS with 2% w/v 
bovine serum albumin (A7906, Sigma-Aldrich, Inc.) for one hour at room temperature. Tissue 
sections were incubated overnight at 4ºC with the following primary antibodies: rabbit anti-
Notch1 (ab27526, Abcam, diluted 1:100), rabbit anti-Notch2 (ab8926, Abcam, diluted 1:100), 
rabbit anti-Notch3 (ab23426, Abcam, diluted 1:160), rabbit anti-Dll1 (ab10554, Abcam, 
diluted 1:100), rabbit anti-Dll4 (ab7280; Abcam, diluted 1:200), rabbit anti-Jagged1 (SC-
8303, Santacruz Biotechnology, diluted 1:50), rabbit anti-Hes1 (ab71559, Abcam, diluted 
1:100), rabbit anti-Hes5 (ab25374, Abcam, diluted 1:100), goat anti-3β-HSD (SC-30820, 
Santacruz Biotechnology, diluted 1:300), rabbit anti-DAZL (ab34139, Abcam, diluted 1:250), 
and rabbit anti-DDX4 (ab13840, Abcam, diluted 1:200). The negative controls were 
performed with the polyclonal rabbit IgG (ab27478, Abcam, diluted 1:100) and, for the 3β-
HSD antibody, with the goat control IgG (ab37373, Abcam, diluted 1:300). All primary 
antibodies were diluted in blocking solution. The peroxidase conjugated monoclonal mouse 
anti-goat/sheep IgG antibody (A9452, Sigma-Aldrich, Inc., diluted 1:100) and the peroxidase 
conjugated goat anti-rabbit IgG polyclonal antibody (Dako 410972, diluted 1:100) were used 
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as secondary antibodies respectively for the anti-3β-HSD antibody, and the remaining 
primary antibodies. Staining was evaluated in the entire testis slice, considering several 
seminiferous tubules per slide. Expression patterns were established following the evaluation 
of a minimum of 24 slices (3 slices/testis x 2 testis x 4 animals) for each Notch component 
(plus 24 twin-cell marker slides) in each of the four time-points evaluated. In the case of 
Hes1 and Hes5, only nuclear staining was considered positive, indicating activation of Notch 
signaling. The antibodies for the Notch components and effectors were previously validated 
by others in the mouse (anti-Notch1 (Cheng et al., 2007), anti-Notch3 (Feng, Krebs, & 
Gridley, 2010), anti-Dll1, (Sörensen, Adams, & Gossler, 2009) anti-Dll4, (Sörensen et al., 
2009) anti-Jagged1, (Bielesz et al., 2010) anti-Hes1 (Rahman et al., 2013) and anti-Hes5 
(Takanaga et al., 2009)) and rat species (anti-Notch2 (Saravanamuthu, Gao, & Zelenka, 
2009)). Except for Notch1, all antibodies were polyclonal and the different lots used were 
originated from different animals (according to manufacturers). To further confirm the 
specificity of staining, the expression pattern obtained for Notch1 and Jagged1 was 
evaluated with different antibodies (the anti-Notch1, Ab52627, diluted 1:50 and the anti-
Jagged1, Ab7771, diluted 1:100). We selected Notch1 (because all assays were performed 
with the same antibody lot) and Jagged1 (due to the specific expression pattern) as the 
targets for these repeats. Evaluation was performed on tissue sections from the same 
paraffin blocks of the same previously used animals. The two different antibodies against 
Notch1 and Jagged1 were simultaneously compared in twin slides (Figure 8).  
 
Figure 8 – Evaluation of the specificity of positive staining of Notch1 and Jagged1, 
using different antibodies. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Notch1: 
comparison between the anti-Notch1 (Ab27526) (A) and the anti-Notch1 (Ab52627) (B) antibodies; 
Positive staining was present in spermatogonia, round spermatids and Sertoli cells. Jagged1: 
comparison between the anti-Jagged1 (sc-8303) (C) and the anti-Jagged1 (Ab7771) (D) antibodies. 
Positive staining was present in the residual bodies at the sperm head tip. Control was done with 
rabbit IgG. Arrows point to spermatogonia cells. Asterisks mark Sertoli cells. Arrow heads point to 





Dissected testes of four additional CD1 male mice were individually collected, immediately 
frozen in liquid nitrogen and stored at −80 ºC until assay. RNA extraction, cDNA synthesis 
and mRNA transcription was performed as previously described (Silva et al., 2012). The 
detection of Notch pathway genes (Notch1, Notch2, Notch3, Dll1, Dll4, Jagged1) and gene 
effectors (Hes1, Hes2, Hes5, Nrarp) were analyzed with specific primer pair sequences. 
Transcription of gene HPRT1 was used as an endogenous control. Primer pair sequences in 
Annex I. 
 
3.5 Statistical analysis 
The relative frequency of pachytene spermatocytes expressing Notch2, Notch3 and Dll4 
were determined by counting all marked and unmarked pachytene spermatocytes, in five 
different seminiferous tubules sections, at each of the spermatogenic cycle stages (I-II; III-IV; 
V-VI; VII-VIII; IX-X), in all testis. This totalized a mean of 1.005 (range: 812-1172) counted 
cells per animal. Differences between spermatogenic cycle stages were evaluated through 
ANOVA. As the Levene test for homogeneity of variances showed unequal variances 
between stages the Post Hoc test Tamhane’s T2 was performed. Significance was assumed 
at the 0.05 level (p< 0.05). 
 
4 Results 
4.1 Notch components and Notch effectors are transcribed in adult mouse testis 
As shown in Figure 9, all the analyzed Notch pathway components and Notch pathway 
effectors are transcribed in the adult mouse testis, as evidenced by RT-PCR.  
 
4.2 Notch3 and Dll4 are expressed in spermatogonia and Sertoli cells in pn day 4 
mice testis. 
At pn day 4, when seminiferous tubules only present spermatogonia and Sertoli cells, only 
Notch3 and Dll4 are expressed in these cells (Figure 10 A and B). Spermatogonia were 





Figure 9 – Transcription of Notch pathway components and effectors in the adult 
mouse testis, evidenced by RT-PCR. 
 
Gel electrophoresis RT-PCR results of: (A) Notch pathway gene transcripts - Notch1, Notch2, Notch3, 
Dll1, Dll4, Jagged1 and HPRT1 (endogenous control gene); (B) Notch pathway gene effectors - Hes1, 
Hes2, Hes5, Nrarp and HPRT1 (endogenous control gene). 
 
4.3 Notch1, Notch2 and Dll4 are expressed in cells initiating meiosis at puberty, on 
pn day 15. 
At pn day 15, Dll4 expression is no longer observed in spermatogonia and become specific 
of cells initiating meiosis, which were marked with anti-DDX4 antibody in twin slides (Figure 
10 D and E). Notch1 and Notch2 are also expressed in germ cells initiating meiosis (Figure 
10 F and G), while Notch3 expression continues to be present in spermatogonia (Figure 10 
H) but not in Sertoli cells.  
 
4.4 Dll1 and Jagged1 are first expressed when spermatids start to elongate at 1 
month of life. 
At 1 month of age, spermatids are about to complete their differentiation and to be released 
from the seminiferous epithelium. All analyzed Notch components are expressed in the 
seminiferous tubules (Figure 10 I-N). Notch1 is expressed in spermatogonia and Sertoli cells 
(Figure 10 I). Notch2, Notch3 and Dll4 (Figure 10 J, K and M, respectively) are expressed in 
almost all germ cells. The most interesting feature at this time-point is the specific expression 
of Dll1 (Figure 10 L) and Jagged1 (Figure 10 N) in the elongated spermatids.  
32 
 
Figure 10 – Immunolocalization of Notch pathway components in the post-natal 
developing testis. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). At pn day 4 (4d), 
Dll4 (A) and Notch3 (B) are expressed in spermatogonia and Sertoli cells. Spermatogonia cells are 
marked with anti-DAZL antibody (C). At pn day 15 (15d), Dll4 is expressed in germ cells initiating 
meiosis (D), marked with anti-DDX4 antibody (E). Notch1 (F) and Notch2 (G) are also expressed in 
germ cells entering meiosis. Spermatogonia express Notch3 (H). At 1 month pn (1M), spermatogenic 
cycle stage IX-X (I-O), Notch1 is expressed in undifferentiated germ cells and Sertoli cells (I), while 
Notch2 and Notch3 are ubiquitously expressed in germ cells (J and K). Dll1 is specifically found in 
elongated spermatids nucleus (L) and Jagged1 in the elongated spermatids cytoplasm (N), while Dll4 
is ubiquitously expressed in germ cells and in some Sertoli cells (M). Controls were done with rabbit 
IgG (O). Arrows point to spermatogonia; Asterisks mark germ cells entering meiosis; Arrow heads 
point to elongated spermatids; Tailed arrows point to elongated spermatids’ cytoplasm; st - Sertoli 
cells. 
 
4.5 Notch pathway components have a unique expression pattern along the 
spermatogenic cycle in adult life.  
These expression patterns are illustrated in Figure 11 and 12, and resumed schematically in 
Figure 13. At adulthood (3 months of life), throughout the spermatogenic cycle, 
spermatogonia express Notch1 and Notch3 (Figure 11 A-C and M-O, respectively). When 
spermatogonia differentiate into preleptotene spermatocytes, at stage VII-VIII, these latter 
cells start to express Notch2 (Figure 11 J). Stage IX-X leptotene spermatocytes only express 
Dll4 (Figure 12 K). However, when leptotene spermatocytes differentiate into zygotene 





Figure 11 – Expression of Notch pathway receptors during the spermatogenic cycle. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Notch1 is 
expressed in spermatogonia and Sertoli cells at all spermatogenic stages (A-F), stage VII-VIII 
preleptotene spermatocytes and round spermatids (D). Notch2 is expressed in all germ cells, except 
spermatogonia and leptotene and zygotene spermatocytes (G-L). Notch3 is only absent from 
leptotene and zygotene spermatocytes (M-R). Notch2 and Notch3 are present in the elongated 
spermatid cytoplasm (G-R). Control was done with rabbit IgG (S-X). Asterisks mark spermatogonia; pl 
mark preleptotene spermatocytes; Arrow heads point to round spermatids; Arrows point to elongated 






Figure 12 – Expression of Notch pathway ligands during the spermatogenic cycle. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Dll1 is specifically 
present in the head of elongated spermatids, between stage IX-X and stage III-IV (A-F). Dll4 show a 
dynamic expression pattern (G-L), being expressed mainly from stage V-VI pachytene spermatocytes 
onwards (I), but also in stage IX-X leptotene spermatocytes and Sertoli cells (K). Jagged1 is observed 
in elongated spermatids’ cytoplasm and in diplotene spermatocytes (M-R). Control was done with 
rabbit IgG (S-X). Arrow head point to stage V-VI pachytene spermatocytes; bold arrow point to stage 
IX-X leptotene spermatocytes; Arrows point to elongated spermatids’ cytoplasm; asterisks mark 







Figure 13 – Schematic illustration of expression patterns of Notch pathway 
components along the spermatogenic cycle. 
Adapted draw-scheme (R. A. Hess & Franca, 2008) representing the mouse stages (I-XII) of the cycle 
of the seminiferous epithelium in the mouse. Cellular associations of layers of the seminiferous 
tubules, from the basement membrane to the lumen, are drawn with Sertoli cells separating each 
stage. Spermatogonia (A, In, B); spermatocytes (Pl- preleptotene, L- leptotene, Z- zygotene, P- 
pachytene, D- diakinesis, Mi- meiotic division); round spermatids (1-8); elongated spermatids (9-16). 
Localization of expression of Notch pathway components (top – receptors; bottom – ligands) is drawn 
in different colors, according to legend. 
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From stage I-II to stage IX-X, pachytene spermatocytes increasingly express Notch2, Notch3 
and Dll4 (Figure 11 G-K, M-Q and Figure 12 G-K, respectively). These data is graphically 
illustrated in Figure 14: from stage I-II to stage IX-X, the relative frequency of the cellular 
expression of Notch2, Notch3 and Dll4 significantly and gradually increases, respectively, 
from 50%, 66% and 14% to 95%. In the final step of meiosis, at stage XI-XII, diplotene 
spermatocytes also express Jagged1 (Figure 12 R). Following the second meiotic division 
and the formation of round spermatids, from stage I-II to stage V-VI, only Notch2, Notch3 and 
Dll4 expression is present (Figure 11 G-J, M-P and Figure 12 G-J, respectively). At stage VII-
VIII, Notch1 is also expressed in round spermatids (Figure 11 D).  
 
Figure 14 – Evolution of the relative frequency of pachytene spermatocytes 
expressing Notch2, Notch3 or Dll4 along the spermatogenic cycle (stages I-II to IX-X). 
Error bars represent the standard error of the mean (SEM). Columns with different superscript differ 
significantly. Notch2: abc, p<0.05; Notch3: yz, p<0.05; Dll4: jkl, p<0.05. 
 
Dll1 starts to be expressed in the nuclear part of elongated spermatids when these cells 
begin to differentiate, at stage IX-X, and is expressed until stage III-IV (Figure 12 E, F, A and 
B). Notch2, Notch3 and Dll4 are also expressed in elongated spermatids at all stages but 
only in the cytoplasm (Figure 11 G-L, M-R and Figure 12 G-L, respectively). Jagged1 is 
located in the residual bodies of elongated spermatids between stage XI-XII and stage VII-
VIII (Figure 12 R and M-P). This ligand seems to be translocated from the lumen to the basal 
region of the seminiferous tubules (Figure 15 A-D). This pattern is associated, following the 
release of sperm cells within the lumen of seminiferous tubules, with the engulfment of 
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spermatids’ residual bodies by Sertoli cells and their transfer to the basement membrane 
region of the seminiferous tubule (Figure 15 C-D).  
Both Notch1 and Dll4 are expressed in Sertoli cells. However, while Notch1 is present in 
Sertoli cells at all stages (Figure 11 A-F), Dll4 is only present in some of these cells at stage 
IX-X (Figure 12 K). 
 
Figure 15 – Jagged1 translocation within the residual bodies. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Jagged1 is located 
in the elongated spermatids’ cytoplasm at stage V (A). At stage VIII, Jagged1 is located in the residual 
bodies at the sperm head tip (B). Following release of sperm cells from the seminiferous epithelium, at 
stage IX, residual bodies containing Jagged1 are progressively translocated towards the basement 
membrane and localized near the Sertoli cells nuclei (C-D). Bold arrow point to residual bodies 
containing Jagged1 in the sperm head tip. Arrow heads point to residual bodies containing Jagged1 at 
the luminal surface of the seminiferous epithelium. Arrows point to residual bodies containing Jagged1 
near Sertoli cells nuclei. Asterisks mark Sertoli cells. 
 
4.6 Notch pathway effectors Hes1 and Hes5 are expressed during adult mice 
spermatogenesis. 
As shown in Figure 16, Hes1 is detected in Sertoli and spermatogonia cells, and Hes5 is 
detected in Sertoli cells and elongated spermatids. 
 
4.7 Notch pathway components display a dynamic expression pattern in Leydig 
cells along post-natal testis development  
Leydig cells were identified in the interstitial space through the presence of 3β-HSD, an 
enzyme of the steroidogenic metabolic pathway (Figure 17 E,K,P). At pn day 4, Dll1, Dll4, 
Notch2 and Notch3 are expressed in these cells (Figure 17 A-D), whereas at pn day 15, 
expression of Dll1, Notch1, Notch2 and Notch3 is identified (Figure 17 G-J). From 1 month of 
life onwards only the Notch receptors continue to be expressed in Leydig cells (Figure 17 M-
O). However, in adulthood, endothelial cells of blood vessels present in the interstitial space 





Figure 16 – Expression of Notch pathway effectors Hes1 and Hes5 during adult 
spermatogenesis. 
 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Only nuclear 
staining was considered positive. Hes1 is expressed in stage VII-VIII Sertoli and spermatogonia cells 
(B). Hes5 is expressed in stage IX-X Sertoli cells and elongated spermatids (D). Control was done with 
rabbit IgG (A, C). Arrow heads point to spermatogonia cells. Arrows point to Sertoli cells. Tailed arrows 
point to elongated spermatids. 
 
5 Discussion 
Transcription of Notch pathway components is present in the adult mouse testis. The use of 
whole testis tissue for RT-PCR probably originates some background noise resulting from 
transcription outside the seminiferous tubules (endothelial cells, smooth muscle cells and 
mesenchymal cells) (Zavadil, Cermak, Soto-Nieves, & Böttinger, 2004; Boucher, Gridley, & 
Liaw, 2012). Nevertheless, this result strongly leads to the suggestion that Notch pathway 
genes are transcribed in the seminiferous tubules during adult spermatogenesis. 
Furthermore, the observed transcription of Notch effector genes may indicate that Notch 





Figure 17 – Dynamic expression of Notch pathway components in Leydig cells during 
mouse post-natal testis development. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Expression of Dll1, 
Dll4, Notch2 and Notch3 is observed at pn day 4 (4d) (A-D), while expression of Dll1, Notch1, Notch2 
and Notch3 is present at pn day 15 (15d) (G-J). Notch1, Notch2 and Notch3 continue to be expressed 
at 1 month pn (1M) (M-O). Leydig cells were co-localized in twin slides with the anti-3β-HSD antibody 
(E,K,P). Control was done with rabbit IgG (F,L,Q). 
 
Notch pathway components show a dynamic expression pattern in the mouse testis along 
the pn life. Although the expression of this pathway was already reported in the mammalian 
testis (Dirami et al., 2001; Hayashi et al., 2001; Mori et al., 2003; Hayashi, et al., 2004b; von 
Schönfeldt et al., 2004; Sahin et al., 2005; Hahn et al., 2009; Hasegawa et al., 2011; Garcia 
et al., 2013), this is the first integrated evaluation of expression of multiple Notch components 
in the testis along pn key time-points (pre-puberty, onset of puberty, adulthood). Additionally, 
our work is the first to describe Notch expression along the spermatogenic cycle. In pre-
pubertal male mice, Dll4 and Notch3 are expressed in spermatogonia. As in the reported 
epithelial canonical function (Artavanis-Tsakonas et al., 1995; Borggrefe & Oswald, 2009), 
Notch signaling may be involved in maintaining the undifferentiated quiescent pool of 
spermatogonia. Dirami et al. (Dirami et al., 2001) immunolocalized Notch 1-3, Dll1 (Dll4 was 
not screened), Jagged1 and Jagged2 in spermatogonia cells of pre-pubertal mice testis 
primary cell cultures, obtained as lysates. Inconsistencies between the above results and 
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those obtained by us may arise from the use of different models. Disruption of testis 
architecture and in-vitro culture of testis cells may induce deviations in the gene expression 
profiles of cells. Hasegawa et al. (Hasegawa et al., 2011), using an in situ hybridization 
approach, only found transcripts of Jagged2 in spermatogonia of pre-pubertal mice. This 
inconsistency may result from a temporal dissociation between gene transcription and 
expression. 
Dll4 and Notch3 are also expressed in Sertoli cells of pre-pubertal mice. These results 
contrast with those reported by Dirami et al. (Dirami et al., 2001) using primary cell cultures 
(Notch2 and Jagged1 immunolocalized) and Hasegawa et al. (Hasegawa et al., 2011) using 
an in situ hybridization approach (Notch1 transcription detected). These inconsistencies may 
arise from comments addressed above for spermatogonia. Although it was reported that 
Notch signaling in Sertoli cells (and germ cells) has no effect on spermatogenesis 
(Hasegawa et al., 2011), a recent study (Garcia et al., 2013), also using genetically modified 
mice, showed that overexpression of Notch1 in Sertoli cells induces a depletion of the 
spermatogonia pool caused by an aberrant exit of gonocytes from the mitotic arrest. 
Therefore, as also prompted by our gene expression results, the above study (Garcia et al., 
2013) indicate a role of Notch signaling in the regulation of spermatogonia quiescence. 
At onset of puberty Dll4 stops being expressed in spermatogonia and, together with 
receptors Notch1 and Notch2, undergoes expression in germ cells entering meiosis. 
Expression of Notch1 in germ cells entering meiosis was also described in rats (Hayashi et 
al., 2001). These features prompt for a role of Notch signaling in the onset of meiosis, as also 
reported in Caenorhabditis elegans (Lambie & Kimble, 1991).  
At adulthood, the specific dynamic expression of Notch pathway components in different cell 
types at different stages of the spermatogenic cycle suggests a central role of Notch 
signaling in the regulation of spermatogenesis. At stage VII-VIII of the spermatogenic cycle, 
when spermatogonia differentiate into pre-leptotene spermatocytes, all three Notch receptors 
are expressed, which may be related to spermatogonia fate, towards either self-renewal or 
differentiation. Expression of Notch1-3 in spermatogonia at adulthood was also reported by 
others (Mori et al., 2003; von Schönfeldt et al., 2004; Sahin et al., 2005), and the involvement 
of Notch in the regulation of spermatogonia fate was also suggested (Hofmann, Braydich-
Stolle, & Dym, 2005). However, Notch3 mutant mice were not infertile (Krebs et al., 2003), 




Figure 18 – Jagged1 expression in endothelial cells of testis interstitial blood vessels. 
 
Positive immunostaining in brown color, counterstaining with haematoxylin (400x magnification). 
Jagged1 is present in endothelial cells of adult testis interstitial blood vessels (A). Leydig cells are in 
contact with the testis interstitial blood vessels. Leydig cells were co-localized in twin slides with the 
anti-3β-HSD antibody (B). Arrows point to endothelial cells. Arrow heads point to Leydig cells. 
 
Stage IX-X leptotene spermatocytes only express the ligand Dll4. This ligand may be 
signaling back to the pre-leptotene spermatocytes, regulating their progression into the next 
differentiation step. Intriguingly, at stage XI-XII, when leptotene spermatocytes differentiate 
into zygotene spermatocytes, no expression of Notch pathway components is observed. The 
proportion of pachytene spermatocytes expressing Notch2, Notch3 and Dll4 increases from 
stage I-II to stage IX-X, when almost all these cells express these Notch pathway 
components. Here again, expression of Notch receptors 2 and 3 and the ligand Dll4 may be 
associated to cell differentiation progression. At stage XI-XII, at the final step of meiosis, 
Jagged1 is specifically expressed. Notch pathway expression was previously associated with 
cell division (Bultje, Castaneda-Castellanos, & Jan, 2009; Das & Storey, 2012). Results here 
presented, prompt for a role of Jagged1 in the completion of meiosis. 
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We found all the three analyzed Notch receptors and Dll4 in round spermatids. Notch1 was 
only identified in stage VII-VIII, when these cells start to elongate. The expression of Notch 
receptors in round spermatids was already identified in mice (Mori et al., 2003) and rat 
(Sahin et al., 2005). Dll1 was only observed in the nuclear part of elongated spermatids. This 
cellular localization was unique among Notch ligands and receptors, as Notch2, Notch3, Dll4 
and Jagged1 are also present in elongated spermatids, but in the cytoplasm. Residual 
bodies result from the elimination of part of the cytoplasm content of elongated spermatids, 
through an asymmetric cell partition (Firlit & Davis, 1965; Hess et al., 1993). This asymmetric 
partition of cellular components may lead to changes in the distribution of Notch pathway 
components inside the cell, which may affect the ability of neighboring cells to deliver and 
receive Notch signaling. 
Jagged1 is mainly expressed in the elongated spermatid cytoplasm. Interestingly, this ligand 
seems to be transported inside the residual body from the elongated spermatid to the 
adjacent Sertoli cell. Within Sertoli cells, this structure containing Jagged1 is transported 
from the luminal position of the seminiferous tubule to near the basement membrane. To the 
best knowledge of authors, this is the first report of such a Notch ligand translocation from 
one cell type to another. The effect of this engulfment is unknown. This could be associated 
with the activation of Notch1 in Sertoli cells or simply may represent a cell phagocytic 
function. The ectoplasmic specialization, the elongated spermatid anchoring system, 
maintains adherence between Sertoli cells and elongated spermatids, and also confers cell 
orientation and polarity within the seminiferous epithelium (Wong, Mruk, & Cheng, 2008). 
The Par complex proteins were associated to ectoplasmic specialization in spermatid 
orientation (Wong et al., 2008). Notch signaling was associated to cell polarity decisions in 
tissues involving Par complex proteins, such as the neural epithelium (Afonso & Henrique, 
2006; Bultje et al., 2009). Here, the expression of Notch components near the elongated 
spermatid anchoring system may be associated with germ cell polarity definition and sperm 
release. Notch pathway was suggested to be associated with acrosome formation (Hayashi 
et al., 2001; Sahin et al., 2005). Results here presented regarding Dll1 expression are 
consistent with a possible role in acrosome formation and overall sperm head shaping.  
As RT-PCR detection of Notch effectors in whole testis does not discriminate between 
somatic and germ cells transcription, and since Notch signaling activation in germ cells 
remains controversial, we evaluated the activation of Notch pathway in adult 
spermatogenesis, through the nuclear localization of Notch effector proteins. From the Notch 
effector genes transcribed in the testis (see above), the more representative effector genes 
(Hes1 and Hes5) were selected for this evaluation. The detection of these proteins (Hes1 
and Hes5) in the nucleus indicates that the pathway is activated during adult 
spermatogenesis. Overall, the expression patterns identified in this study prompt for a role of 
Notch signaling in the regulation of spermatogenesis. This is supported by several other 
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studies relating this pathway with male infertility (Hayashi et al., 2001; Hayashi, 2004b; Sahin 
et al., 2005; Lupien et al., 2006; Garcia et al., 2013). In mice, treatment with specific 
antibodies directed against Notch1 and Jagged2 induced a spermatogenic blockade 
(Hayashi et al., 2001). However, recently Hasegawa et al. (2011) reported that Notch 
signaling was not required for normal spermatogenesis and Baptista et al. (2012) reported 
that Notch1 expression was dispensable for spermatogenesis. These studies (Hasegawa et 
al., 2011; Batista et al., 2012) use genetic engineered mice with conditional deletions in 
Pofut1 gene. Pofut1 protein is responsible for transfer of O-fucose to EGF repeats in Notch 
receptors, which alters receptor configuration (Wang et al., 2001). However, in mammals, an 
unrelated endoplasmic reticulum α-glucosidase 1 can compensate for Pofut1 in promoting 
Notch folding and function and thus, Pofut1 is not absolutely required for stable cell surface 
expression of Notch (Stahl et al., 2008). Batista et al. (2012) also evaluated mutant mice with 
conditional deletion of Notch1 in spermatogonia cells and observed no phenotype in 
spermatogenesis and fertility. However, redundancy in Notch receptors function may be 
crucial to normal signaling since paralogues exert redundant or additive functions in 
maintaining the balance (Zeng et al., 1998; Kitamoto & Hayasaka, 2005). Recently, Garcia et 
al. (2013), using a GFP expression reporter driven by a RBP-J promoter, reported that Notch 
pathway is not active during spermatogenesis. The discrepancy between our results and 
those reported in the above study (Garcia et al., 2013) is difficult to explain. In our study, the 
presence of the Notch pathway effectors (Hes1 and Hes5) in the nucleus was detected in the 
adult testis, both in Sertoli (as also reported in (Hasegawa et al., 2011)) and germ cells which 
indicates that the pathway is active during spermatogenesis. The activation of Notch pathway 
during spermatogenesis was also proposed by others (Hayashi et al., 2001; Mori et al., 2003; 
Hofmann et al., 2005; Sahin et al., 2005).  
Expression of Notch pathway components shows a dynamic pattern in Leydig cells along the 
pn life. Expression of Notch2, Notch3, Dll1 and Dll4 was observed in the pre-pubertal Leydig 
cells, while only the three Notch receptors (1-3) were observed in Leydig cells at adulthood. 
This change in the expression pattern may be related with the turn-over of the Leydig cell 
population (from embryonic to adult Leydig cells). During embryonic development, evolving 
blood vessels have a relevant role in testis morphogenesis, and expression of Jagged1 in 
interstitial cells was associated with maintenance of fetal Leydig progenitor cell populations 
(DeFalco et al., 2013). In adult mice we observed expression of Jagged1 in endothelial cells 
of blood vessels surrounding Leydig cells. We hypothesize that a paracrine regulation of 
Leydig cell function may be in place through the signaling from neighboring endothelial cells, 





Here are reported the transcription and dynamic expression patterns of Notch pathway 
components along testis pn development and throughout the adult spermatogenic cycle. 
Results here described prompt for a role of Notch signaling in spermatogonia pool 
maintenance, onset of spermatogenesis, pace of the spermatogenic cycle, spermatid 
differentiation and regulation of pn Leydig cells function. We suggest that similarly to what 
happens in somitogenesis (Morimoto, Takahashi, Endo, & Saga, 2005; Niwa et al., 2007), 
Notch pathway components may regulate the pace of spermatogenesis at several points, 
contributing to the coordination and orchestration of the complex proliferative and 
differentiation cellular events that take place along the spermatogenic cycle. This can be 
inferred from Figure 13 that schematically illustrates expression of Notch components along 
the spermatogenic cycle. As shown, specific combinations of receptor/ligand expression are 
associated with key events occurring during the spermatogenic cycle, namely differentiation 
of spermatogonia, onset and completion of meiosis, and spermatid differentiation. Notch 
signaling results from the specific activation of Notch receptors (Shimizu et al., 2002; Yuan et 
al., 2012). In the complex cellular syncytium that constitutes the seminiferous epithelium, 
ligand expression by one cellular type may signal back to the preceding cell types, regulating 
their progression into the next differentiation step. Additionally, cell-autonomous Notch 
signaling may trigger forward cell differentiation. The presence of different receptors within a 
cell-type may be relevant for cell identity and function. The expression patterns observed 
address the need of future studies involving conditional specific Notch pathway mutant mice 





Chapter II - Notch pathway gene components and effectors are differentially 
transcribed and expressed along the epididymis epithelium. 
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Spermatozoa undergo sequential maturation changes during their transit along the 
epididymis. These changes, critical for the acquisition of fertilizing ability, are modulated by 
proteins secreted by epididymal epithelial cells, mainly transferred to spermatozoa within 
cytoplasmic exocytosis vesicles, the epididymosomes. This dynamic process requires a 
finely tuned epithelial gene expression. The Notch cell signaling pathway is a major regulator 
of cell fate decisions in several tissues, including the testis. Here, we evaluated the 
transcription and expression patterns of Notch components (Notch1-3, Dll1, Dll4 and 
Jagged1) and effectors (Hes1, Hes2, Hes5 and Nrarp) in the adult mouse epididymis.  
Notch components and effectors are transcribed and expressed in the epididymis and 
deferens duct of adult male mouse, and nuclear detection of Notch effectors indicates that 
Notch signaling is active. Each segment of the epididymis and the deferens duct exhibit a 
specific combination of epithelial receptor/ligand/effector expression patterns. Notch 
components (but not effectors) are identified in the cytoplasmic droplet of spermatozoa, in a 
dynamic and specific pattern along the epididymis. Additionally, Notch components are 
identified within large and small vesicles in the epididymis lumen. We hypothesize that these 
vesicles (putative epididymosomes) allow Notch signaling at distance from epididymal 
epithelial cells to spermatozoa. Altogether, these results prompt for a role of Notch signaling 
in the regulation of the pace of serial events occurring along the epididymis, through 
signaling between epithelial cell types and spermatozoa. This may be crucial for the 
orchestration of epithelial cell secretory function, luminal milieu homeostasis and 
spermatozoa maturation.  
 
 




In the mouse, following spermatogenesis, spermatozoa travel along the epididymis for 10-13 
days, being then stored in the tail and deferens duct (Turner, 1995; Belleannée et al., 2012). 
During transit and storage, sperm cells sequentially undergo a series of maturational 
changes that lead to the generation of fully functional gametes. These changes are 
modulated by proteins produced by epididymis epithelial cells, liberated into the lumen 
(Cuasnicú et al., 1984), which interact with spermatozoa (Sullivan et al., 2005). Epididymis 
epithelial cells also provide instructive signals to spermatozoa by transferring proteins within 
vesicles named epididymosomes (Saez et al., 2003; Caballero et al., 2013), already 
described in several mammalian species (Légaré et al., 1999; Frenette & Sullivan, 2001; 
Rejraji et al., 2006; Caballero et al., 2013). The protein composition of epididymosomes 
varies along the epididymis, and from this organ to the ejaculated semen (Frenette, et al., 
2006a; Girouard et al., 2011). Although it is now consensual that the interaction between 
epididymosomes and spermatozoa is critical for sperm cells maturation (Sullivan et al., 
2007), the complex and finely tuned regulation of this interaction is yet very poorly 
understood. Deciphering the mechanisms that regulate the maturation of sperm cells will 
have a relevant impact in the development of new reproductive medicine strategies for 
fertility control, both in humans and animals. 
The epididymis is divided into four segments known, from proximal to distal, as the initial 
segment, the head/caput, the body/corpus, and the tail/cauda (Abou-Haïla & Fain-Maurel, 
1984; Turner et al., 2003). The epithelium contains different cell types with specific functions 
(Joseph et al., 2011; Belleannée et al., 2012). Principal cells comprise the majority of the 
epithelial cell population, and synthesize essentially all proteins liberated into the epididymis 
lumen (Sun & Flickinger, 1979; Joseph et al., 2011), namely within epididymosomes 
(Sullivan et al., 2007). Narrow and apical cells are mainly present in the initial segment 
(Adamali & Hermo, 1996; Joseph et al., 2011), and are associated with protein degradation 
and lumen pH control (Adamali & Hermo, 1996). Clear cells are present throughout the 
epididymis, but are more frequent in the body and tail. These large cells, characterized by 
the presence of numerous vesicles and endosomes in their apical region (Hermo, Dworkin, & 
Oko, 1988), display strong endocytic activity, being responsible for the uptake of proteins 
excreted by the epididymis epithelium, as well as the contents of spermatozoa’s cytoplasmic 
droplet (Hermo et al., 1988). Basal cells, located against the basement membrane, sense the 
luminal environment and may regulate function of principal and clear cells (Cheung et al., 
2005; Shum et al., 2009). The composition of the intraluminal milieu varies along the 
epididymis, reflecting a fine regulation of gene expression in epididymis epithelial cells (Krull 
et al., 1993; Guyonnet et al., 2011). 
Notch is an evolutionarily well-conserved cell signaling pathway implicated in cell fate 
decisions in several tissues (Artavanis-Tsakonas et al., 1995; Borggrefe & Oswald, 2009). 
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Our recent work (Murta et al., 2013) showed that Notch signaling is active during testis 
development and adult spermatogenesis. Although the Notch pathway involvement in 
epididymis development has been reported (Hayashi et al., 2004c; Lupien et al., 2006; Hahn 
et al., 2009), it is unknown whether activation of Notch signaling occurs in the adult male. In 
mammals, four receptors (Notch1-4) and five ligands (three delta-like - Dll1, Dll3 and Dll4 - 
and two serrate-like - Jagged1 and Jagged2) were identified (Borggrefe & Oswald, 2009). 
Notch receptors are activated by binding with ligands expressed on neighboring cells. This 
leads to the cleavage of Notch receptors intracellular domain by a γ-secretase complex and 
its translocation to the nucleus, thus regulating transcription of Notch target genes (Borggrefe 
& Oswald, 2009). The more ubiquitous Notch target genes are the hairy/enhancer of split 
genes (Ohtsuka et al., 1999; Fischer & Gessler, 2007).  
Here, we evaluated the transcription of Notch component and effector genes, and their 
expression patterns along the epididymis of adult male mouse. We found that Notch 
signaling is active in epididymis epithelial cells, and that Notch proteins are present in the 
cytoplasmic droplet of spermatozoa and within vesicles in the epididymis lumen. The 
expression patterns of Notch components and effectors are specific for each epithelial cell 
type along the epididymis. These results prompt for a role of Notch signaling as a regulator of 
epididymis epithelial function and spermatozoa maturation.  
 
3. Materials and Methods 
3.1. Animals 
Experiments were conducted in compliance with the Portuguese legislation for the use of 
animals for experimental purposes (Decreto-Lei nº 129/92 and Portaria nº 1005/92, DR nº 
245, série I-B, 4930-42) and with the European Union legislation (Directive n. 86/609/EEC, 
from the 24th November 1986). Mice manipulation protocols were approved by the national 
regulatory agency (DGAV – Direção Geral de Alimentação e Veterinária) and the Institutional 
Animal Care and Use Committee (CEBEA – Comissão de Ética e Bem-Estar Animal). All 
authors are accredited as FELASA category C scientists or equivalent. 
CD1 mice were maintained in a 12-hour light/dark cycle, in ventilated cages with corn cob as 
bedding, and were given access to standard laboratory diet and water ad libitum. The mice 
health was routinely monitored. Outbred CD1 animals (n = 6) with three months of age were 
chosen to introduce normal biological variability within the experiment. Prior to beginning of 
the experiment, mice were caged separately with used female bedding, and after four days 
joined with a female until the observation of a vaginal plug, to grant normal reproductive 




3.2. Experimental Design 
Mice were euthanized by cervical dislocation under ketamine (15mg/kg)/xylazine (1mg/kg) 
anesthesia, followed by exsanguination. Reproductive tracts were collected and the 
epididymis and deferens duct dissected free of the testis. Each epididymis was divided into 
the following segments: efferent duct, initial segment, proximal head, distal head, proximal 
body, distal body, tail and deferens duct. All segments from one side were processed for IHC 
and the contralateral ones processed for RNA extraction and subsequent RT-PCR.  
 
3.3. Immunohistochemistry 
Epididymis segments were fixed in 4% neutral phosphate buffered formalin at room 
temperature for 24h and, after subsequent dehydration in ethanol, were embedded in 
paraffin. Spatial localization of expression of Notch pathway components (Notch1, Notch2, 
Notch3, Dll1, Dll4, Jagged1) and effectors (Hes1, Hes2, Hes5) was evaluated by IHC, 
according to a previously described method (Silva et al., 2010). Slices were orientated in 
parallel to the longitudinal axis, considering sequential sections of 3 µm and sequential twin-
slides for each Notch component (minimum of 3 slices per epididymis for each Notch 
component and effector in all 6 animals). Tissue sections were counterstained with 
haematoxylin. The antigen retrieval step was performed in citrate buffer (10mM, pH 6.0), 
except for anti-Notch1, anti-Hes1, anti-Hes2 and anti-Hes5 antibodies (Tris-EDTA, pH 9.0). 
Blocking was performed in PBS with 2% w/v bovine serum albumin (A7906, Sigma-Aldrich, 
Inc.) for one hour at room temperature. Tissue sections were incubated overnight at 4ºC with 
the following primary antibodies: rabbit anti-Notch1 (ab27526, Abcam, diluted 1:100), rabbit 
anti-Notch2 (ab8926, Abcam, diluted 1:100), rabbit anti-Notch3 (ab23426, Abcam, diluted 
1:160), rabbit anti-Dll1 (ab10554, Abcam, diluted 1:100), rabbit anti-Dll4 (ab7280; Abcam, 
diluted 1:200), rabbit anti-Jagged1 (SC-8303, SantaCruz Biotechnology, diluted 1:50), rabbit 
anti-Hes1 (ab71559, Abcam, diluted 1:100), rabbit anti-Hes2 (ab134685, Abcam, diluted 
1:100) and rabbit anti-Hes5 (ab25374, Abcam, diluted 1:200). The negative controls were 
performed with the polyclonal rabbit IgG (ab27478, Abcam, diluted 1:100). All primary 
antibodies were diluted in blocking solution. The peroxidase conjugated goat anti-rabbit IgG 
polyclonal antibody (Dako 410972, diluted 1:100) was used as secondary antibody. Staining 
was evaluated in the entire slice, and expression patterns were established following the 
evaluation of a minimum of 18 slices (3 slices/epididymis x 6 animals) for each Notch 
component and effector. Antibodies anti-Notch components and effectors were previously 
validated by others in the mouse (anti-Notch1 (Cheng et al., 2007), anti-Notch3 (Feng et al., 
2010), anti-Dll1, (Sörensen et al., 2009) anti-Dll4, (Sörensen et al., 2009) anti-Jagged1, 
(Bielesz et al., 2010) anti-Hes1 (Rahman et al., 2013) and anti-Hes5 (Takanaga et al., 2009)) 
and rat species (anti-Notch2 (Saravanamuthu et al., 2009)). The anti-Hes2 antibody is 
predicted to work in mouse, according to the manufacturer. 
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Notch signaling activation was considered to be present only when nuclear detection of 
Notch effectors (Hes1, Hes2 and Hes5) was evident. 
 
3.4. RT-PCR 
Epididymis segments were individually and immediately frozen in liquid nitrogen and stored 
at −80 ºC until assay. RNA extraction, cDNA synthesis and mRNA transcription was 
performed as previously described (Silva et al., 2012). The detection of Notch pathway 
genes (Notch1, Notch2, Notch3, Dll1, Dll4, Jagged1) and gene effectors (Hes1, Hes2, Hes5, 
Nrarp) were analyzed with specific primer pair sequences. Transcription of gene β2mg was 
used as an endogenous control. Primer pair sequences are available in Annex I. 
 
4. Results  
4.1. Notch pathway component and effector genes are transcribed along the 
epididymis and in the deferens duct. 
As shown in Figure 19, all Notch component genes (Notch1-3, Dll1, Dll4, Jagged1) are 
transcribed in the three epididymis segments and in the deferens duct. Of the Notch effector 
genes (Hes1, Hes2, Hes5 and Nrarp), only Hes1 and Nrarp are transcribed in the three 
epididymis segments and in the deferens duct, while Hes5 is transcribed in the epididymis 
body and in the deferens duct, and Hes2 has a low transcription in the epididymis body and 
tail.  
 
4.2. Notch pathway components and effectors are differentially expressed along the 
epididymis and in the deferens duct. 
Figure 20 shows the expression patterns of Notch components along the epididymis and in 
the deferens duct. Below follows a brief description of the most notable features. Notch1 is 
expressed in principal cells of the epididymis and deferens duct, in narrow and apical cells, 
and in basal cells of the initial segment (A, G, M, S, a, g, m, s). Notch2 is ubiquitous, being 
expressed along the epididymis and deferens duct (B, H, N, T, b, h, n, t). Notch3 is 
expressed in most epithelial cell types, although for each cell type expression occurs in 
specific segments (C, I, O, U, c, i, o, u). Dll1 is expressed in principal cells of most of the 
epididymis and deferens duct, and in basal cells of the epididymis body, tail and deferens 
duct (D, J, P, V, d, j, p, v). Dll4 is also expressed in principal cells of most of the epididymis 
and deferens duct, in narrow and apical cells, and in basal cells along the epididymis (E, K, 
Q, W, e, k, q, w). Dll4 is the only ligand expressed in clear cells (k). Jagged1 is expressed in 
principal and basal cells until the epididymis tail and in narrow and apical cells (F, L, R, X, f, l, 
r, x).  
Figure 21 shows the detection of Notch effectors along the epididymis and deferens duct. 
Hes1 is detected in all epididymis and deferens duct epithelial cells (A, D, G, J, M, P, S, V). 
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Hes2 is not detected in the nucleus of epididymis head and deferens duct epithelial cells (B, 
E, H, K, N, Q, T, W), although being detected in the cytoplasm of the deferens duct 
epithelium (W). Hes5 is only detected in epithelial cells of the body (O, R).  
All the above information is schematically illustrated in Figure 22 and summarized in Table 1.  
 
Figure 19 – Transcription of Notch pathway component and effector genes along the 
epididymis and in the deferens duct. 
 
Gel visualization of Reverse Transcriptase PCR results of samples recovered from different segments 
of the epididymis (head, body, tail) and from the deferens duct. β2mg: internal control of reaction 




Figure 20 – Expression patterns of Notch pathway components along the epididymis 
and in the deferens duct. 
  
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Control was 
produced with rabbit IgG. Narrow and apical cells were only identified in the initial segment and 
epididymis head, and clear cells were only identified in the epididymis body. Arrow heads point to 
narrow and apical cells. Arrows point to basal cells. Bold arrows point to clear cells. Notch1 is 
expressed in principal cells along the epididymis and deferens duct (A, G, M, S, a, g, m, s ), in narrow 
and apical cells (S), and in basal cells of the initial segment (G). Notch2 is expressed in all epithelial 
cell types along the epididymis and deferens duct (B, H, N, T, b, h, n, t). Notch3 is expressed in 
principal cells (except in the proximal head segment), in narrow and apical cells, and in basal cells of 
the initial segment, distal head segment, proximal body segment, tail and deferens duct (C, I, O, U, c, 
i, o, u). Dll1 is expressed in efferent duct, body and tail principal cells, and in basal cells of the body, 
tail and deferens duct (D, J, P, V, d, j, p, v). Dll4 is expressed in principal cells (except in proximal 
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head, distal body and tail), in initial segment and distal head narrow and apical cells, in clear cells, and 
in basal cells (except in proximal head, distal body and tail) (E, K, Q, W, e, k, q, w). Jagged1 is 
expressed in principal (except tail and deferens duct), basal (except tail and deferens duct) and in 
narrow and apical cells (F, L, R, X, f, l, r, x). 
  
4.3. Notch pathway components, but not Notch effectors, are differentially detected 
in epididymis spermatozoa and lumen 
Figure 23 shows the detection patterns of Notch components in spermatozoa and the lumen 
along the epididymis. Notch effectors were not detected in spermatozoa and the epididymis 
lumen. As shown, Notch1 is detected over the sperm head, in spermatozoa present in the 
epididymis head (A). Notch2, Notch3, Dll1 and Dll4 are detected in spermatozoa’s 
cytoplasmic droplet. However, while Notch2 and Dll4 are detected along the entire 
epididymis (B, H, N and E, K, Q, respectively), Notch3 is only detected in the epididymis 
body (I), and Dll1 is only detected in the epididymis body and tail (J, P). Jagged1 is not 
detected in spermatozoa’s cytoplasmic droplet.  
Additionally to the detection in spermatozoa’s cytoplasmic droplet, Notch components were 
also detected within large and small vesicles in the epididymis lumen. Notch2, Notch3 and 
Dll1 were detected in large vesicles (H, I, J, respectively), Dll4 in large and small vesicles (K, 
Q), and Jagged1 only in small vesicles in the body and tail segments (L, R).  
 
5 Discussion  
Here is reported the dynamic transcription and expression patterns of Notch pathway 
component and effector genes in the adult mouse epididymis and deferens duct. Although 
some Notch components were previously identified during epididymis post-natal (Hayashi, 
2004c) and pre-natal development (Lupien et al., 2006; Hahn et al., 2009), this study reports 
for the first time the dynamics of Notch transcription, and expression in different epithelial cell 
types along the epididymis and deferens duct of adult male mice. Notch pathway 
components show a dynamic and specific expression pattern in different epithelial cell types 
along the epididymis and deferens duct. Each epididymis segment shows a specific 
combination of Notch components’ epithelial expression. The nuclear detection of Notch 
effectors in the epididymis and deferens duct epithelium confirms that Notch signaling is 
active. Altogether, these results strongly prompt for a role of Notch signaling in epididymis 
function. 
Notch components are expressed and effectors Hes1 and Hes2 are detected in the efferent 
ducts’ epithelium. The efferent ducts allow the transport of spermatozoa from the testis to the 
epididymis, and their epithelial function is modulated by luminal factors arising from the testis 
(Joseph et al., 2011). It is possible that Notch signaling is regulating cilium function, as 




Figure 21– Detection of Notch pathway effectors along the epididymis and in the 
deferens duct. 
 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Notch signaling 
activation was considered to be present only when nuclear detection of Notch effectors (Hes1, Hes2 
and Hes5) was evident. Control was produced with rabbit IgG. Narrow and apical cells were only 
identified in the initial segment and epididymis head, and clear cells were only identified in the 
epididymis body. Arrow heads point to narrow and apical cells. Arrows point to basal cells. Hes1 is 
ubiquitously detected in epithelial cells along the epididymis and deferens duct (A, D, G, J, M, P, S, V). 
Hes2 is not detected in the epididymis head and deferens duct epithelium (B, E, H, K, N, Q, T, W). 




Figure 22 - Schematic illustration of expression patterns of Notch pathway 
components and effectors along the epididymis and in the deferens duct. 
 
Draw-scheme representing mouse epididymis epithelium, and the cellular localization of Notch 
components and effectors expression (from left to right: receptors; ligands; effectors). Arrow heads 
point to narrow and apical cells. Bold arrows point to clear cells. Arrows point to basal cells. Principal 
cells are unmarked. 
 
As depicted from Figure 22 and Table 1, each epididymis segment shows a specific 
combination of Notch receptor/ligand/effector gene expression pattern in their epithelium. 
This may indicate that Notch signaling is differentially and dynamically regulating epididymis 
function. These unique combinations of receptor/ligand/effector expression probably elicit 
specific responses in each cell type in the different epididymis segments. The composition of 
the epididymis luminal milieu changes along its segments, which relies on a well-
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orchestrated and fine regulation of epididymis gene expression (Krull et al., 1993; Guyonnet 
et al., 2011). Whereas secretions from epididymis head and body are related to sperm 
motility and fertilizing ability (Turner, 1995), secretions from the tail are related to 
spermatozoa storage in conditions that preserve their fertilizing ability (Jones & Murdoch, 
1996). Thus, Notch signaling along the epididymis may be relevant for the serial regulation of 
the epithelium’s secretory functions, which in turn regulate spermatozoa maturation. This 
may encompass the regulation of the pace of epithelial secretory and spermatozoa 
maturation events, as also proposed for spermatogenesis (Murta et al., 2013). Additionally, 
Notch signaling may be regulating the epithelium homeostasis, controlling the intercellular 
signaling between different cell types. 
 
Table 1 – Epididymis segment specific expression combinations of Notch pathway 
component and effector genes in each cell type. 
  
IS – Initial segment, Head P – epididymis head proximal segment, Head D – epididymis head distal 
segment, Body P – epididymis body proximal segment, Body D – epididymis body distal segment, 
Deferens – Deferens duct, N1 – Notch1, N2 – Notch2, N3 – Notch3, D1 - Dll1, D4 – Dll4, J1 – 
Jagged1, H1 – Hes1, H2 – Hes2, H5 – Hes5. 
 
  
Cell types Proteins IS Head P Head D Body P Body D Tail Deferens
Receptors N1/N2/N3 N1/N2 N1/N2/N3 N1/N2/N3 N1/N2/N3 N1/N2/N3 N1/N2
Ligands D4/J1 J1 D4/J1 D1/D4/J1 D1/J1 D1 D4
Effectors H1/H2 H1 H1 H1/H2/H5 H1/H2/H5 H1/H2 H1
Receptors N1/N2/N3 N1/N2/N3 N1/N2/N3
Ligands D4/J1 J1 D4/J1




Receptors N1/N2/N3 N2 N2/N3 N2/N3 N2 N2/N3 N2/N3
Ligands D4/J1 J1 D4/J1 D1/D4/J1 D1/J1 D1 D1/D4








Figure 23 – Expression patterns of Notch pathway components in epididymis 
spermatozoa and lumen. 
Positive staining in brown, counterstaining with haematoxylin (1000x magnification). Notch1 is 
detected over the sperm head in the epididymis head (A). Notch2, Notch3, Dll1 and Dll4 are detected 
in the spermatozoa’s cytoplasmic droplet: Notch2 is detected along the epididymis (B, H, N); Notch3 is 
detected in the epididymis body (I); Dll1 is detected in the epididymis body and tail (J, P); Dll4 is 
detected along the epididymis (E, K, Q). Notch2 (H), Notch3 (I), Dll1 (J) and Dll4 (K, Q) are detected 
within large vesicles in the epididymis lumen. Dll4 is also detected within small vesicles (K, Q), as well 
as Jagged1 in the lumen of the epididymis body and tail (L, R). Dll4 and Jagged1 are detected in the 
spermatozoa’s tail: Dll4 is detected along the epididymis; Jagged1 is only detected in the epididymis 
body. Arrows point to Notch1. Arrow heads point to cytoplasmic droplets. Bold arrows point to large 
vesicles. Tailed arrows point to small vesicles. 
 
Notch2, Notch3, Dll1 and Dll4 are detected in the cytoplasmic droplet of spermatozoa, and 
together with Jagged1 are also detected within large and small vesicles in the epididymis 
lumen. The presence of these Notch components follows a specific pattern along the 
epididymis. As Notch effector genes are not detected in spermatozoa and in the epididymis 
lumen, and expression of both Notch component and effector genes occurs in epididymis 
epithelial cells, we propose that these proteins are transferred to spermatozoa and to the 
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lumen within epididymosomes, as reported for other proteins (Légaré et al., 1999; Frenette & 
Sullivan, 2001; Sullivan et al., 2007). This may allow signaling at distance between 
epididymis epithelial cells, spermatozoa and oviduct/uterine epithelial cells. Notch signaling 
at distance was recently reported (Sheldon et al., 2010; Lu et al., 2013). Transfer of Notch 
components between different testis cell types was recently described by us (Murta et al., 
2013). The timely orchestrated transfer of Notch proteins to epididymis spermatozoa and 
luminal fluid may be relevant for sperm cells’ maturation or interaction with the oviduct and 
oocyte, as also observed with other proteins (Légaré et al., 1999; Frenette et al., 2004; 
Sullivan et al., 2005; Frenette, Thabet, & Sullivan, 2006b).  
All Notch components and effectors are transcribed in the epididymis. The use of whole 
tissue for RT-PCR probably originates some background noise resulting from transcription 
outside the epididymis epithelium (endothelial cells, smooth muscle cells and mesenchymal 
cells) (Zavadil et al., 2004; Boucher et al., 2012). This may explain inconsistencies between 
transcription and expression. 
In conclusion, Notch signaling is active in the epididymis and deferens duct of adult male 
mouse. Each segment of the epididymis and the deferens duct exhibit a specific combination 
of epithelial receptor/ligand/effector expression patterns. Notch components are detected in 
the cytoplasmic droplet of spermatozoa, and within large and small vesicles in the epididymis 
lumen, in a dynamic and specific fashion along the epididymis. Altogether, these results 
prompt for a regulatory role of Notch signaling in epididymis function. We hypothesize that 
Notch signaling may regulate the pace of serial events occurring along the epididymis. This 
signaling between different epithelial cell types and spermatozoa along the epididymis may 
be crucial for epithelial differential secretory function, luminal milieu homeostasis and 






Chapter III - In vivo Notch blockade induces male germ cell fate aberrations and 
apoptosis, and increases spermatozoa defects 
 
 
Murta, D., Batista, M., Trindade, A., Silva, E., Henrique, D., Duarte, A., Lopes da Costa, L.  
 




Objective: Evaluate effects of Notch pathway blockade in spermatogenesis 
Design: Comparison of spermatogenesis between control untreated and DAPT treated adult 
mice 
Setting: University laboratory 
Animals: CD1 laboratory mice 
Interventions: DAPT treatment and euthanasia 
Main Outcome Measures: Testis samples were collected and processed for 
immunohistochemistry. Expression patterns of Notch components were evaluated. Germ 
cells identity, morphology and apoptosis were determined. Spermatozoa were collected from 
the epididymis tail and assessed for motility, morphology, concentration, and in vitro 
fertilization. Plasma testosterone concentrations were measured. Transcription of Notch 
effectors was analyzed in epididymis tissue. 
Results: In vivo Notch pathway blockade by DAPT disrupted the expression patterns of 
Notch components in the testis, induced male germ cell fate aberrations and apoptosis, 
mainly in the last stages of the spermatogenic cycle, and increased epididymis spermatozoa 
defects.  
Conclusions: Blockade of Notch signaling in the testis and epididymis induced abnormal 
spermatogenesis and spermatozoa maturation, which implicates Notch signaling in the 









Mammalian spermatogenesis involves continuous serial cellular proliferation and 
differentiation events, which occur in the complex cellular syncytium of the seminiferous 
tubules. These spatial-temporal cellular changes characterize the spermatogenic cycle, 
which, in the mouse, encompasses 12 stages (Oakberg, 1957). Released spermatozoa 
sequentially undergo maturation changes during transit along the epididymis, which lead to 
the acquisition of fertilizing ability (Cooper & Yeung, 2006). These changes are modulated by 
epididymis epithelial cells, through the sequential modification of the luminal milieu 
composition, and the transfer of proteins to spermatozoa (Sullivan et al., 2007). Germ cell 
remodeling occurring at the spermatogenic cycle and epithelial secretion along the 
epididymis require a finely tuned cellular signaling and a well-orchestrated gene expression. 
Deciphering the regulatory signaling behind these events could potentially lead to the 
development of new therapeutic strategies addressed to male infertility and contraception. 
Notch is an evolutionarily conserved cell signaling pathway implicated in cell fate decisions in 
several tissues (Artavanis-Tsakonas et al., 1995; Borggrefe & Oswald, 2009). In mammals, 
four receptors (Notch1-4) and five ligands (Dll1, Dll3, Dll4, Jagged1 and Jagged2) were 
described (Borggrefe & Oswald, 2009). Notch signaling occurs following the coupling of the 
extracellular domain of receptors with ligands expressed on neighboring cells, which leads to 
cleavage of Notch intracellular domain (NICD) by a γ-secretase and its translocation to the 
nucleus. Here, it forms a complex with a transcriptional regulator RBP-jk and other co-
regulators, regulating transcription of effector target genes (Borggrefe & Oswald, 2009). 
From the limited set of Notch target genes so far identified, the hairy/enhancer of split genes 
are the most ubiquitous (Fischer & Gessler, 2007). 
The role of Notch signaling in mammalian spermatogenesis is controversial. Several studies 
detected expression of Notch proteins in the testis of neonate and adult mice (Dirami et al., 
2001; Mori et al., 2003; von Schönfeldt et al., 2004; Garcia & Hofmann, 2013; Garcia et al., 
2013), or associated this pathway with male infertility (Hayashi et al., 2001; Hayashi, 2004b; 
Sahin et al., 2005). However, two studies (Hasegawa et al., 2011; Batista et al., 2012), using 
genetically engineered mice, reported that the majority of Notch genes are not transcribed in 
the seminiferous tubules, and that Notch blockade in germ and Sertoli cells has no effects in 
the normal course of spermatogenesis. Recently, we described the expression patterns of 
Notch component and effector genes along mouse testis post-natal development and 
throughout the spermatogenic cycle (Murta et al., 2013). Results prompted for a relevant role 
of Notch signaling in mammalian testis development and spermatogenesis.  
The objective of this study was to evaluate the effects of in vivo Notch blockade on 
spermatogenesis and epididymis function. Based on previous results, our hypothesis was 
that Notch signaling is a major regulator of germ cell fate decisions occurring during the 
spermatogenic cycle, and of spermatozoa maturational changes occurring along the 
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epididymis. To test this hypothesis we blocked in vivo Notch signaling using the γ-secretase 
inhibitor N-S-phenyl-glycine-t-butyl ester (DAPT), and evaluated the expression patterns of 
Notch component genes, germ cell fate and apoptosis during spermatogenesis, and 
epididymis spermatozoa characteristics. Validating our hypothesis, blockade of Notch 
signaling induced abnormal spermatogenesis and spermatozoa maturation. This phenotype 
indicates a relevant regulatory role of Notch signaling in male reproductive function.  
 
3. Materials and methods 
3.1 Animals 
All experiments were conducted in accordance with the Portuguese legislation for the use of 
animals for experimental purposes (Decreto-Lei nº 129/92 and Portaria nº 1005/92, DR nº 
245, série I-B, 4930-42) and with the European Union legislation (Directive n. 86/609/EEC, 
from the 24th November 1986). Mice manipulation protocols were approved by the national 
regulatory agency (DGAV – Direção Geral de Alimentação e Veterinária) and the Institutional 
Animal Care and Use Committee (CEBEA – Comissão de Ética e Bem-Estar Animal). All 
authors are accredited as FELASA category C scientists or equivalent. 
Outbred CD1 mice were chosen to introduce normal biological variability within the 
experiment. Mice were maintained in a 12-hour light/dark cycle, in ventilated cages with corn 
cob as bedding, and were given access to standard laboratory diet and water ad libitum. 
Mice health was monitored daily. Prior to the experiment, male mice were caged separately 
with used female bedding and, after four days, joined with a female until the production of a 
vaginal plug, to grant normal reproductive behavior and the presence of active 
spermatogenesis. 
 
3.2 Experimental Design  
Male mice (n = 24) with 3 months of age were randomly assigned to 4 groups: i) DAPT 
(Sigma-Aldrich, Inc., D5942) treatment during 25 days; ii) DAPT treatment during 43 days; iii) 
Control group (vehicle alone) during 25 days; and iv) Control group (vehicle alone) during 43 
days. In adult mice, spermatogenesis (release of spermatozoa in the seminiferous tubule’s 
lumen) takes 43 days (Clermont & Trott, 1969). We evaluated DAPT treatment effects at half 
the time (25 days) and at the time (43 days) required to accomplish spermatogenesis. Side-
effects of Notch blockade by γ-secretase inhibitors are time and dose dependent (Doerfler, 
Shearman, & Perlmutter, 2001). To reduce toxicity, a low dose regimen of 5mg/Kg/day, 5 
days per week was used (Teachey et al., 2008). DAPT powder was reconstituted in 100% 
ethanol (1 mg/mL) and stored in aliquots as stock solution at -20°C. Each day, fresh 
treatment solution was prepared, containing a mixture of 90% corn oil and 10% ethanol 
(Teachey et al., 2008). DAPT and vehicle alone were administered by oral gavage. 
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At the end of the experiment (25 and 43 days), during last hour of dark, mice were 
euthanized through cervical dislocation under ketamine (15mg/kg)/xylazine (1mg/kg) 
anesthesia, followed by exsanguination. A blood sample was collected immediately before 
cervical dislocation and processed for plasma testosterone analysis. From each mouse, the 
testis and one epididymis were dissected free and processed for IHC; one epididymis head 
was processed for RNA extraction, and one epididymis tail used to collect spermatozoa to 
perform a sperm analysis and an in vitro fertilization (IVF) assay. 
 
3.3 Quantitative Gene Transcription Analysis (qRT-PCR) 
Epididymis heads were immediately frozen in liquid nitrogen and stored at −80ºC. RNA 
extraction, cDNA synthesis and mRNA transcription was performed as previously described 
(Silva et al., 2012). Quantification of Notch effector genes Hes1, Hes2, Hes5 and Nrarp 
transcripts was done using selected primers (pair sequences available in Annex I). 
Transcription of gene β2mg was used as an endogenous control. Real-time PCR was 
performed in duplicate wells on StepOnePlus™ (Applied Biosystems, Foster City, CA, USA). 
All PCR reactions were carried out in 96-well optical reaction plates (Applied Biosystems, 
Warrington, UK) with 6.25µl Power SYBR® Green PCR Master Mix (Applied Biosystems, 
Warrington, UK), 2.5ng of diluted cDNA and 80 nM of each primer in a total reaction volume 
of 12µl.  
 
3.4 Histological Evaluation and Apoptosis Assay 
Paraffin sections were stained with haematoxylin. Spermatogenic cycle stages were 
identified as previously described (Hess & Franca, 2008). Stages were grouped in two (I-II, 
III-IV, V-VI, VII-VIII, IX-X, XI-XII) to facilitate description.  
Apoptosis was evaluated by the terminal deoxynucleotidyltransferase-mediated dUTP nick 
end labeling (TUNEL) assay, for in situ visualization of DNA fragmentation, according to 
manufacturer’s instructions (Chemicon, Millipore). The percentage of apoptotic cells was 
determined for each cell type and spermatogenic cycle stage. This evaluation was performed 
on a total of 30 seminiferous tubules per animal. 
 
3.5 Immunohistochemistry  
The spatial expression patterns of Notch components were determined following IHC, 
according to a method previously described (Silva et al., 2010). Staining was evaluated in the 
entire slice. Testis expression patterns were established following the evaluation of a 
minimum of 36 slices (3 slices/testis x 2 testis x 6 animals) for each Notch component (plus 
12 twin-slides with cell marker) in each of the four experimental groups. 
The anti-3β-HSD antibody was used to identify Leydig cells and the anti-DAZL antibody was 
used to identify germ cells. The antibodies against Notch components were previously 
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validated by others in the mouse (anti-Notch1 (Cheng et al., 2007), anti-Notch3 (Feng et al., 
2010), anti-Dll1 (Sörensen et al., 2009), anti-Dll4 (Sörensen et al., 2009), anti-Jagged1 
(Bielesz et al., 2010)) and rat species (anti-Notch2 (Saravanamuthu et al., 2009)). The 
antigen retrieval step was performed in citrate buffer (10mM, pH 6.0), except for the anti-
Notch1 antibody (Tris-EDTA, pH 9.0). Blocking was performed in PBS with 2% bovine serum 
albumin (Sigma-Aldrich, Inc.) for 1 hour at room temperature. Sections were incubated 
overnight at 4ºC with each primary antibody: Notch1 (ab27526, Abcam), diluted 1:100; 
Notch2 (ab8926, Abcam), diluted 1:100; Notch3 (ab23426, Abcam), diluted 1:160; Dll1 
(ab10554, Abcam), diluted 1:100; Dll4 (ab7280; Abcam), diluted 1:200; Jagged1 (SC-8303, 
Santa Cruz Biotechnology), diluted 1:50; 3β-HSD (SC-30820, Santa Cruz Biotechnology), 
diluted 1:300, and DAZL (ab34139; Abcam), diluted 1:250. Negative controls used the 
polyclonal rabbit IgG (ab27478, Abcam), diluted 1:100 and, for the 3β-HSD antibody, the 
goat control IgG (ab37373, Abcam), diluted 1:300. All primary antibodies were diluted in 
blocking solution. The peroxidase conjugated monoclonal mouse anti-goat/sheep IgG 
antibody (A9452, Sigma-Aldrich, Inc.), diluted 1:100, was used as secondary antibody for the 
3β-HSD antibody, and the peroxidase conjugated goat anti-rabbit IgG polyclonal antibody 
(Dako 410972), diluted 1:100, was used as secondary antibody for the remaining primary 
antibodies.  
 
3.6 Epididymis Sperm Analysis 
Epididymis tails were placed in 200µl of Human Tubarian Fluid (HTF) medium at 37 ºC, and 
sliced to allow recovery of luminal fluid. After 5 minutes, tissue was removed from medium, 
and a sample of sperm suspension taken immediately for analysis. Sperm motility 
(progressive forward motility) was evaluated in a 37ºC heated microscope slide. Sperm 
concentration was evaluated in a Neubauer chamber. Total viable sperm/mL was calculated 
(motility x concentration). Sperm morphology was evaluated in eosin-nigrosin stained slides. 
 
3.7 In Vitro Fertilization and Embryo Development 
Epididymis tail spermatozoa were capacitated through incubation in HTF at 37ºC for 2 hours. 
Concentration of viable spermatozoa was normalized to 106/mL. Cumulus-oocyte complexes 
were recovered from superovulated CD1 female mice at 13 hours post hCG injection. 
Oocytes were in vitro inseminated and in vitro cultured in KSOM for 4 days. Cleavage rate 
(proportion embryos ≥ 2 cell stage) and blastocyst rate were evaluated at the end-point of 
culture. Procedures for female superovulation, in vitro insemination and in vitro embryo 




3.8 Measurement of Plasma Testosterone Concentrations 
Total plasma testosterone was assayed without extraction by a solid-phase, competitive 
chemiluminescent enzyme immunoassay (Immulite 1000, Siemens Healthcare Diagnostics, 
Lda., Amadora, Portugal), using a commercial kit (Immulite 1000 Total Testosterone kit, 
Siemens). The inter-assay coefficients of variation were 8.9% and 9.7% for two different 
controls used in the assay (for concentrations of 279 and 735 ngdL−1, respectively; 
Multivalent Control Module, Siemens Healthcare Diagnostics). The intra-assay coefficient of 
variation was 5.1%. 
 
3.9 Statistical Analysis 
Data analysis was performed with the SPSS version 19.0 statistic software. Comparisons 
between groups used the Student’s t-test or One-way ANOVA followed by Bonferroni or 
Tamhane's T2 post-hoc tests (assuming homogeneity of variances or not, respectively). 
Homogeneity of variances was evaluated through the Levene test. Significance was 
determined at the 5% confidence level (p<0.05). 
 
4 Results 
4.1 DAPT Treatment Decreases Transcription of Notch Effector genes Hes1, Hes2, 
Hes5 and Nrarp 
In DAPT treated mice, transcription levels in the epididymis head decreased approximately 
30-40% for genes Hes1, Hes2 and Nrarp, and 75% for gene Hes5, compared with control 
mice (Figure 24).  
 
Figure 24 - DAPT decreases transcription of downstream Notch effector genes Hes1, 
Hes2, Hes5 and Nrarp. 
 
Comparison between a representative animal of each group (Control and DAPT treatment). 
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4.2 DAPT Treatment Disrupts Expression Patterns of Notch Components in the 
Testis 
Disruption of the normal expression patterns was already foreseeable after 25 days of 
treatment (data not shown), but became evident after 43 days of DAPT treatment. Figures 25 
and 26 schematically illustrate the changes in expression patterns of Notch components in 
the testis, following 43 days of DAPT treatment. Figure 27 shows the main changes in 
expression detected in DAPT treated mice. Notch1, Notch2 and Dll1 do not change their 
expression patterns. Notch3 shows ectopic expression in Sertoli cells at stages VI-IX and in 
leptotene and zygotene spermatocytes at stages IX-XII. (B and C). Dll4 stops being 
expressed in leptotene spermatocytes and Sertoli cells at stage IX-X (E and F), and shows 
ectopic expression in pachytene spermatocytes at stage I-IV and in zygotene spermatocytes 
at stage XI-XII (H and I). Jagged1 shows the most extensive changes in the expression 
pattern following DAPT treatment. Ectopic expression is observed in spermatogonia at 
stages II-VII (K and L), in round and elongated spermatids at stage VII-VIII, in leptotene and 
pachytene spermatocytes at stages IX-X (N and O), and in zygotene spermatocytes at 
stages XI-XII (R and S). Additionally, Jagged1 stops being expressed in diplotene 
spermatocytes and germ cells finalizing meiosis at stages XI-XII (R and S).  
Figure 28A shows the percentage of pachytene spermatocytes expressing Dll4 along the 
spermatogenic cycle. As can be depicted, DAPT treatment significantly advances expression 
of this ligand in the spermatogenic cycle. Expression of Notch receptors in pachytene 
spermatocytes is not altered. 
Following DAPT treatment, interstitial Leydig cells gain expression of Jagged1 (Figure 29), 
whereas all other Notch components do not change their expression pattern. 
 
4.3 DAPT treatment induces germ cell fate aberrations and germ cell abnormal 
morphology 
Figure 28B shows the main effects of DAPT treatment on germ cell fate and morphology. 
Abnormal germ cell fate and morphology are observed in almost all seminiferous tubules, 
and although the majority of germ cells proceed in differentiation, this largely leads to the 
production of morphologically abnormal cells. Round spermatids fail to elongate, become 
round, pyknotic and are released into the lumen (E, H), sometimes displaying a small 
nucleus (E). Other germ cells fail to enter a normal cell division. These cells become 
enlarged, with vacuolated cytoplasm and several nuclear fragments (F and G). These 
anomalous cells express all Notch components, are not marked by DAZL (Figure 30 A-F), 
are TUNEL negative (Figure 30 G-I), and are released in the lumen, being also identified in 
the epididymis lumen (Figure 31).  
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Figure 25 – Schematic illustration of expression patterns of Notch pathway receptors 
along the spermatogenic cycle: comparison between control and DAPT treated mice. 
 
Draw-scheme representing stages (I-XII) of the spermatogenic cycle. Spermatogonia (A, In, B); 
spermatocytes (Pl- preleptotene, L- leptotene, Z- zygotene, P- pachytene, D- diakinesis, Mi- meiotic 
division); round spermatids (1-8); elongated spermatids (9-16). Spatial localization of expression of 




Figure 26 – Schematic illustration of expression patterns of Notch pathway ligands 
along the spermatogenic cycle: comparison between control and DAPT treated mice. 
 
Draw-scheme representing stages (I-XII) of the spermatogenic cycle. Spermatogonia (A, In, B); 
spermatocytes (Pl- preleptotene, L- leptotene, Z- zygotene, P- pachytene, D- diakinesis, Mi- meiotic 
division); round spermatids (1-8); elongated spermatids (9-16). Spatial localization of expression of 




Figure 27 – Disruption of expression patterns of Notch components along the 
spermatogenic cycle following DAPT treatment. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Arrow heads point 
Sertoli cells. Tailed arrows point leptotene spermatocytes. Bold arrows point zygotene spermatocytes. 
Arrows point spermatogonia. Red arrows point pachytene spermatocytes. Control (CTRL) slides used 
rabbit IgG (A, D, G, J, M, P). Notch3 shows ectopic expression in Sertoli cells and in leptotene 
spermatocytes at stages IX-X. (B and C). Dll4 stops being expressed in leptotene spermatocytes and 
Sertoli cells at stage IX-X (E and F), and shows ectopic expression in zygotene spermatocytes at 
stage XI-XII (H and I). Jagged1 shows ectopic expression in spermatogonia at stages V-VI (K and L); 
in leptotene and pachytene spermatocytes at stages IX-X, (N, O); and in zygotene spermatocytes at 
stages XI-XII (R and S). 
 
4.4 DAPT treatment induces increased apoptosis in germ cells  
As shown in Figure 32A, compared to control groups, DAPT treatment induces a significantly 
higher rate of apoptosis in germ cells. However, the apoptotic rate in germ cells is not 
significantly different following the two DAPT treatment lengths. Apoptosis is mainly observed 
at the XI-XII stage, and overall differences in the apoptosis rate observed between DAPT 
treatment and control groups, arise mainly from differences observed at this cycle stage. 
Zygotene spermatocytes and germ cells undergoing last steps of meiotic divisions are the 
most affected by DAPT treatment (Figure 32 B and C).  
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Figure 28 A – DAPT treatment significantly changes the proportion of pachytene 
spermatocytes expressing Dll4. B - DAPT treatment induces formation of abnormal 
germ cells. 
A - (*) p< 0.05; (***) p< 0.001. B - Haematoxylin staining (400x magnification). Arrows mark spermatids 
that fail to elongate. Arrow heads mark germ cells with several small nucleus/nuclear fragments. 
Asterisk marks giant multinucleated germ cell. Seminiferous tubules from control mice (A-D). 
Elongating spermatids appear with several round small nuclei (E, H). Giant multinucleated germ cells 
(F). Enlarged germ cells with vacuolated cytoplasm and several nuclear fragments (G). Round 




Figure 29– DAPT treatment disrupts Jagged1 expression in testis interstitial Leydig 
cells. 
  
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Control (CTRL) 
slides used rabbit IgG (A). Jagged1 is not expressed in Leydig cells of control mice (B), but becomes 
expressed following DAPT treatment (C). Leydig cells are co-localized in twin slides with marker 3β-
HSD (D). 
 
4.5 DAPT treatment disrupts expression patterns of Notch components in 
spermatozoa. 
Expression of Notch2 in the cytoplasmic droplet of spermatozoa along the epididymis is 
decreased in DAPT treated mice, compared to control mice (Figure 33 A, B, G, H, M, N). In 
contrast, expression of Dll1 in the cytoplasmic droplet of spermatozoa along the epididymis is 
increased in DAPT treated mice, compared to control mice (C, D, I, J, O, P). In DAPT treated 
mice, Jagged1 is now expressed in the cytoplasmic droplet of spermatozoa, contrary to that 
observed in control mice, where Jagged1 is only detected in the epididymis lumen (E, F, K, 
L, Q, R). 
 
4.6 DAPT treatment induces decreased motility and increases morphologic defects 
in epididymis spermatozoa.  
As shown in Figure 34A and B, epididymis spermatozoa’s progressive forward motility and 
viable sperm/mL of DAPT treated mice are significantly lower than that of control mice, 
although sperm concentration is not significantly affected by treatment. As expected from 
testis histology results, the proportion of spermatozoa with morphological defects is 
significantly higher in DAPT treated mice than in control mice (Figure 34A). The main 
morphological defects are primary anomalies of the sperm head and midpiece, including 
bent, thin and club-shaped heads, coiled, folded and deformed midpieces, and coiled 




Figure 30 – Abnormal germ cells loose identity. 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Germ cells of 
control mice stain with marker DAZL (A and D). Most abnormal germ cells of DAPT treated mice do 
not stain with marker DAZL (B, C, E and F). TUNEL staining of seminiferous tubules of control (G) and 
DAPT treated (H and I) mice. Abnormal germ cells are TUNEL negative. Arrow heads point abnormal 
germ cells. Arrows point normal dividing germ cells. 
 
4.7 Plasma testosterone concentrations are not affected by DAPT treatment. 
Plasma testosterone concentrations of DAPT treated and control mice are similar (Figure 
35A). 
 
4.8 Fertilizing ability of viable spermatozoa is not affected by DAPT treatment. 





Figure 31 – Abnormal germ cells are released into the epididymis lumen. 
Staining with haematoxylin (400x magnification). Tissue sections from epididymis head and tail lumen 
of control (A and E) and DAPT treated (B-D and F-H) mice. DAPT treated mice show abnormal germ 
cells in the epididymis lumen. Arrow heads point abnormal germ cells. 
 
5 Discussion 
We recently described the transcription and expression patterns of Notch component and 
effector genes in mouse testis post-natal development and along the adult spermatogenic 
cycle (Murta et al., 2013). Results indicated that Notch signaling is active, and prompted for a 
relevant regulatory role of Notch signaling in testis development and during 
spermatogenesis. This conducted to the phenotypic evaluation of in vivo blockade of Notch 
signaling using the γ-secretase inhibitor DAPT.  
To evaluate the level of Notch signaling blockade, transcription of main Notch effector genes 
was analyzed in the epididymis head. This tissue was elected based on its strong epithelial 
expression of Notch component and effector genes (results not shown), and its close 
anatomical proximity and functional relationship with the testis. DAPT decreased 
transcription of Notch effector genes, which evidences that treatment attained the expected 
biological effect. However, the efficacy of treatment was incomplete, probably due to the low 
drug dosage used. This dosage was chosen to avoid toxic secondary effects associated to 
the long treatment schedule, as described by others (Teachey et al., 2008). Therefore, 
results here discussed have to be addressed assuming that most of Notch signaling is still 
potentially active, and that a more efficacious blockade could induce a more representative 






Figure 32 – DAPT treatment significantly increases apoptosis during spermatogenesis 
A – Relative frequency of apoptotic germ cells at all spermatogenic cycle stages and at stages XI-XII. 
Error bars represent the standard error of the mean (SEM). Columns with different superscript differ 
significantly. ab, p< 0.05. B – Apoptosis TUNEL evaluation. TUNEL positive staining in brown, 
counterstaining with haematoxylin (400x magnification). Arrows mark cells at last steps of meiosis. 
Apoptosis in seminiferous tubules of control (A-C) and DAPT treated (D-F) mice. Cells at last steps of 
meiosis are more affected (C, F). C – Relative frequency of apoptotic germ cell types at the most 
affected spermatogenic stage (XI-XII). Error bars represent the standard error of the mean (SEM). 
Columns with different superscript differ significantly: ab, p< 0.05. 
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Figure 33 – DAPT treatment disrupts expression patterns of Notch components in 
epididymis spermatozoa. 
 
Positive staining in brown, counterstaining with haematoxylin (1,000x magnification). Notch2 is 
expressed in spermatozoa cytoplasmic droplet along the epididymis of control mice (A, G, M), but only 
in the epididymis head of DAPT treated mice (B). Dll1 is only expressed in a few spermatozoa 
cytoplasmic droplets in the epididymis body and tail of control mice (I, O), but in most spermatozoa 
cytoplasmic droplets along the epididymis of DAPT treated mice (D, J, P). Jagged1 is not expressed in 
spermatozoa but is detected in the lumen of epididymis body and tail of control mice (K, Q). Jagged1 
is expressed in spermatozoa cytoplasmic droplets along the epididymis in DAPT treated mice (F, L, 
R). Arrow heads point to spermatozoa cytoplasmic droplets. Tailed arrows point to Jagged1 in the 
epididymis lumen. 
 
In vivo Notch blockade disrupts expression patterns of Notch components (Notch3, Dll4 and 
Jagged1). Enhanced expression of Notch3 may be due to a decrease in the activation of 
other receptors. This can also lead to the increase in available ligands and justify the 
enhanced expression of Dll4 and Jagged1, as a compensatory effect. However, as germ cell 
fate and identity are probably the result of unique expression combinations of receptors and 
ligands (Murta et al., 2013), ectopic expression of Notch components may induce 
disturbances in these events, and induce abnormal progression of spermatogenesis, as 




Figure 34 – DAPT treatment significantly decreases spermatozoa motility and viability, 
and increases morphologic defects. 
A – Epididymis tail spermatozoa motility (progressive forward motility) and morphology evaluation.  
(*) p< 0.05; (**) p< 0.01 B – Epididymis tail spermatozoa concentration (number of spermatozoa per mL 
of collection medium) and viability (number of motile spermatozoa per mL of collection medium) 
evaluation. (*) p< 0.05 C – Main spermatozoa morphologic defects found in DAPT treated mice, eosin-
nigrosin stain (400x magnification). Normal spermatozoa (a), morphological defects (b-d). 
  
In vivo Notch blockade induces the formation of morphologically abnormal germ cells, 
including elongated spermatids with a round nucleus and multinucleated vacuolated giant 
cells. The ectoplasmic specialization is the elongated spermatid anchoring system, which 
maintains adherence to Sertoli cells, and confers cell orientation and polarity within the 
seminiferous epithelium (Wong et al., 2008). This spermatid anchoring system is mainly 
composed by Par complex proteins (Wong et al., 2008). Notch signaling is associated to cell 
polarity decisions in tissues involving Par complex proteins, such as the neural epithelium 
(Afonso & Henrique, 2006; Bultje et al., 2009). We have recently reported expression of 
Notch components in the elongated spermatid anchoring system, and nuclear detection of 
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Hes5 in Sertoli cells and in elongating spermatids (Murta et al., 2013). Notch blockade 
induces abnormal spermatid elongation and its premature release into the lumen, and the 
presence of abnormal cells in the lumen of seminiferous tubules and epididymis. This 
indicates a regulatory role of Notch signaling in spermatid’s elongation and maintenance of 
the elongated spermatid anchoring system. Notch pathway was associated with cell division 
(Bultje et al., 2009; Das & Storey, 2012). The formation of multinucleated cells and the 
increased apoptosis of germ cells undergoing the final steps of the meiotic divisions, 
following Notch blockade, indicate that Notch signaling is involved in the regulation of germ 
cell meiosis.  
 
Figure 35 – A - Plasma testosterone concentrations of control and DAPT treated mice. 
B - Cleavage and blastocyst rates following IVF with viable spermatozoa of control and 
DAPT treated mice. 
 
 
In vivo Notch blockade significantly increases the rate of apoptosis in germ cells, mainly at 
stage XI-XII of the spermatogenic cycle. Zygotene spermatocytes are the germ cells most 
affected by apoptosis. Interestingly, these germ cells do not normally express Notch 
components (Murta et al., 2013), but exhibit ectopic expression of Notch3, Dll4 and Jagged1 
following DAPT treatment. Apoptosis in these germ cells may follow loss of identity due to 
blockade of Notch signaling. However, abnormal germ cells stop expressing marker DAZL 
(which indicates loss of germ cell identity), but do not become apoptotic.  
In vivo Notch blockade disrupted the expression patterns of Notch components in Leydig 
interstitial cells, inducing ectopic expression of Jagged1. However, this had no effect on 
plasma testosterone concentrations. 
In vivo Notch blockade disrupted the expression pattern of Notch components in epididymis 
spermatozoa, inducing the ectopic expression of Notch2, Dll1 and Jagged1 in the 
cytoplasmic droplet of spermatozoa. Therefore, Notch blockade might also be affecting 
epididymis epithelial function, impairing spermatozoa maturation. This may be associated 
with the significant decrease in epididymis spermatozoa’s progressive forward motility 
observed following DAPT treatment.  
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In vivo Notch blockade significantly increased the proportion of epididymis spermatozoa with 
primary morphological defects. This feature probably arises from disturbances in 
spermatogenesis, as discussed above, and is also probably contributing to the decrease in 
epididymis spermatozoa progressive forward motility.  
Reduced sperm motility and increased sperm morphological defects are associated with 
reduced fertility (Guzick et al., 2001). Although experimental mice were not allowed to breed 
following DAPT treatment, we performed IVF using viable spermatozoa of DAPT treated and 
control mice. Similar cleavage and blastocyst rates were obtained using viable sperm from 
males of both groups. This indicates that viable spermatozoa arising from non-affected (or 
less-affected) seminiferous tubules are fertile. However, total number of viable spermatozoa 
was significantly lower in DAPT treated than in control mice, which may affect fertility. 
Therefore, the putative effects of abnormal Notch signaling on fertility are probably related 
with the level of Notch pathway activity. Notch deregulation in the testis was associated with 
male fertility problems (Hayashi et al., 2001; Hayashi, 2004b; Sahin et al., 2005; Hahn et al., 
2009), and potentially linked with maintenance and growth of testicular germ cell tumors 
(Hayashi, Yamada, Kageyama, & Kihara, 2004a; Garcia & Hofmann, 2013).  
In conclusion, in vivo Notch blockade disrupts expression patterns of Notch components in 
the testis and in epididymis spermatozoa, induces germ cell fate aberrations, morphological 
abnormalities and apoptosis, decreases motility and increases morphological defects in 
epididymis spermatozoa. This indicates that Notch signaling has a major regulatory role in 
spermatogenesis, namely in germ cell fate and identity, meiosis, differentiation of spermatids, 
and on epididymis spermatozoa maturation. This turns the Notch pathway into an attractive 
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1. Abstract  
Ovarian dynamics along the adult female EC is characterized by cyclic follicle and CL 
development. These events are tightly regulated, involving extensive cell-to-cell 
communication. However, the molecular mechanisms behind these cellular interactions are 
poorly understood. Notch is an evolutionarily well-conserved cell signaling pathway 
implicated in cell fate decisions in several tissues. Here, we evaluated the expression 
patterns of Notch component and effector genes during follicle and CL development along 
the EC. 
Five mature CD1 female mice were euthanized at each EC stage. Blood samples were 
collected for P4 measurement, ovaries were processed for IHC, and expression patterns of 
Notch components (Notch1, 2 and 3, Jagged1 and Dll1 and Dll4), and effectors (Hes1, Hes2 
and Hes5) were characterized. Nuclear detection of Notch effectors indicates that Notch 
signaling is active in the ovary. Notch components and effectors are differentially expressed 
during follicle and CL development along the EC. The spatial and temporal specific 
expression patterns are associated with follicle growth, selection and ovulation/atresia, and 

















Only a small proportion of the ovarian pool of primordial follicles escapes their arrested state 
and resumes growth and development, during female adulthood. This cyclic follicle 
development leads to ovulation and formation of the CL. The follicle and CL, cyclic transient 
endocrine glands, secrete steroid hormones (E2 and P4) that are major regulators of the EC. 
The mouse EC sequentially comprises four stages (proestrus, estrus, metestrus, diestrus) 
and a total length of 4-5 days. Circulating concentrations of E2 peak prior to ovulation, which 
occurs at estrus, whereas P4 concentrations rise during metestrus and diestrus, and then 
decline from proestrus to estrus (Wood et al., 2007). Follicle and CL development and 
steroidogenesis are finely regulated events, involving complex cell-to-cell communication and 
signaling (Stocco et al., 2007). The molecular mechanisms behind this ovarian cellular 
remodeling are still poorly understood. Deciphering these mechanisms could potentially lead 
to the development of new therapeutic strategies addressed to infertility and contraception.  
Notch cell signaling is an evolutionarily conserved pathway that is implicated in cell fate 
decisions in several tissues (Artavanis-Tsakonas et al., 1995; Borggrefe & Oswald, 2009). In 
mammals, four receptors (Notch1-4) and five ligands (three delta-like - Dll1, Dll3 and Dll4 - 
and two serrate-like - Jagged1 and Jagged2) were identified (Borggrefe & Oswald, 2009). 
Notch signaling is activated by binding of the receptor extracellular domain to ligands 
expressed on neighboring cells. This leads to cleavage of the Notch intracellular domain by a 
γ-secretase complex and its translocation to the nucleus, where it associates with other 
transcriptional factors, thus regulating transcription of Notch effector target genes (Borggrefe 
& Oswald, 2009). Only a limited set of Notch target genes were identified in various cellular 
and developmental contexts (Borggrefe & Oswald, 2009), being the hairy/enhancer of split 
genes the most ubiquitous (Fischer & Gessler, 2007). 
Notch signaling was implicated in oocyte and follicle development in Caenorhabditis elegans 
(Kimble & Crittenden, 2007) and Drosophila (López-schier & Johnston, 2001; Ward et al., 
2006; Assa-Kunik et al., 2007; Song et al., 2007), and Notch components were identified in 
the neonate (Trombly et al., 2009; Xu & Gridley, 2013) and adult mammalian ovary (Baker & 
Spears, 1999; Johnson et al., 2001; Hahn et al., 2005; Vorontchikhina et al., 2005; 
Hernandez et al., 2011; Zhang et al., 2011; Fraser et al., 2012; García-Pascual et al., 2013; 
Jovanovic et al., 2013). Additionally, in rodents and primates, aberrant Notch signaling was 
associated with female reproductive disturbances (Trombly et al., 2009; Hernandez et al., 
2011; Fraser et al., 2012; García-Pascual et al., 2013; Xu & Gridley, 2013) and ovarian 
cancer (Park, Shih, & Wang, 2008; Wang, Wu, Wang, & Xin, 2010). Still, the overall available 
information regarding the potential involvement of Notch signaling in the regulation of ovarian 
cellular remodeling is fragmentary.  
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The objective of this study was to evaluate the expression patterns of Notch component and 
effector genes in the mouse ovary along the EC, and their relationship with cellular 
remodeling events occurring during follicle and CL development. Our main hypothesis is that 





Experiments were conducted in compliance with the Portuguese legislation for the use of 
animals for experimental purposes (Decreto-Lei nº 129/92 and Portaria nº 1005/92, DR nº 
245, série I-B, 4930-42) and with the European Union legislation (Directive n. 86/609/EEC, 
from the 24th November 1986). Experimental protocols were approved by the national 
regulatory agency (DGAV – Direção Geral de Alimentação e Veterinária) and the Institutional 
Animal Care and Use Committee (CEBEA – Comissão de Ética e Bem-Estar Animal). All 
authors are accredited as FELASA category C scientists or equivalent. 
CD1 female mice with 3 months of age were maintained in a 12-hour light/dark cycle, in 
ventilated cages with corn cob as bedding, and were given access to standard laboratory diet 
and water ad libitum. The mice health was routinely monitored. Blood samples (1 mL) were 
collected by intracardiac puncture under ketamine (15mg/kg)/xylazine (1mg/kg) anesthesia, 
just before euthanasia through cervical dislocation followed by exsanguination. Outbred CD1 
mice were used to introduce normal biological variability within the experiment. 
 
3.2 Experimental Design 
Expression patterns of Notch pathway components and effectors were evaluated at each of 
the four EC stages (proestrus, estrus, metestrus, and diestrus). Mice were sequentially 
monitored by vaginal smears and the EC stage determined by cytological evaluation. Five 
CD1 female mice were euthanized at each EC stage, and the ovaries were processed for 
IHC. EC stages were confirmed by histological examination of the ovaries and tubular tract, 
and by circulating P4 concentrations as described by others (Wood et al., 2007).  
 
3.3 Immunohistochemistry  
Ovaries were fixed in 4% neutral phosphate buffered formalin at room temperature for 24 
hours and, after subsequent dehydration in ethanol, tissues were embedded in paraffin. 
Samples were sliced towards the center of ovary in several twin slides. Counterstaining was 
done with haematoxylin. Positive staining (brown) was evaluated in the entire slice. Spatial 
localization of expression of Notch pathway components (Notch1, Notch2, Notch3, Dll1, Dll4, 
Jagged1) and effectors (Hes1, Hes2 and Hes5) was evaluated through IHC, as previously 
described (Silva et al., 2010). Proliferating Cell Nuclear Antigen (PCNA) cell marker was 
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used to identify proliferating cells (Zheng, Fricke, Reynolds, & Redmer, 1994; Oktay, 
Schenken, & Nelson, 1995). Only nuclear detection of Notch effectors was considered 
indicative of Notch signaling activation. The antigen retrieval step was performed in citrate 
buffer (10mM, pH 6.0), except for the anti-Notch1, anti-Hes1, anti-Hes2 and anti-Hes5 
antibodies (Tris-EDTA, pH 9.0). Blocking was performed in PBS with 2% w/v bovine serum 
albumin (A7906, Sigma-Aldrich, Inc.) for one hour at room temperature. Sequential sections 
of 3 µm were incubated with primary antibodies anti Notch1 (ab27526, Abcam, diluted 
1:100), Notch2 (ab8926, Abcam, diluted 1:100), Notch3 (ab23426, Abcam, diluted 1:160), 
Dll1 (ab10554, Abcam, diluted 1:100), Dll4 (ab7280; Abcam, diluted 1:200), Jagged1 (SC-
8303, Santa Cruz Biotechnology, diluted 1:50), Hes1 (ab71559, Abcam, diluted 1:100), Hes2 
(ab134685, Abcam, diluted 1:100), Hes5 (ab25374, Abcam, diluted 1:200) and PCNA 
(ab18197, Abcam,, diluted 1:400) overnight at 4ºC. The negative controls were performed 
with a polyclonal rabbit IgG (ab27478, Abcam, diluted 1:100), incubated overnight at 4ºC. All 
primary antibodies were diluted in blocking solution. The peroxidase conjugated goat anti-
rabbit IgG polyclonal antibody (Dako 410972, diluted 1:100) was used as secondary 
antibody.  
The above antibodies were previously validated by others in the mouse (anti-Notch1:(Cheng 
et al., 2007); anti-Notch3: (Feng et al., 2010); anti-Dll1: (Sörensen et al., 2009); anti-Dll4: 
(Sörensen et al., 2009); anti-Jagged1: (Bielesz et al., 2010); anti-Hes1: (Rahman et al., 
2013); and anti-Hes5: (Takanaga et al., 2009)) and rat species (anti-Notch2: 
(Saravanamuthu et al., 2009)), but predicted to work in mouse. According to the 
manufacturer, the anti-Hes2 antibody is predicted to work in the mouse.  
 
3.4 Progesterone Assay 
Blood samples (1 mL) were collected by cardiac puncture just prior cervical dislocation, into 
heparin containing eppendorfs, centrifuged and plasma stored at -20ºC until assay. Plasma 
progesterone concentrations were measured, without extraction, by a solid-phase, 
competitive chemiluminescent enzyme immunoassay (Immulite 1000, Siemens Healthcare 
Diagnostics, Lda., Amadora, Portugal), using a commercial kit (Immulite 1000 Progesterone 
kit, Siemens). Concentrations of P4 were used as an additional aid to stage the EC.  
 
4 Results 
4.1 Notch pathway component and effector genes are differentially expressed 
during follicle development 
Figure 36 shows the expression patterns of Notch component genes during follicle 
development. As shown, Notch1 is not expressed in follicles (B-D), whereas Notch2 is 
expressed at all follicle developmental stages (E-F). Notch3 is not expressed in primordial 
and early primary follicles, but is expressed in granulosa cells of primary (G), pre-antral and 
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antral follicles and theca cells (I, K; follicle staging by PCNA staining - H, J). In antral follicles 
Notch3 is mainly expressed in granulosa cells of the antrum border (I), where PCNA staining 
is strong (J). Dll1 is not expressed in primordial and primary follicles, but is expressed in 
granulosa cells of secondary follicles (L-M). This ligand completely surrounds the oocyte in 
pre-antral and antral follicle stages (O; follicle staging by PCNA staining - N, P). Dll4 is 
expressed at all follicle developmental stages (Q-R). Jagged1 is expressed in granulosa cells 
from primordial to pre-antral follicles, but is not expressed in large antral follicles (S, T, V; 
follicle staging by PCNA staining - U). These results are schematically illustrated in Figure 
37. 
Figure 38 shows the detection of Notch effectors during follicle development. Hes1 is 
detected in granulosa cells at all follicle stages, except antral follicles (C-H). This effector is 
also detected in theca cells and in oocytes of developmentally advanced follicle stages (E, 
H). Hes2 is not detected in follicles (I-K), whereas Hes5 is detected in granulosa cells and 
oocytes at all follicle developmental stages (L-P). 
 
4.2 Notch pathway component and effector genes are differentially expressed 
during corpus luteum development.  
Figure 39 shows expression patterns of Notch component genes during CL development. 
Notch1 is expressed in luteal cells at all EC stages (A-D). Notch2 is also expressed in luteal 
cells at all stages, but staining is increased during diestrus (E-H). Notch3 is expressed in CL 
capillaries and theca cells at all stages (I-L), but only at estrus in luteal cells, evidencing a 
strong staining (J). Dll1 is only expressed in small luteal cells during metestrus and diestrus 
(M-P). Dll4 is expressed in luteal cells at all stages, mainly during proestrus (Q-T). Jagged1 
is expressed in a subset of luteal cells at all stages (U-X), but staining is weak at estrus, 
metaestrus and diestrus (V-X). 
Figure 40 shows the detection of Notch effectors during CL development. Hes1 is detected in 
luteal cells at all EC stages, evidencing strong staining at metestrus (E-H). Hes2 is only 
detected in luteal cells at diestrus (I-L). Hes5 is detected in luteal cells at all EC stages, 
showing a strong staining at proestrus (M-P). Bottom-right corner windows show nuclear 
detection of Notch effectors at a higher magnification (A-P). PCNA staining was used to 





Figure 36 – Expression patterns of Notch pathway component genes during follicle 
development 
Positive staining in brown, counterstaining with haematoxylin. Magnification 400X (A-H, K-V) or 
100X (I, J). Arrows – primordial and early primary follicles; asterisks – primary follicles; Arrow heads 
– secondary follicles; pa – preantral follicles; ant – antral follicles. Scale bars –50 µm. Negative 
controls were performed with polyclonal rabbit IgG (A). PCNA in twin slides is used to stage follicle 
development (Oktay et al., 1995) (H, J, N, P, U). Notch1 is not expressed in follicles (B-D), whereas 
Notch2 is expressed at all follicle stages (E, F). Notch3 is only not expressed in primordial follicles 
(G, I, K). Dll1 is expressed in primary follicles, and surrounding the oocyte along follicle development 
(L, M, O). Dll4 is expressed at all follicle stages (Q, R). Jagged1 is expressed until antrum formation 
(S, T, V). 
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Figure 37 – Schematic illustration of expression patterns of Notch pathway 
components during follicle development 
 
Draw adapted from Orisaka et al. (Orisaka, Tajima, Tsang, & Kotsuji, 2009). 
 
5 Discussion 
Here is reported for the first time the dynamic expression of Notch component and effector 
genes during follicle and CL development along the mouse EC. Although Notch 
components were already identified in the mouse ovary (Baker & Spears, 1999; Johnson et 
al., 2001; Vorontchikhina et al., 2005; Hernandez et al., 2011; Zhang et al., 2011; García-
Pascual et al., 2013; Jovanovic et al., 2013; Xu & Gridley, 2013), this is the first integrated 
evaluation of the expression of multiple Notch component and effector genes along the EC, 




Figure 38 – Detection of Notch pathway effectors during follicle development. 
 
Positive staining in brown, counterstaining with haematoxylin. Magnification 400x (A, B, C, E, I, K, L, 
O) or 1,000x (D, F, G, H, J, M, N, P). Arrows – primordial and early primary follicles; red arrows - 
nuclear staining; asterisks – primary follicles; Arrow heads – secondary follicles; tailed arrows – 
theca cells; pa – preantral follicles. Scale bars – 50 µm. Detection of Notch effector proteins in the 
nucleus was considered indicative of Notch signaling activation. Negative controls were performed 
with the polyclonal rabbit IgG (A, B). Hes1 is detected in granulosa cells (C-H), oocytes of advanced 
stage follicles (E) and theca cells (H). Hes2 is not detected in follicles (I-K). Hes5 is detected in 
granulosa cells and oocytes of all follicle stages (L-P). 
 
Primordial follicles express Notch2, Dll4, Jagged1, Hes1 and Hes5. Some of these proteins 
(Notch2, Jagged1 and Hes1) were associated with primordial follicle nest formation and 
primordial follicle regulation (Trombly et al., 2009; Xu & Gridley, 2013). Additionally, Notch2 
was identified in developing follicles (Johnson et al., 2001; Zhang et al., 2011), and its role 
in granulosa cells’ proliferation was demonstrated in vitro (Zhang et al., 2011). Notch3 is 
expressed in follicular theca and granulosa cells of primary and subsequent follicle stages, 
showing strong expression in antral follicles. In the literature, expression of Notch3 in 
follicles is controversial. This receptor was only identified in capillary endothelial cells 
(Jovanovic et al., 2013), or as here reported, also in developing follicles (Johnson et al., 
2001). As Notch3 knockout mice are viable and fertile (Krebs et al., 2003), this receptor 
may play a redundant role in follicle development. However, Notch3 overexpression is 
associated with ovarian cancer (Park et al., 2008). Notch1 is not expressed in follicles. This 
observation is consistent with other studies identifying expression of Notch1 only in 




Figure 39 – Expression patterns of Notch pathway component genes during corpus 
luteum development. 
 
    (Legend in the next page) 
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(Figure 39 - Legend) Positive staining in brown, counterstaining with haematoxylin (100x 
magnification). Scale bar –50 µm. Negative controls were performed with the polyclonal rabbit IgG (a, 
d). Notch1 (A-D) and Notch2 (E-H) are expressed in luteal cells at all EC stages. Notch3 is expressed 
in CL endothelial and theca cells at all EC stages (I-L), and in luteal cells during estrus (J). Dll1 is 
expressed in in small luteal cells during metestrus and diestrus (M-P). Dll4 (Q-T) and Jagged1 (U-X) 
are expressed in luteal cells at all EC stages. 
 
This is the first study reporting Dll1 expression in the ovary. Dll1 is specifically expressed in 
a subset of granulosa cells of primary follicles. This observation leads to the suggestion 
that signaling through Dll1 is regulating follicle development in a canonical Notch signaling 
mode. This ligand is expressed surrounding the oocyte of secondary follicles and 
subsequent stages of follicle development, and may play a role in oocyte/granulosa cell 
signaling. In contrast, Dll4 is ubiquitously expressed during follicle development, and 
Jagged1 is expressed in primordial and pre-antral follicles. Although Jagged1 was already 
identified in follicles (Johnson et al., 2001; Zhang et al., 2011), expression of Dll4 and 
Jagged1 was also reported to occur only in capillary endothelial cells (Vorontchikhina et al., 
2005; Jovanovic et al., 2013). Notch effectors are detected in the nucleus of follicular cells, 
indicating activation of Notch signaling during follicle development. This is in accordance 
with other studies (Johnson et al., 2001; Trombly et al., 2009). Recently, Hes1 was shown 
to be necessary to oocyte development and maturation (Manosalva, González, & 
Kageyama, 2013). 
The expression patterns of Notch component and effector genes here described prompt for 
a regulatory role of Notch signaling in follicle development. Notch2, Dll4 and Jagged1 may 
be enrolled in primary follicle pool maintenance. Later, receptors Notch2 and Notch3, and 
ligands Dll1, Dll4 and Jagged1, may be involved in triggering follicle development. Notch2 
and Dll4 are always expressed in oocytes and granulosa cells, potentially indicating a role 
in cell identity. Although Jagged2 expression was not evaluated, this ligand was also 
associated to follicle development (Johnson et al., 2001). 
The CL is the site of extensive cellular remodeling, involving growth, differentiation, and 
death of granulosa, theca, capillary, and mesenchymal cells. Interactions between these 
cell types are essential to the steroidogenic competence of the CL (Stocco et al., 2007). In 
rodents, CL regression occurs in two steps. The early functional regression is associated 
with a significant decrease in P4 synthesis, and the later structural regression is associated 
with luteal cells programmed death (Stocco et al., 2007). Regression of previous cycle CL 
occurs during proestrus (Gaytán et al., 2000). Notch components were identified in CL 
vasculature (Vorontchikhina et al., 2005) and, more recently, shown to play a regulatory 
role in CL capillary network establishment (Fraser et al., 2012; García-Pascual et al., 
2013). Notch1, Notch4 and Dll4 were also identified in luteal cells during pregnancy in the 
rat (Hernandez et al., 2011). 
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Figure 40 – Detection of Notch pathway effectors during corpus luteum development. 
 
Positive staining in brown, counterstaining with haematoxylin (100x magnification – A-T; bottom-right 
corner windows show nuclear detection at 1,000x magnification – A-P). Negative controls were 
performed with the polyclonal rabbit IgG (A-D). Scale bar –50 µm. 
Detection of Notch effector proteins in the nucleus was considered indicative of Notch signaling 
activation. Hes1 and Hes5 are detected in luteal cells at all EC stages (E-H and M-P, respectively). 
Hes2 is only detected in luteal cells during diestrus (I-L). PCNA staining was used to confirm CL stage 




We identified active Notch signaling in luteal cells during CL development. To the best 
knowledge of authors the nuclear detection of Notch effectors in luteal cells is novel. As 
observed in other tissues, Notch signaling is potentially regulating the cellular remodeling 
associated with CL development and steroidogenesis. The main changes observed in 
expression patterns of Notch components in the CL are coincidental with P4 peaking and 
CL regression. Notch2, Dll1, Hes1 and Hes2 expression are associated with CL increasing 
steroidogenesis, whereas Notch3, Dll4, Jagged1 and Hes5 are associated with CL 
regression.  
In conclusion, Notch signaling is active during follicle and CL development along the mouse 
EC. Notch component and effector genes are dynamically and differentially expressed in the 
ovary along the EC. The spatial and temporal relationship between expression patterns and 
key cellular events, prompt for a major regulatory role of Notch signaling in follicle and CL 
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1. Abstract  
The oviduct and uterus undergo extensive cellular remodeling along the EC, to establish 
receptivity for developing embryos. The molecular regulatory mechanisms behind these 
dynamic cellular events, involving extensive cell-to-cell signaling, are poorly understood. 
Notch is an evolutionarily conserved cell signaling pathway implicated in cell fate decisions in 
several tissues. Here, we evaluated the transcription and expression patterns of Notch 
component and effector genes in the mouse oviduct and uterus along the EC. 
Mature CD1 female mice were euthanized at each of the four EC stages. One oviduct and 
the uterus were processed for IHC and the expression patterns of Notch components 
(Notch1-3, Jagged1 and Dll1 and Dll4), and effectors (Hes1, Hes2 and Hes5) were 
evaluated. The other oviduct was processed for RNA extraction and RT-PCR analysis. 
All Notch component and effector genes are transcribed in the oviduct. Transcription levels of 
Notch components and effectors in the oviduct increase from the proliferative to the secretory 
phase of the EC, and transcription patterns are associated with plasma P4 concentrations 
along the EC. Notch components (except Dll1), and effectors are expressed in the oviduct, 
uterine luminal and glandular epithelia. Each component/effector shows a specific expression 
pattern. Uterine luminal and glandular epithelia show a unique combination of Notch 
receptors/ligands/effectors expression along the EC. Nuclear detection of Notch effectors 
indicates that Notch signaling is active. These results prompt for a regulatory role of Notch 











During the EC, the oviduct and uterus undergo extensive cellular remodeling, to allow 
fertilization and development of embryos. In humans and mice, cyclic cellular proliferation, 
apoptosis and differentiation, extracellular matrix turnover, angiogenesis and leukocyte 
infiltration, are regulated by ovarian steroids estradiol and P4. The mouse EC lasts 4–5 days 
and encompasses four stages (proestrus, estrus, metestrus, and diestrus). Circulating 
concentrations of E2 peak prior to ovulation, which occurs at estrus, whereas P4 
concentrations rise during metestrus and diestrus, and then decline from proestrus to estrus 
(Wood et al., 2007).  
The molecular regulatory mechanisms behind oviduct and uterus’ cellular remodeling along 
the EC are poorly understood. Deciphering these mechanisms could potentially lead to the 
development of new therapeutic strategies addressed to infertility and contraception. Notch is 
an evolutionarily conserved cell signaling pathway implicated in cell fate decisions in several 
tissues (Artavanis-Tsakonas et al., 1995)(Borggrefe & Oswald, 2009). In mammals, four 
receptors (Notch1-4) and five ligands (three delta-like - Dll1, Dll3 and Dll4 - and two serrate-
like - Jagged1 and Jagged2) were identified (Borggrefe & Oswald, 2009). Notch signaling is 
activated by binding of the extracellular domain of receptors with ligands expressed on 
neighboring cells. This leads to cleavage of Notch intracellular domain by a γ-secretase and 
its translocation to the nucleus, where it associates with other transcriptional factors, thus 
regulating transcription of Notch effector target genes (Borggrefe & Oswald, 2009). Only a 
limited set of Notch effector genes were identified, being the hairy/enhancer of split genes 
the most ubiquitous (Fischer & Gessler, 2007). 
Notch components were detected in the mammalian uterus (Cobellis et al., 2008; Mazella et 
al., 2008; Mikhailik et al., 2009; Afshar, et al., 2012a; Afshar, et al., 2012b; Degaki et al., 
2012) and Notch1 was reported as a relevant regulator of uterine function (Afshar, et al., 
2012a; Afshar, et al., 2012b). However, the potential involvement of Notch signaling in the 
regulation of cyclic oviduct and uterine cellular changes occurring along the EC is unknown. 
Our main hypothesis is that Notch signaling is a major regulator of oviduct and uterine 
epithelial cyclic changes. As a first approach to test this hypothesis, we evaluated the 
transcription and expression patterns of Notch component and effector genes in the oviduct 
and uterus of mice along the EC. Results indicate that Notch signaling is active, and prompt 







3. Materials and Methods 
3.1. Animals 
Experiments were conducted in compliance with the Portuguese legislation for the use of 
animals for experimental purposes (Decreto-Lei nº 129/92 and Portaria nº 1005/92, DR nº 
245, série I-B, 4930-42) and with the European Union legislation (Directive n. 86/609/EEC, 
from the 24th November 1986). Experimental protocols were approved by the national 
regulatory agency (DGAV – Direção Geral de Alimentação e Veterinária) and the Institutional 
Animal Care and Use Committee (CEBEA – Comissão de Ética e Bem-Estar Animal). All 
authors are accredited as FELASA category C scientists or equivalent. 
CD1 female mice with 3 months of age were maintained in a 12-hour light/dark cycle, in 
ventilated cages with corn cob as bedding, and were given access to standard laboratory diet 
and water ad libitum. The mice health was routinely monitored. Blood samples (1 mL) were 
collected by intracardiac puncture under ketamine (15mg/kg)/xylazine (1mg/kg) anesthesia, 
just before euthanasia through cervical dislocation followed by exsanguination.  
 
3.2. Experimental Design 
Female EC was monitored by cytological evaluation of vaginal smears. Females were 
euthanized at each of the EC stages (proestrus, estrus, metestrus, diestrus) and one oviduct 
and the uterus collected and processed for IHC. Paraffin embedded sections were stained 
with haematoxylin, and the EC stage confirmed by histological analysis (Wood et al., 2007). 
The other oviduct was processed for RNA extraction and RT-PCR analysis. Blood samples 
were processed for measurement of plasma P4 concentrations by a chemiluminescence 
assay. Only mice undergoing normal estrous cycles, with expected vaginal cytology, uterus 
histology and P4 concentrations for each EC stage, were included in the study. Overall, 20 
female mice (5 per each EC stage) were used. 
 
3.3. Immunohistochemistry 
Oviduct and uterus samples were fixed in 4% neutral phosphate buffered formalin at room 
temperature for 24 hours and, after subsequent dehydration in ethanol, tissues were 
embedded in paraffin. Spatial localization of expression of Notch pathway components 
(Notch1, Notch2, Notch3, Dll1, Dll4, Jagged1) and effectors (Hes1, Hes2 and Hes5) was 
evaluated through IHC, as previously described (Silva et al., 2010). The antigen retrieval step 
was performed in citrate buffer (10mM, pH 6.0), except for the anti-Notch1, anti-Hes1, anti-
Hes2 and anti-Hes5 antibodies (Tris-EDTA, pH 9.0). Blocking was performed in PBS with 2% 
w/v bovine serum albumin (A7906, Sigma-Aldrich, Inc.) for one hour at room temperature. 
Sequential sections of 3 µm were incubated with primary antibodies for Notch1 (ab27526, 
Abcam, diluted 1:100), Notch2 (ab8926, Abcam, diluted 1:100), Notch3 (ab23426, Abcam, 
diluted 1:160), Dll1 (ab10554, Abcam, diluted 1:100), Dll4 (ab7280; Abcam, diluted 1:200), 
Jagged1 (SC-8303, Santacruz Biotechnology, diluted 1:50), Hes1 (ab71559, Abcam, diluted 
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1:100), Hes2 (ab134685, Abcam, diluted 1:100) and Hes5 (ab25374, Abcam, diluted 1:200) 
overnight at 4ºC. The negative controls were performed with the polyclonal rabbit IgG 
(ab27478, abcam, diluted 1:100), incubated overnight at 4ºC. All primary antibodies were 
diluted in blocking solution. The peroxidase conjugated goat anti-rabbit IgG polyclonal 
antibody (Dako 410972, diluted 1:100) was used as secondary antibody. Counterstaining 
was done with haematoxylin. Staining was evaluated in the entire slice.  
The antibodies against Notch components and effectors were previously validated by others 
in the mouse (anti-Notch1(Cheng et al., 2007), anti-Notch3 (Feng et al., 2010), anti-Dll1, 
(Sörensen et al., 2009) anti-Dll4, (Sörensen et al., 2009), anti-Jagged1 (Bielesz et al., 2010), 
anti-Hes1 (Rahman et al., 2013) and anti-Hes5 (Takanaga et al., 2009)) and rat species 
(anti-Notch2 (Saravanamuthu et al., 2009)), but predicted to work in mouse. According to the 
manufacturer the anti-Hes2 antibody reacts with mouse. 
 
3.4. Quantitative Gene Transcription Analysis (qRT-PCR). 
Oviducts were immediately frozen in liquid nitrogen and stored at −80 ºC. RNA extraction, 
cDNA synthesis and mRNA transcription was performed as previously described (Silva et al., 
2012). Quantification of Notch1, Notch2, Notch3, Dll1, Dll4, Jagged1, Hes1, Hes2, Hes5 and 
Nrarp transcripts was done using selected primers (pair sequences are available in Annex I). 
Transcription of gene RPS29 was used as an endogenous control. Real-time PCR was 
performed in duplicate wells on StepOnePlus™ (Applied Biosystems, Foster City, CA, USA). 
All PCR reactions were carried out in 96-well optical reaction plates (Applied 
Biosystems,Warrington, UK) with 6.25µl of Power SYBR® Green PCR Master Mix (Applied 
Biosystems, Warrington, UK), 2.5ng of diluted cDNA, 80 nM of each primer in a total reaction 
volume of 12µl. Relative transcription levels were obtained for each animal and for each 
gene, comparing transcription levels at each EC stage with proestrus stage mean. Mean 
transcription levels were then calculated for each gene at each EC stage. 
 
3.5. Progesterone Assay 
Blood samples (1 mL) were collected by cardiac puncture just prior cervical dislocation, into 
heparin containing eppendorfs, centrifuged and plasma stored at -20ºC until assay. Plasma 
P4 concentrations were measured, without extraction, by a solid-phase, competitive 
chemiluminescent enzyme immunoassay (Immulite 1000, Siemens Healthcare Diagnostics, 
Lda., Amadora, Portugal), using a commercial kit (Immulite 1000 Progesterone kit, Siemens). 
The inter-assay coefficients of variation were 9,7, 9.2% and 6.9% for three different controls 
used in the assay (for concentrations of 1.8, 3.4 and 15.3 ngmL−1, respectively; Multivalent 
Control Module, Siemens Healthcare Diagnostics). The intra-assay coefficient of variation 
was 5.5%. Mean plasma P4 concentrations were (mean ± SD; ng/mL) 5.4 ± 0.6, 3.9 ± 0.6, 





3.6. Statistical Analysis 
Data analysis was performed with the SPSS version 19.0 statistic software. Linear 
associations between gene transcription levels in the oviduct and plasma P4 concentrations 
were analyzed through Pearson’s correlation coefficient. Significance was determined at the 
5% confidence level (p< 0.05). 
 
4. Results 
4.1. Notch pathway component and effector genes are differentially transcribed in 
the oviduct along the estrous cycle 
Figure 41 shows the association between oviduct gene transcription and plasma P4 profiles 
along the EC. To ease interpretation, each graph illustrates a duplication of the EC. As 
shown, Notch receptors and ligands Dll4 and Jagged1 genes (A-C and E-F, respectively) 
increase transcription along the EC, from the proliferative to the secretory phases of the EC, 
following the pattern of plasma P4 concentrations. Ligand gene Dll1 has low transcription 
levels along the EC, although shows a mild increase in transcription during metestrus (D). 
Transcription of Notch effector genes Hes1, Hes5 and Nrarp (G, I and J, respectively) also 
increase along the EC, following the pattern of plasma P4 concentrations, although 
transcription of Hes5 peak in metestrus.  
 
4.2. Oviduct gene transcription of Notch pathway components and effectors are 
correlated, and correlate with plasma P4 concentrations along the EC 
Table 2 shows results of the Pearson’s correlation coefficient analysis between transcription 
levels of Notch components and effectors, and plasma P4 concentrations. As shown 
significant correlations are observed between transcription levels of Notch receptors, ligands 





Figure 41 – Association between plasma P4 concentrations and transcription levels of 
Notch pathway component and effector genes in the oviduct along the estrous cycle. 
 
Transcription of each gene in each EC stage is compared with mean proestrus transcription. RPS29 
gene was used as endogenous control. Error bars represent the standard error of the mean (SEM).  
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Table 2 – Pearson’s correlation coefficient analysis between transcription levels of 
Notch pathway component and effector genes, and estrous cycle stage and plasma P4 
concentrations.  
 
Significant associations in grey. Jag1 – Jagged1; r – Pearson’s correlation coefficient; EC – estrous 
cycle; * p< 0.05; ** p< 0.01; 
 
4.3. Notch pathway component and effector genes are differentially expressed in 
oviduct epithelial cells along the estrous cycle 
Figure 42 shows the expression patterns of Notch components in oviduct (isthmus and 
ampulla) epithelial cells along the EC. Below follows a description of most notorious features. 
Notch1 is expressed in the ampulla along the EC (A, M, a, m); in the isthmus is expressed in 
the epithelium cripts, and is not expressed in metestrus (G, S, g, s). Notch2 and Notch3 are 
expressed in the ampulla and isthmus along the EC (B, H, N, T, b, h, n, t and C, I, O, U, c, i, 
o, u, respectively); expression of Notch2 is increased during metestrus and diestrus (b, h, n, 





Notch1 Nocth2 Notch3 Dll1 Dll4 Jag1 Hes1 Hes2 Hes5 Nrarp
r 1,00 ,625
* -0,10 0,23 0,12 0,06 0,31 ,457
* 0,19 0,06 -0,06 0,13
p 0,02 0,68 0,36 0,62 0,81 0,20 0,05 0,43 0,82 0,82 0,60
r ,625
* 1,00 0,38 ,669
**
0,51
* 0,30 0,24 ,575
*
,552
* -0,38 0,36 0,39
p 0,02 0,16 0,01 0,05 0,29 0,38 0,02 0,03 0,17 0,19 0,17
r -0,10 0,38 1,00 ,749
**
,847
































p 0,62 0,05 0,00 0,00 0,30 0,75 0,02 0,00 0,76 0,00 0,00
r 0,06 0,30 0,18 0,19 0,25 1,00 -0,09 0,09 0,03 -0,27 ,599
** 0,22
p 0,81 0,29 0,46 0,44 0,30 0,70 0,70 0,90 0,26 0,01 0,37
r 0,31 0,24 -0,30 -0,04 -0,08 -0,09 1,00 0,34 0,12 0,04 -0,26 0,04










* 0,09 0,34 1,00 ,648
** 0,29 0,39 ,534
*








** 0,03 0,12 ,648




p 0,43 0,03 0,00 0,00 0,00 0,90 0,62 0,00 0,23 0,02 0,00
r 0,06 -0,38 0,06 0,21 0,07 -0,27 0,04 0,29 0,29 1,00 -0,22 0,34
p 0,82 0,17 0,81 0,40 0,76 0,26 0,89 0,23 0,23 0,36 0,17







** -0,26 0,39 ,501
* -0,22 1,00 ,473
*
p 0,82 0,19 0,00 0,01 0,00 0,01 0,28 0,09 0,02 0,36 0,04



























Figure 42 – Notch pathway component genes are differentially expressed in the 
oviduct epithelium along the estrous cycle. 
   
(Legend in the next page) 
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(Figure 42 – Legend) Positive staining in brown, counterstaining with haematoxylin (400x 
magnification). Expression is analyzed in two oviduct segments: ampulla and isthmus. Arrows indicate 
ampulla secretory cells. Scale bar –50 µm. Notch1 is expressed in the ampulla along the EC (A, M, a, 
m), and in the isthmus epithelium of the cripts, except at metestrus (G, S, g, s). Notch2 is expressed 
along the entire oviduct and EC (B, H, N, T, b, h, n, t), although expression is increased during 
metestrus and diestrus (b, h, n, t). Notch3 follows a similar expression pattern to Notch2 (C, I, O, U, c, 
I, o, u). Dll1 is not expressed in the oviduct epithelium (D, J, P, V, d, j, p, v). Dll4 is expressed along 
the EC, although with low expression during estrus (E, K, Q, W, e, k, q, w). Jagged1 is not expressed 
during proestrus, and expression increases along the EC (F, L, R, X, f, l, r, x) 
 
Dll1 is not expressed in the oviduct (D, J, P, V, d, j, p, v). Dll4 has low expression during 
estrus, and increases expression, mainly in ampulla secretory cells during metestrus and 
diestrus (E, K, Q, W, e, k, q, w). Jagged1 is not expressed during proestrus, and increases 
expression along the EC (F, L, R, X, f, I ,r, x). 
Figure 43 shows the detection of Notch effectors in the oviduct along the EC. Hes1 and Hes5 
are detected in the oviduct along the EC (B, F, J, N, b, f, j, n, and D, H, L, P, d, h, l, p, 
respectively), whereas Hes2 is only detected during estrus and diestrus (C, G, K, O, c, g, k, 
o). Nuclear detection of Notch effectors indicates that Notch signaling is active in the oviduct 
epithelium. 
 
4.4. Notch pathway component and effector genes are differentially expressed in 
uterus luminal and glandular epithelial cells along the estrous cycle 
Figure 44 shows the expression patterns of Notch components in the uterus epithelium 
(luminal and glandular) along the EC. Below follows a description of most notorious features. 
In the luminal epithelium, Notch1 is expressed at proestrus and diestrus (A, G, M, S), Notch2 
and Notch3 are expressed throughout the EC (B, H, N, T and C, I, O, U, respectively), Dll1 is 
expressed during proestrus and diestrus (D, J, P, V), Dll4 is expressed throughout the EC (E, 
K, Q, W), and Jagged1 is not expressed during estrus (F, L, R, X). 
In the glandular epithelium, Notch1 has a low expression during proestrus and estrus and is 
not expressed during metestrus and diestrus (a, g, m, s); Notch2 is expressed along the EC 
(b, h, n, t), whereas Notch3 is not expressed during estrus (c, i, o, u); Dll1 is only expressed 
during proestrus (d, j, p, v), Dll4 is expressed throughout the EC (e, k, q, w), and Jagged1 is 




Figure 43 – Detection of Notch pathway effectors in the oviduct epithelium along the 
estrous cycle. 
 
(Legend in the next page) 
99 
 
(Figure 43 – Legend) Positive staining in brown, counterstaining with haematoxylin (400x 
magnification; bottom-left windows show nuclear detection at 1,000x magnification). Only nuclear 
detection of Notch effectors is indicative of active Notch signaling. Expression is analyzed in two 
oviduct segments: ampulla and isthmus. Arrows indicate ampulla secretory cells. Scale bar – 50 µm. 
Negative controls were performed with the polyclonal rabbit IgG (A, E, I, M, a, e, i, m). Hes1 is 
detected along the EC, showing increased detection during metestrus (B, F, J, N, b, f, j, n). Hes2 is 
only detected during estrus and diestrus, in the ampulla and in the isthmus cripts (C, G, K, O, c, g, k, 
o). Hes5 is detected along the EC but decrease expression during estrus (D, H, L, P, d, h, l, p). 
 
Figure 45 shows the detection of Notch effectors in uterus luminal and glandular epithelia 
along the EC. In the luminal epithelium, Hes1 and Hes5 are detected throughout the EC; 
however, during proestrus and diestrus Hes1 has a low detection (B, F, J, N), and Hes5 is 
only detected in the nucleus of epithelial cells during proestrus (D, H, L, P); Hes2 is not 
detected in the uterus luminal epithelium during the EC (C, G, K, O). 
In the glandular epithelium, Hes1 and Hes5 are detected along the EC. As in the luminal 
epithelium, Hes1 has a low detection during diestrus (b, f, j, n), and Hes5 is only 
unequivocally detected in the nucleus of epithelial cells during proestrus, (d, h, l, p); Hes2 is 
only detected during diestrus (c, g, k, o). 
As observed in the oviduct, nuclear detection of Notch effector genes indicates that Notch 
signaling is also active in the uterus luminal and glandular epithelia. 
 
4.5. Uterine luminal and glandular epithelia show unique combinations of Notch 
receptor/ligand/effector expression along the estrous cycle 
This information is summarized in Table 3. As can be depicted, uterus luminal and glandular 
epithelial Notch receptor/ligand/effector expression combinations are specific of each stage 
of the EC. 
 
4.6. Notch pathway component and effector genes are expressed in uterus stroma 
cells along the estrous cycle, and Notch2 and Notch3 are expressed in endometrial 
neutrophils at metestrus 
Figure 46 shows the expression patterns of Notch pathway component and effector genes in 
uterus stroma cells along the EC. As shown, all Notch components are expressed in stroma 
cells along the EC (B-G). Notch 2 and Notch3 are specifically expressed in endometrium 
neutrophils during metestrus (C and D). Notch effectors Hes1 and Hes5 are detected in the 
stroma cells along the EC (H and J), whereas Hes2 is not detected in the stroma (I). Again, 




Figure 44 – Notch pathway component genes are differentially expressed in uterus 
luminal and glandular epithelia along the estrous cycle. 
 
(Legend in the next page) 
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(Figure 44 – Legend) Positive staining in brown, counterstaining with haematoxylin (400x 
magnification). Expression is evaluated in luminal (A-X) and glandular (a-x) epithelia. Scale bar – 50 
µm. Luminal epithelium: Notch1 is expressed during proestrus (A) and diestrus (S), but not during 
estrus (G) and metestrus (M). Notch2 is expressed along the EC (B, H, N, T). Notch3 is expressed 
along the EC (C, I, O, U), but with weak expression during estrus (I). Dll1 is not expressed during 
estrus (J) and metestrus (P), and has a weak expression during proestrus (D) and diestrus (V). Dll4 is 
expressed along the EC (E, K, Q, W). Jagged1 is expressed during proestrus (F), metestrus (R), and 
diestrus (X), but not during estrus (L). 
Glandular epithelium: Notch1 shows low expression during proestrus (a) and estrus (g) and is not 
expressed during metestrus (m) and diestrus (s). Notch2 is expressed along the EC (d, h, n, t). Notch3 
is expressed during proestrus (c), metestrus (o), and diestrus (u), but not during estrus (i). Dll1 shows 
a very weak expression during proestrus (d) and is not expressed during the remaining EC stages (j, 
p, v). Dll4 is expressed along the EC (e, k, q, w). Jagged1 is expressed during proestrus (f), metestrus 
(r) and diestrus (x) but not during estrus (l). 
 
5. Discussion 
Here is described for the first time the transcription and dynamic expression patterns of 
Notch pathway component and effector genes in oviduct and uterus epithelia, and uterus 
stroma, along the mouse EC. Although some Notch components were identified in the 
human (Cobellis et al., 2008; Mazella et al., 2008; Mikhailik et al., 2009; Afshar, et al., 2012b) 
and mouse (Afshar, et al., 2012a; Degaki et al., 2012) uterus, this study is the first to provide 
an integrated spatial and temporal characterization of epithelial Notch signaling in the oviduct 
and uterus. 
Oviduct luminal ciliated and secretory epithelial cells undergo cyclic changes during the EC 
(Myoungkun & Bridges, 2011). These epithelial changes require a finely tuned cell 
signaling and a well-orchestrated gene expression. Notch cell signaling pathway is a major 
regulator of cell fate decisions in several tissues (Artavanis-Tsakonas et al., 1995; 
Borggrefe & Oswald, 2009). Notch pathway component and effector genes are 
differentially transcribed and expressed in the oviduct along the EC, and nuclear detection 
of Notch effectors indicates that Notch signaling is active in the oviduct epithelium. This 
prompts for a regulatory role of Notch signaling in oviduct epithelial function. 
As expected EC stage is significantly correlated with plasma P4 concentrations. Notch 
component and effector genes (except Hes2) increase oviduct transcription levels from the 
proliferative (proestrus and estrus) to the secretory (metestrus and diestrus) stage of the 
EC, following the profile of plasma P4 concentrations. Significant positive correlations are 
observed between EC stage and Notch2, Notch3, Jagged1 and Hes1 oviduct transcription 
levels, and Jagged1 oviduct transcription levels are significantly correlated with plasma P4 




Figure 45 – Detection of Notch effectors in uterus luminal and glandular epithelia 
along the estrous cycle. 
 
(Figure legend in the next page) 
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(Figure 45 – Legend) Positive staining in brown, counterstaining with haematoxylin (400x 
magnification; bottom-left windows show nuclear detection at 1,000x magnification). Only nuclear 
detection of Notch effectors is indicative of active Notch signaling. Expression is evaluated in luminal 
and glandular epithelia. Negative controls were performed with the polyclonal rabbit IgG (A, E, I, M, a, 
e, i, m). Scale bar – 50 µm.  
Luminal epithelium: Hes1 is detected during proestrus, estrus and metestrus (B, F, J), and has low 
detection during diestrus (N). Hes2 is not detected during the whole EC (C, G, K, O). Hes5 is only 
detected during proestrus (D, H, L, P).  
Glandular epithelium: Hes1 is detected along the EC (b, f, j, n), but has a low detection during diestrus 
(n). Hes2 is only detected during diestrus (c, g, k, o). Hes5 is detected during proestrus, metestrus and 
diestrus, although nuclear detection only occurs during proestrus (d, h, l, p).  
 
Table 3 – Estrous cycle stage specific expression combinations of Notch pathway 
component and effector genes in uterus luminal and glandular epithelia. 
  
N1 – Notch1, N2 – Notch2, N3 – Notch3, D1 - Dll1, D4 – Dll4, J1 – Jagged1, H1 – Hes1, H2 – Hes2, 
H5 – Hes5. 
 
Transcription levels of the three receptors (Notch1-3) and of three effectors (Hes1, Hes5 
and Nrarp) are significantly correlated with those of Jagged1, which implies Jagged1 as the 
main Notch pathway ligand in the oviduct. Additionally, significant correlations between 
transcription levels of Notch components (both receptors and ligands) and Hes genes, 
indicates that Hes transcription is a direct result of Notch pathway activation. 
These transcription results are in accordance with expression patterns evidenced by IHC 
analysis. Notch2, Notch3 and Dll4 show increased expression after ovulation. Differential 
transcription and expression of Notch components and effectors is not only temporal, but 
also spatial. Notch3, Dll4, Jagged1, Hes1 and Hes5 are specifically expressed in oviduct 
ampulla secretory cells, although in different combinations along the EC stages. This result 
leads to the suggestion that Notch signaling is regulating oviduct secretory function along 
Proteins Proestrus Estrus Metestrus Diestrus
Receptors N1/N2/N3 N2/N3 N2/N3 N1/N2/N3
Ligands D1/D4/J1 D4 D4/J1 D1/D4/J1
Effectors H1/H5 H1 H1 H1
Receptors N1/N2/N3 N1/N2 N2/N3 N2/N3
Ligands D1/D4/J1 D4 D4/J1 D4/J1









the EC. Notch1 and Hes2 are specifically expressed in oviduct isthmus crypts, mainly 
during estrus and diestrus, which may be related with the regulation of cellular turnover 
along the EC. 
 
Figure 46 – Notch pathway components and effectors are present in uterus stroma 
cells. 
 
Positive staining in brown, counterstaining with haematoxylin (400x magnification). Only nuclear 
detection of Notch effectors is indicative of active Notch signaling. Negative controls were performed 
with the polyclonal rabbit IgG, metestrus image (A). Arrow heads indicate stroma cells. Arrows 
indicate neutrophils. Scale bar –50 µm. 
Notch1 is expressed during diestrus (B). Notch2 and Notch3 are expressed in stroma cells and 
neutrophils during metestrus (C and D, respectively). Dll1 and Dll4 are expressed during diestrus (E 
and F, respectively). Jagged1 is expressed during estrus (G). Hes1 and Hes5 are detected during 
estrus (H and J, respectively). Hes2 is not detected, estrus image (I).   
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Endometrium undergoes extensive cellular remodeling along the EC, in response to 
circulating concentrations of E2 and P4. In the mouse, changes that define transition from 
one stage to the other occur over a 24 hour period, which denotes a rapid cellular 
response to hormonal fluctuations (Hewitt et al., 2003). The Notch pathway component and 
effector genes are differentially expressed in uterus luminal and glandular epithelia along 
the EC. Unique expression combinations of receptor/ligand/effector genes are observed in 
the luminal and glandular epithelia at each EC stage. It is plausible that these specific 
expression combinations of Notch receptor/ligand/effector genes are related to definition of 
cellular events occurring at each EC stage, as Notch signaling results from the specific 
activation of Notch receptors (Shimizu et al., 2002; Yuan et al., 2012). 
Uterine stroma cellular dynamics along the EC is modulated by ovarian steroids (Wood et 
al., 2007). Notch pathway component and effector genes (except Hes2), are expressed in 
stroma cells along the EC. As suggested for uterine luminal and glandular epithelial cells, 
Notch signaling may be involved in the regulation of cellular changes, through signaling 
between epithelial and stroma cells. Metestrus migration of neutrophils into the luminal 
epithelium is well documented (Corbeil et al., 1985). Metestrus uterine stroma neutrophils 
express Notch2 and Notch3 receptors. Notch signaling has recently been implicated in 
immune response (Degaki et al., 2012; Ito, Connett, Kunkel, & Matsukawa, 2012; Radtke, 
Macdonald, & Tacchini-Cottier, 2013). Results here described also associate Notch 
signaling to immunity cells and potentially to endometrial immunity function.  
In conclusion, Notch pathway component and effector genes are differentially transcribed 
and expressed in the mouse oviduct and uterus along the EC. In the oviduct, Notch 
component and effector genes are transcribed following the pattern of plasma P4 
concentrations along the EC, indicating a P4 regulation of Notch signaling. Notch oviduct 
and uterus dynamic expression patterns are spatially and temporally specific, resulting in 
unique expression combinations of Notch receptor/ligand/effector genes in oviduct luminal 
epithelium, uterus luminal and glandular epithelia and endometrium stroma cells, at each 
EC stage. Nuclear detection of Notch effectors indicates that Notch signaling is active. 
Altogether, these results prompt for a regulatory role of Notch signaling in oviduct and 










GENERAL DISCUSSION AND CONCLUSIONS 
 
 
The objective of the experimental work included in this thesis was the evaluation of Notch 
pathway involvement in male and female reproductive function. Chapters I and II considered 
the evaluation of the transcription and expression patterns of Notch pathway components 
and effectors in male reproductive tract (testis and epididymis), and their relationship with 
key cellular remodeling events occurring along pn testis development and along the adult 
spermatogenic cycle and epididymal transit of spermatozoa. Chapter III evaluated in vivo 
blockade of Notch signaling in male reproductive function. Chapters IV and V considered the 
evaluation of the transcription and expression patterns of Notch pathway components and 
effectors in female reproductive tract (ovary, oviduct and uterus), and their relationship with 
key cellular remodeling events occurring along the EC. 
Results here presented in the first two chapters indicate that Notch pathway is associated 
with major cellular remodeling events occurring in the testis during spermatogenesis and in 
the epididymis during transit of spermatozoa. Results presented in the third chapter indicate 
that Notch blockade induces abnormal spermatogenesis and epididymis function. Overall, 
these results prompt for a major regulatory role of Notch in testis pn development, 
spermatogenesis and spermatozoa maturation.  
Figure 47 summarizes the Notch pathway components detection and the proposed role of 
Notch signaling during testis pn development. As shown, we suggest that Notch is regulating 
spermatogonia quiescence and spermatogenesis onset, through an epithelial canonical 
pathway (Artavanis-Tsakonas et al., 1995; Borggrefe & Oswald, 2009). Notch pathway 
components were previously detected during testis pn development (Dirami et al., 2001; 
Hasegawa et al., 2011). However, results presented in Chapter I constitute the first 
integrated evaluation of the spatial and temporal presence of Notch components and 
effectors during testis pn development and along the adult spermatogenesis. Our proposed 
role of Notch signaling in the regulation of early pn spermatogonia quiescence is in 
accordance with recent data published by others (Garcia et al., 2013; Garcia & Hofmann, 
2013). A role for Notch signaling at the onset of meiosis was previously reported in C. 





Figure 47 – Proposed role of Notch signaling during testis post-natal development and 
onset of spermatogenesis.  
 
The main Notch components participating in each role are represented in shapes and colors according 
to legend. pn – post-natal; St – Sertoli cell; Sp – spermatogonia; P – preleptotene spermatocyte. 
 
Notch pathway component and effector genes show specific expression patterns during the 
spermatogenic cycle in adult spermatogenesis. Although the presence of Notch pathway 
components in male germ cells was previously reported, the so far available information is 
very fragmentary and controversial (Hayashi et al., 2001; Mori, et al., 2003; Hayashi, et al., 
2004b; von Schönfeldt, et al., 2004; Sahin et al., 2005; Hahn et al., 2009; Hasegawa et al., 
2011; Garcia et al., 2013). Results described in Chapter I indicate that Notch signaling is 
active during spermatogenesis, and lead to the suggestion that Notch may regulate germ 
cells differentiation. This hypothesis is supported by studies associating Notch signaling with 
male infertility (Hayashi et al., 2001; Hayashi, et al., 2004b; Sahin et al., 2005; Lupien et al., 
2006; Garcia et al., 2013; Huang et al., 2013). However, the role of Notch signaling during 
spermatogenesis is controversial, as recent studies using genetically modified mice 
(Hasegawa et al., 2011; Batista et al., 2012) reported that Notch signaling was not necessary 
for spermatogenesis. Although, Notch1 loss of function in germ cells had no phenotype in 
spermatogenesis and fertility (Batista et al., 2012; Huang et al., 2013), Notch1 gain of 
function in germ cells induced spermatogenesis failure (Huang et al., 2013). This 
controversial results may be explained taking in consideration that Notch activity is dosage 
dependent (Trindade et al., 2012), and redundancy in Notch receptors may be crucial to 
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normal signaling, since paralogues exert redundant or additive functions in maintaining the 
balance (Zeng et al., 1998; Kitamoto & Hayasaka, 2005). 
Based on results presented in Chapters I and III, Figure 48 summarizes our proposed role of 
Notch signaling in the regulation of the spermatogenic cycle. Similarly to what happens in 
somitogenesis (Morimoto et al., 2005; Niwa et al., 2007), Notch pathway components may 
regulate the pace of spermatogenesis at several key points, contributing to the coordination 
and orchestration of the complex cellular remodeling events that take place along the 
spermatogenic cycle. Specific combinations of receptor/ligand expression are not only 
associated with key events occurring during the spermatogenic cycle, but also these 
combinations may be determinant for germ cells identity. Notch signaling results from the 
specific activation of Notch receptors (Shimizu et al., 2002; Yuan et al., 2012). The presence 
of different receptors within a cell-type may be relevant for cell identity and function. This 
assumption gain support from results described in Chapter III. Following DAPT treatment, the 
expression patterns of some Notch components were changed, including ectopic expression 
in other germ cell types. These changes in expression patterns, probably compensatory 
following the decrease in Notch activation, induced formation of aberrant germ cells, loss of 
germ cell identity and increased apoptosis of specific cell types.  
Analysis of specific effects on germ cell identity and morphology following DAPT treatment 
may indicate specific regulatory roles during the spermatogenic cycle. These are the cases 
of germ cell anchorage to Sertoli cells, polarity (sperm head shaping) and meiosis. The 
ectoplasmic specialization (the elongated spermatid anchoring system) maintains adherence 
between Sertoli and germ cells, and also confers cell orientation and polarity within the 
seminiferous epithelium. This structure is associated with Par complex proteins (Wong et al., 
2008), and Notch signaling was associated to cell polarity decisions in tissues involving Par 
complex proteins (Afonso & Henrique, 2006; Bultje et al., 2009). Results presented in 
Chapter III allow the association between germ cell defects observed following DAPT 
treatment and changes in Notch expression in those cellular types. Cellular defects 
originated during meiosis are also related with changes in expression patterns of Notch 
components following Notch blockade, and in accordance with recent studies associating 






Figure 48 – Proposed roles of Notch signaling in the regulation of the spermatogenic 
cycle. 
Draw-scheme representing stages (I-XII) of the mouse spermatogenic cycle. Spermatogonia (In, B); 
spermatocytes (Pl- preleptotene, L- leptotene, Z- zygotene, P- pachytene, D- diakinesis, Mi- meiotic 
division); round spermatids (1-8); elongated spermatids (9-16). Different arrows represent the main 
roles proposed for Notch signaling. The main Notch components and effectors participating in each 





Results from Chapter II and III prompt for a role of Notch signaling in spermatozoa 
maturation along the epididymis. Each epididymis segment shows a specific combination of 
expression patterns of Notch components and effectors in each cell type. Additionally, some 
Notch components were detected in spermatozoa and in the epididymis lumen, in a dynamic 
specific pattern along the epididymis. Although Notch involvement in epididymis development 
was already reported (Hayashi, et al., 2004c; Lupien et al., 2006; Hahn et al., 2009), Notch 
gene transcription and expression in the adult epididymis and the enrollment of Notch 
signaling in spermatozoa maturation is novel. In Chapter II we suggest that Notch 
components are transferred at distance, between epididymis epithelial cells and 
spermatozoa. Notch signaling at distance was recently reported in other tissues (Sheldon et 
al., 2010; Lu et al., 2013), and transfer of Notch components between different germ cell 
types was also evidenced in work described in Chapter I. Protein transfer through 
epididymosomes is a key step in spermatozoa maturation (Saez et al., 2003; Caballero et al., 
2013). We suggest that transfer of Notch components, within epididymosomes, to 
spermatozoa and the epididymis lumen may play a role in spermatozoa maturation, or later 
on, in spermatozoa interactions with oocytes and the oviduct. This proposed mechanism is 
schematically illustrated in Figure 49 
 
Figure 49 – Schematic illustration of a proposed role of Notch in epididymis function. 
 
Draw-scheme representing the epididymis epithelium and lumen. Arrows represent Notch 
components’ dynamics along the epididymis. The Notch components dynamics are represented in 
shapes and colors according to legend. 
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Notch components and effectors were detected in Sertoli cells, and their expression patterns 
were changed following DAPT treatment. The role of Notch signaling in Sertoli cells is 
controversial. Active Notch signaling in Sertoli cells was previously reported, although it was 
considered unessential to spermatogenesis (Hasegawa et al., 2011). This was not 
corroborated by results recently reported by (Garcia et al., 2013; Garcia & Hofmann, 2013). 
Results described in this thesis are in alignment with these latter studies. Notch signaling 
was also detected in Leydig cells, and Notch expression patterns were changed following 
DAPT treatment. However, this had no effect on adult plasma testosterone concentrations. 
The presence of Notch signaling in Leydig  cells was also reported by others (Sahin et al., 
2005), and the potential role of Notch in the regulation of Leydig cell population during 
embryonic and post-natal development suggested (Tang et al., 2008; DeFalco et al., 2013). 
Still, the Notch involvement in adult Leydig cells function is unknown.  
Results of Chapter IV established the Notch component and effector gene expression 
patterns in the ovary, and related them with cellular remodeling events associated with 
follicle and CL development. Results prompt for a role of Notch signaling in follicle pool 
maintenance, follicle recruitment and development. Figure 50 schematically illustrates the 
proposed role of Notch signaling in the above ovarian cellular events.  
 
Figure 50 – Proposed role of Notch signaling in the regulation of follicle and corpus 
luteum development. 
 
Draw-scheme representing the ovarian follicles and corpus luteum. The main Notch components and 
effectors participating in each role are represented in shapes and colors according to legend. 
 
Notch components and effectors had already been identified in follicles and the CL (Johnson 
et al., 2001; Trombly et al., 2009; Zhang et al., 2011; Jovanovic et al., 2013).  However, 
results described in this thesis are the first to provide an integrated (spatial and temporal) 
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assessment of Notch components and effectors along the EC, and the first to identify and 
characterize Dll1 and Dll4 expression in follicle development. The association between Notch 
signaling and follicle growth was also recently reported by others (Trombly et al., 2009; 
Zhang et al., 2011; Xu & Gridley, 2013).  
Notch components and effectors were identified in luteal, theca and capillary cells within the 
CL. Expression patterns change along with CL development and regression. Notch signaling 
was already associated to CL function through the regulation of neo-angiogenesis within the 
CL (Fraser et al., 2012; García-Pascual et al., 2013). Results here presented also prompt for 
a direct regulation of luteal cells function, as also suggested by others (Hernandez et al., 
2011). 
Notch component and effector genes are differentially transcribed and expressed along the 
oviduct segments. The presence of Notch signaling in the oviduct epithelium is novel. The 
patterns of expression here described lead us to propose a role for Notch signaling in oviduct 
epithelial cells along the EC, which is schematically illustrated in Figure 51. 
 
Figure 51 – Proposed role for Notch signaling in the oviduct epithelium. 
 
(Legend in the next page) 
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(Figure 51 – Legend) Draw-scheme representing two portions (ampulla and isthmus) of the oviduct 
epithelium. The main Notch components and effectors participating in each role are represented in 
shapes and colors according to legend. 
 
Data regarding Notch presence in the uterus are scarce and incomplete (Cobellis et al., 
2008; Mazella et al., 2008; Afshar, et al., 2012a; Afshar, et al., 2012b). Results described in 
Chapter V, show that Notch component and effector genes are dynamically and specifically 
expressed in the uterus luminal and glandular epithelium along the EC. This prompts for a 
major role of Notch signaling in the regulation of uterus epithelial cells identity, fate and 
function. This regulation is associated to cellular remodeling events occurring along the EC, 
to prepare the uterus for embryo implantation. Notch enrolment in embryo implantation was 
already reported (Afshar, et al., 2012a; Afshar, et al., 2012b). As in this thesis, expression of 
Notch components have been described in uterus stroma cells (Cobellis et al., 2008; Mazella 
et al., 2008; Afshar, et al., 2012a; Afshar, et al., 2012b). The proposed role of Notch signaling 
in the regulation of uterus luminal and glandular epithelia and stroma is schematically 
summarized in Figure 52. 
 
Figure 52 – Proposed role for Notch signaling in the uterus luminal and glandular 
epithelia, and stroma. 
 
Draw-scheme representing the uterus. The main Notch components and effectors participating in each 








The experimental work presented in this thesis contributed to the integrated (spatial and 
temporal) evaluation of the role of Notch signaling in male and female reproductive function. 
This area of research has gained increasing interest in the very last few years, due to an 
increasing evidence of the major regulatory role of this cell signaling pathway in key cellular 
events occurring in male and female reproductive biology. Progress on the comprehension of 
the role of Notch in mammalian reproduction has dramatically increased, however several 
controversial issues remain. Results described in this thesis prompt for a major regulatory 
role of Notch signaling in the following reproductive events: 
 Testis post-natal development (spermatogonia quiescence, onset of 
spermatogenesis); 
 Spermatogenesis (pace of the spermatogenic cycle, germ cell identity and 
fate); 
 Epididymis function (signaling between epithelium and spermatozoa); 
 Follicle development; 
 Corpus luteum development and regression;  
 Oviduct and uterus epithelia function. 
All the above events involve extensive cellular remodeling and intercellular communication. 
Notch signaling may play a pivotal role in the orchestration of these cellular events, and 





Most published studies involving genetically modified mice are targeted to Notch1 function. 
Results presented in this thesis indicate that the specific combination of Notch component 
and effector genes is critical for germ cell identity and fate. Therefore, functional evaluation of 
other Notch components through the phenotypic analysis of mutant mice is necessary. 
Mutant mice have now been produced in the host laboratory during the development of this 
work. Studies with these models, focusing mainly on ligands Dll4 and Jagged1, have already 
been started and will hopefully add novel and relevant information regarding the role of Notch 
signaling in mammalian reproductive function. Considering all available information, Notch 
pathway is a promising therapeutic target. It is expectable that additional advances in this 
field will lead to the development of new therapeutic strategies of fertility control in the male 
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ANNEX I - Primer pair sequences list 
 
 
  Primer  Sequence Gene 
Receptors 
Notch1_F 5’ ACAGTAACCCCTGCATCCAC 3’ 
Notch1 
Notch1_R 5’ GGTTGGACTCACACTCGTTG 3’ 
Notch2-F 5’ GACTGCACAGAAGACGTGGA 3’ 
Notch2 
Notch2-R 5’ GCGTAGCCCTTCAGACACTC 3’ 
Notch3_F 5’ GTGTCAATGGTGGTGTCTGC 3’ 
Notch3 
Notch3_R 5’ GCACACTCATCCACATCCAG 3’ 
Ligands 
Dll1_F 5’ GTTGTCTCCATGGCACCTG 3’ 
Dll1 
Dll1_R 5’ TGCACGGCTTATGGTGAGTA 3’ 
Dll4 – F 5’ GGAACCTTCTCACTCAACATCC 3’ 
Dll4 
Dll4 – R 5’ CTCGTCTGTTCGCCAAATCT 3’ 
Jag1_F 5’ CCAGCCAGTGAAGACCAAGT 3’ 
Jagged1 
Jag1_R 5’ CAATTCGCTGCAAATGTGTT 3’ 
Effectors 
Hes1_F 5’ GCGAAGGGCAAGAATAAATG 3’ 
Hes1 
Hes1_R 5’ TGTCTGCCTTCTCTAGCTTGG 3’ 
Hes2_F 5’ CGGATCAACGAGAGCCTAAG 3’ 
Hes2 
Hes2_R 5’ GTCTGCCTTCTCCAACTTCG 3’ 
Hes5_F 5’ GCACCAGCCCAACTCCAA 3’ 
Hes5 
Hes5_R 5’ GGCGAAGGCTTTGCTGTGT 3’ 
Nrarp_F 5’ AGTCGCTGCTGCAGAACAT 3’ 
Nrarp 
Nrarp_R 5’ AACAGCTTCACCAGCTCCAG 3’ 
Endogenous 
controls 
B2mg_F 5’ CGGTGACCCTGGTCTTTCTG 3’ 
β2mg 
B2mg_R 5’ TCAGTATGTTCGGCTTCCCATT 3’ 
HPRT1_F 5’ GTCGTGATTAGCGATGATGAACC 3’ 
HPRT1 
HPRT1_R 5’ GCAAGTCTTTCAGTCCTGTCCATAA 3’ 
RPS29_F 5’ CACGGTCTGATCCGCAAATAC 3’ 
RPS29 
RPS29_R 5’ ACTAGCATGATCGGTTCCACTTG 3’ 
 
